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Iron Imaging In Myocardial Infarction Reperfusion Injury
Abstract
Reperfusion injury is additional injury that may occur following restoration of blood flow to ischemic
tissue. A better understanding of the mechanistic process underlying reperfusion injury, and the
development of non-invasive imaging tools to assess it, are necessary to mitigate this pathologic
condition in patients suffering from a heart attack. In this thesis, I investigated the relationship between
the duration of myocardial ischemia and reperfusion injury using magnetic resonance imaging (MRI). A
fundamental principle of this investigation was the pathologic role of iron in reperfusion injury and its
contribution to the MRI signal. Since iron has moderate volume magnetic susceptibility (χ), which is
influenced in part by its redox state and ligand binding, pathologic iron accumulation can cause the tissue
to become relatively more paramagnetic than non-ischemic myocardium. A unique aspect of my work
was to map the magnetic susceptibility of ischemic myocardium using information obtained from the MRI
signal phase. Altogether, these studies showed the spatial distributions of paramagnetic shifts of the
infarcted myocardium in the acute, sub-acute and chronic phases of post-infarction injury, and to find their
association with ischemia time and extent of iron deposition.
My research is supported by a wealth of studies using in vivo and tissue explant imaging, and molecular
assays in animal models and in humans. I performed validation studies to elucidate the role of iron in
reperfusion injury using histology, immunohistochemistry, inductively coupled plasma optical emission
spectrometry (ICP-OES), and electron paramagnetic resonance (EPR) spectroscopy. Infarct iron
concentration was elevated compared to healthy (remote) myocardium in reperfused and non-reperfused
(permanently occluded) infarcts. Sources of iron came from the extracellular space including hemoglobin
byproducts and the intracellular space including the cell’s labile iron pool. Iron handling and homeostasis
at the cellular level was analyzed using real-time PCR, where mRNA analysis showed upregulation of
ferritin which acts as an iron chelator and upregulation of heme oxygenase which is an enzyme that
breaks down hemoglobin.
There are some important and novel findings to my work. To our knowledge, we were the first to detect
iron in myocardial tissue by using magnetic susceptibility as an MR imaging biomarker both in pre-clinical
and clinical studies. Experiments validating the presence of iron uncovered the dynamic wound healing
process and the temporal evolution of iron, which declined from 3-days to 8-weeks post-infarction
indicating the clearance of iron from the infarct region. It was discovered that increased ischemia
duration caused a significant increase in infarct transmurality, microvascular obstruction, and iron
content. Permanent coronary occlusion without reperfusion caused a completely transmural infarct.
Despite permanent infarcts showing a lack of T2*-weighted hypointensity, there was a paramagnetic shift
and elevated iron concentration in the permanent infarcts. This led us to further investigate sources of
iron within the infarct region and discover a significant increase in labile iron concentration, which is
expected to originate from intracellular myocytes.
While conventional cardiovascular MRI corroborates the findings of iron deposition, magnetic
susceptibility imaging showed improved detection of tissue iron deposition and mitigates confounding
factors such as edema and fibrosis. At high field strength (7 T) and high resolution, there was improved
correspondence between MR imaging and infarct pathophysiology, where regions containing sparse iron
deposition could be better detected compared to imaging at 3 T. Unlike conventional relaxation-based
measurements, magnetic susceptibility showed independence of field strength. Myocardial infarction
patients receiving reperfusion therapy showed magnetic susceptibility changes associated with
hypokinetic myocardial wall motion and microvascular obstruction, demonstrating potential for clinical
translation.

In this thesis I found that iron corresponded to a tissue paramagnetic shift. Both iron and magnetic
susceptibility varied depending on the ischemia duration and post-infarction time point. Magnetic
susceptibility showed improved specificity to iron deposition than conventional imaging approaches. Iron
oxidation state and the type of protein-bound iron likely affect the magnetic susceptibility and change
during wound healing which could be investigated in future work.
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ABSTRACT

IRON IMAGING IN MYOCARDIAL INFARCTION REPERFUSION INJURY

Brianna F. Moon
Walter R. Witschey

Reperfusion injury is additional injury that may occur following restoration of
blood flow to ischemic tissue. A better understanding of the mechanistic process
underlying reperfusion injury, and the development of non-invasive imaging tools to
assess it, are necessary to mitigate this pathologic condition in patients suffering from a
heart attack. In this thesis, I investigated the relationship between the duration of
myocardial ischemia and reperfusion injury using magnetic resonance imaging (MRI). A
fundamental principle of this investigation was the pathologic role of iron in reperfusion
injury and its contribution to the MRI signal. Since iron has moderate volume magnetic
susceptibility (χ), which is influenced in part by its redox state and ligand binding,
pathologic iron accumulation can cause the tissue to become relatively more
paramagnetic than non-ischemic myocardium. A unique aspect of my work was to map
the magnetic susceptibility of ischemic myocardium using information obtained from the
MRI signal phase. Altogether, these studies showed the spatial distributions of
paramagnetic shifts of the infarcted myocardium in the acute, sub-acute and chronic
phases of post-infarction injury, and to find their association with ischemia time and
extent of iron deposition.

viii

My research is supported by a wealth of studies using in vivo and tissue explant
imaging, and molecular assays in animal models and in humans. I performed validation
studies to elucidate the role of iron in reperfusion injury using histology,
immunohistochemistry, inductively coupled plasma optical emission spectrometry (ICPOES), and electron paramagnetic resonance (EPR) spectroscopy. Infarct iron
concentration was elevated compared to healthy (remote) myocardium in reperfused and
non-reperfused (permanently occluded) infarcts. Sources of iron came from the
extracellular space including hemoglobin byproducts and the intracellular space including
the cell’s labile iron pool. Iron handling and homeostasis at the cellular level was
analyzed using real-time PCR, where mRNA analysis showed upregulation of ferritin
which acts as an iron chelator and upregulation of heme oxygenase which is an enzyme
that breaks down hemoglobin.
There are some important and novel findings to my work. To our knowledge, we
were the first to detect iron in myocardial tissue by using magnetic susceptibility as an
MR imaging biomarker both in pre-clinical and clinical studies. Experiments validating
the presence of iron uncovered the dynamic wound healing process and the temporal
evolution of iron, which declined from 3-days to 8-weeks post-infarction indicating the
clearance of iron from the infarct region. It was discovered that increased ischemia
duration caused a significant increase in infarct transmurality, microvascular obstruction,
and iron content. Permanent coronary occlusion without reperfusion caused a completely
transmural infarct. Despite permanent infarcts showing a lack of T2*-weighted
hypointensity, there was a paramagnetic shift and elevated iron concentration in the
permanent infarcts. This led us to further investigate sources of iron within the infarct

ix

region and discover a significant increase in labile iron concentration, which is expected
to originate from intracellular myocytes.
While conventional cardiovascular MRI corroborates the findings of iron
deposition, magnetic susceptibility imaging showed improved detection of tissue iron
deposition and mitigates confounding factors such as edema and fibrosis. At high field
strength (7 T) and high resolution, there was improved correspondence between MR
imaging and infarct pathophysiology, where regions containing sparse iron deposition
could be better detected compared to imaging at 3 T. Unlike conventional relaxationbased measurements, magnetic susceptibility showed independence of field strength.
Myocardial infarction patients receiving reperfusion therapy showed magnetic
susceptibility changes associated with hypokinetic myocardial wall motion and
microvascular obstruction, demonstrating potential for clinical translation.
In this thesis I found that iron corresponded to a tissue paramagnetic shift. Both
iron and magnetic susceptibility varied depending on the ischemia duration and postinfarction time point. Magnetic susceptibility showed improved specificity to iron
deposition than conventional imaging approaches. Iron oxidation state and the type of
protein-bound iron likely affect the magnetic susceptibility and change during wound
healing which could be investigated in future work.
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________________________________________________________________________

Chapter 1
Dissertation Overview
________________________________________________________________________

1.1 Epidemiology of ischemic heart disease
Over the past 80 years, cardiovascular disease remains the leading cause of death
worldwide. In the United States approximately 370,000 deaths per year are attributed to
ischemic heart disease [1, 2]. Cardiovascular disease and specifically ischemic heart
disease cause a societal and economic burden globally. Majority of patients experiencing
a heart attack seek medical care and commonly undergo revascularization therapy, such
as primary percutaneous coronary intervention [3]. In the United States alone, there are
approximately 800,000 people who experience a heart attack per year and require
medical treatment and long-term care [4]. In 2012, the total estimated medical cost of
cardiovascular disease and stroke was $316 billion, which included hospital services, at
home care, and indirect cost of the loss of individual productivity due to premature death
[3]. In contrast, the medical cost of cancer patients was approximately a fourth of the cost
of cardiovascular disease patients. Although there is a decreasing trend of cardiovascular
related deaths with current treatment approaches (Figure 1.1), there is still room for
improvement in the prevention and diagnosis of patients at high risk of future adverse
outcomes and cardiac arrest.

1

Figure 1.1. United States death rates attributed to cardiovascular disease decline but
remain the leading cause of death to date. Data was collected from 2000 to 2013. CVD
= cardiovascular disease, Stroke = all cerebrovascular diseases, CHD = coronary heart
disease. Adapted from [3].

1.2 Diagnosis and treatment of acute myocardial infarction
Acute myocardial infarction, also known as a heart attack is defined as myocyte
necrosis caused by ischemia of the myocardial tissue [5, 6]. Diagnostic symptoms and
findings include: (1) physical attributes of having a heart attack such as shortness of
breath and chest pain, and women may experience additional symptoms like unusual
tiredness, cold-sweats, and dizziness [7]; (2) an abnormal electrocardiogram (ECG) such
as ST-elevation (Figure 1.2); (3) detection of intracoronary thrombus by angiography
(Figure 1.3); (4) loss of viable myocardium that can be detected through hypokinetic wall
motion through bedside imaging such as echocardiography; (5) elevated troponin. The
2

detection of a rise then fall of troponin level has high sensitivity and specificity towards
myocyte necrosis. Troponin is an essential component of myocyte contraction. Therefore
during myocyte apoptosis, troponin is released into the bloodstream and can be detected
through assays [8].

Figure 1.2. Normal versus myocardial infarction ECG. (a) Normal ECG
corresponding to the electrical activity of the heart. ECG traces are detected through
electrodes placed on the chest. The P wave is attributed to atrial depolarization followed
3

by atrial contraction. Blood from the atria then enters the ventricles, followed by
ventricular depolarization and contraction (QRS complex). Lastly, the T wave is
attributed to ventricular repolarization. (b) During the initial 24 hours of infarction, the
ST segment is elevated and is a characteristic clinical finding of acute myocardial
infarction. Figure adapted from [9].

Figure 1.3. Coronary occlusion detected by angiography. (a) Occlusion of the right
coronary artery caused by thrombus (white arrow). (b) After treatment, thrombus
embolization detected distally from initial occlusion (white arrow). (c) After further
treatment, blood flow is restored in the coronary artery. Figure obtained from [10].

Treatments for patients with an acute myocardial infarction include fibrinolytic
therapy and primary percutaneous coronary intervention, each restoring blood flow to the
ischemic tissue. Fibrinolytic medication, including tenecteplase, retaplase, and alteplase
[11-13], targets fibrin and aids in the breakdown of the clot. These medications can be
used with antiplatelet drugs, e.g. Aspirin [14, 15], and anticoagulants, e.g. heparin [16],
each reducing clot formation.
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Primary percutaneous coronary intervention is usually the first form of treatment
of acute myocardial infarction. The procedure involves opening the occluded coronary
artery using balloon catheterization and stent placement guided by angiography.
However, there could be complications including a “no reflow” phenomenon. Although
blood flow has been restored, the blood supply does not reach the downstream tissue
which could be attributed to microvascular damage, endothelial injury, edema, embolism,
vasospasm, myocyte reperfusion injury, or inflammation [5, 17-20].
There are a combination of therapeutic strategies to limit injury associated with
primary percutaneous coronary intervention including (1) GP IIb/IIIa antagonists, a form
of antiplatelet therapy [21-23]; (2) Adenosine, which is a myocyte protectant and limits
myocyte death [24]; (3) Beta blockers, which are cardioprotective and are often
prescribed to patients long term after a heart attack [25]; (4) natriuretic peptides, which
also have cardioprotective effects [26]; (5) hypothermia to conserve energy in myocytes
[27]; and (6) stem cell treatment of damaged myocardial tissue [28-30].
Prevention and diagnosis of the complications associated with primary
percutaneous coronary intervention (reperfusion therapy) is an active area of research and
the focus of this thesis.

1.3 Reperfusion injury and iron deposition
Reperfusion injury is an indication of a severe myocardial infarction [31, 32].
When a coronary artery is occluded, the myocardium becomes ischemic; necrosis begins
at the endocardium and extends out towards the epicardium [33]. To prevent a transmural
infarct, primary percutaneous coronary intervention (PCI) is performed to restore blood
5

to the ischemic region (Figure 1.4). Canine studies in the 1970’s and 80’s by Kloner,
Jennings and Reimer led to discoveries demonstrating the time dependence of ischemia
followed by blood reperfusion with respect to microvascular damage, intraluminal fibrin
thrombi, and extravasation of fibrin deposits and erythrocytes [34]. Therefore, prolonged
ischemia followed by reperfusion could lead to intramyocardial hemorrhage, also referred
to as reperfusion injury.
In two cardiovascular magnetic resonance imaging (MRI) studies enrolling 200
patients, >40% of ST-elevated myocardial infarction (STEMI) patients were diagnosed
with reperfusion injury after PCI-therapy [17, 35]. Although iron affects MRI contrast,
localization of hemorrhage may be underestimated or overestimated based on the
presence of confounding factors, edema and fibrosis, and nonlocal magnetic field
inhomogeneity, respectively [18, 19, 36, 37]. Quantitative Susceptibility Mapping
(QSM), which uses the MR signal phase to quantify tissue magnetic susceptibility, may
be a more specific and sensitive marker of reperfusion injury. QSM is the primary
imaging approach showcased throughout this thesis.
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Figure 1.4. Schematic of primary percutaneous coronary intervention (PCI) therapy
of ST-elevated myocardial infarction (STEMI). When a coronary artery is occluded,
the cardiac tissue distal to the occlusion will become ischemic then necrotic. A physician
will place a balloon catheter, expand the balloon, and place the stent to restore blood flow
to the ischemic tissue.

1.4 Clinical impact of reperfusion injury
While reperfusion remains the most effective strategy for reducing infarct size
and substantially improves myocardial salvage [38, 39], reperfusion injury is
independently associated with adverse tissue remodeling and abnormal cardiac function
such as myocardial wall thinning, ventricular dilation, reduced ejection fraction, and
hypokinetic wall motion [17, 31, 32, 40-44] (Figure 1.5). Patients with reperfusion injury
may be prone to fatal cardiac arrhythmias, cardiac arrest, and heart failure [41, 45].

Figure 1.5. Gross tissue pathology specimen of intramyocardial hemorrhage and
subsequent tissue remodeling. Intramyocardial hemorrhage is a complication of primary
PCI therapy. At 3 days post-infarction, there is extensive hemorrhage (red arrow) in a 90
min occlusion infarct followed by reperfusion (left specimen). Elevated iron content
could lead to the development of reactive oxygen species (ROS), myocyte death, adverse
tissue remodeling, and impaired LV cardiac function. At 8 weeks post-infarction, there is
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left ventricle dilation and myocardial wall thinning causing an overall reduction in
ejection fraction (right specimen).

1.5 Non-invasive imaging methods to assess myocardial infarction
Complications associated with myocardial infarction reperfusion therapy
highlight the need for non-invasive imaging methods, specific to reperfusion injury tissue
characterization. Magnetic resonance imaging (MRI) can be utilized to image the heart,
where relaxation properties (explained further in Chapter 2) are unique to the tissue type.
For example, the ratio of relaxation parameters (T1 and T2) affects the image contrast in
Figure 1.6. The myocardium appears dark and the blood pool inside the left ventricle
appears bright.

Figure 1.6. Magnetic resonance image of the heart. Anatomical short axis view of the
heart and corresponding MRI. The contrast in the MR image is caused by a ratio of T1
and T2 parameters that are unique to the tissue type. The myocardium and liver appear
8

dark, whereas the blood pool inside the left ventricle and fat appear bright. The short axis
view of the heart will be shown throughout this thesis.

There are multiple ways to image the heart (Figure 1.7). For example, a movie of
the heart can be captured, also known as a CINE MRI. CINE imaging provides the ability
to analyze cardiac function and see how the heart contracts and relaxes during a cardiac
cycle. Another example is late gadolinium enhanced (LGE) imaging, where the contrast
agent gadolinium is injected and goes into the myocardial tissue. After a period of time,
the gadolinium washes out of the healthy viable myocardium, which appears dark.
However, the gadolinium remains in the myocardial infarct region and influences the
relaxation parameters causing the tissue to appear bright (hyperintense). Within the
hyperintense infarct there could be a core region that appears dark (hypointense), known
as microvascular obstruction, which is an indicator of a severe myocardial infarction. A
third example is relaxation parameter (T1, T2, T2*) mapping, that can distinguish
between tissue types. For example, T2* is sensitive to field inhomogeneities originating
from iron. Therefore, regions of reperfusion injury will have a decrease in T2*.
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Figure 1.7. Cardiac magnetic resonance imaging techniques. MRI provides the ability
to collect CINE, LGE, and relaxation (T2*) maps from the heart. Each image is a short
axis view of the heart.

Imaging could be used to evaluate the effectiveness of adjunctive therapies for
reperfusion such as periprocedural glycoprotein IIb/IIIa inhibitor [42], iron chelation
therapy [46, 47], and β1-adrenergic receptor antagonists [48]. For example, glycoprotein
IIb/IIIa inhibitor is a potent platelet inhibitor and prevents clotting during reperfusion
therapy [49] but has been strongly and independently associated with reperfusion injury
[42]. Imaging could be used to guide dose optimization of glycoprotein IIb/IIIa inhibitor,
reducing infarct size and hemorrhage.
Reperfusion injury is a strong predictor of long-term adverse clinical outcomes in
STEMI patients [31, 32, 39-41, 43-45, 50]. Imaging methods specific to molecular
components of reperfusion injury might identify patients at high risk for adverse LV
remodeling and heart failure. These patients would then be followed more closely and
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treated affectively, while allowing low risk patients to be followed less frequently, which
would improve overall cost effectiveness for treatment of STEMI patients. Patients at
high risk for post-myocardial infarction adverse cardiac remodeling could be enrolled in
studies of emerging preventative approaches such as stem cell or biomaterial therapy [5153].

1.6 Dissertation overview
1.6.1 Clinical relevance and motivation
The large animal studies in this thesis will improve scientific knowledge by
understanding the physiology of reperfusion injury from the initial ischemic event to the
long-term healing process. Multi-parametric imaging was conducted to assess the
relationship between magnetic susceptibility, cardiac function, relaxation time, histology,
and iron content. The duration of ischemia followed by reperfusion was correlated with
the severity of the hemorrhagic injury, the amount of iron deposition, adverse myocardial
remodeling, and cardiac function. These results shed light on the causes and effects of
reperfusion injury during the wound healing process. Histology reveals and validates the
localization of iron deposition and how it is correlated with fibrotic tissue remodeling and
the immune response.
This thesis aims to benefit patients with ischemic heart disease by utilizing
cardiac QSM to detect the presence of hemorrhage after primary percutaneous coronary
intervention (PCI) therapy, which could lead to targeted periprocedural therapy, and risk
stratification of ST-elevated myocardial infarction (STEMI) patients. Cardiac QSM could
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be used to assess the outcomes of treatment, such as targeted iron-chelation therapy [47,
54] in STEMI patients with reperfusion injury.

1.6.2 Research rationale
Intramyocardial hemorrhage has been reported in 41% [17] and 54% [42] of
STEMI patients after primary percutaneous coronary intervention. These patients are at
high risk for adverse left ventricle (LV) remodeling, impaired LV function and fatal
arrhythmias [17, 41, 42]. Relaxation time MRI such as T2*-mapping is sensitive to
infarct iron content but is also affected by myocardial edema and fibrosis [19].
Quantitative Susceptibility Mapping (QSM), which uses the MR signal phase to quantify
tissue magnetic susceptibility, may be a more specific and sensitive marker of
intramyocardial hemorrhage. The focus of this thesis was to develop and validate cardiac
QSM in a large animal model of myocardial infarction, investigate the association of
magnetic susceptibility with iron content and infarct pathophysiology, and compare QSM
to conventional MRI techniques. Our long-term goal is to implement cardiac QSM in a
clinical setting as a method to help diagnose patients with intramyocardial hemorrhage
and provide risk stratification of STEMI patients to improve periprocedural therapy.

1.6.3 Specific Aims & Hypotheses
The thesis objectives were carried out with the following Specific Aims:
Aim 1. Determine the association of tissue magnetic susceptibility and iron content based
on the duration of ischemia and during dynamic myocardial infarction wound healing.
Aim 1 is addressed in Chapter 4.
12

1a. Implement cardiac QSM in a cross-sectional longitudinal large animal study
and assess the effect of ischemia duration with 45-, 90-, 180-min of coronary
ligation followed by reperfusion or permanent ligation (non-reperfused) and
analyze infarct wound healing at 3 days, 1 week, and 8-weeks post-infarction.
Hypothesis. Myocardial infarct magnetic susceptibility will be affected by the
duration of ischemia and the wound healing process.
1b. Determine the correlation between tissue magnetic susceptibility, iron, and
infarct pathophysiology with inductively coupled plasma - optical emission
spectrometry (ICP-OES), electron paramagnetic resonance (EPR) spectroscopy,
real-time PCR, histology, and immunohistochemistry.
Hypothesis. Elevation in infarct magnetic susceptibility will correspond to infarct
histopathology and iron content.
Aim 2. Compare quantitative susceptibility mapping with conventional MRI of
myocardial infarction at 3 T and 7 T. Aim 2 is addressed in Chapter 5.
2a. Uncover the relationship between magnetic susceptibility and relaxation
measurements for reperfused and non-reperfused infarctions.
Hypothesis. Magnetic susceptibility will be more specific to intramyocardial
hemorrhage compared to relaxation measurements and less affected by
confounding factors such as edema and fibrosis.
2b. Determine the effect of magnetic field strength and voxel size on tissue
magnetic susceptibility, T2*, and R2*.
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Hypothesis. Larger iron-induced magnetic field gradients at 7 T would reduce
myocardial infarction T2*, but not magnetic susceptibility, and 7 T would show
improved detection of hemorrhage and fibrotic regions.
Aim 3. Assess the feasibility of cardiac QSM in ST-elevated myocardial infarction
patients. Aim 3 is addressed in Chapter 4.
3a. Assess infarct severity, cardiac function, and presence of microvascular
obstruction (MVO) and hemorrhage in a cohort of STEMI patients after receiving
primary percutaneous coronary intervention therapy using cardiac QSM and
conventional CMR imaging.
Hypothesis. STEMI patients with intramyocardial hemorrhage will have varying
infarct severity, function, MVO volume, and heterogeneous tissue magnetic
susceptibility.

The outcomes of these Aims are shown throughout the thesis and advance the
field of cardiovascular magnetic resonance imaging (CMR) by implementing a method to
specifically image iron found in reperfusion injury and could provide a rationale for
targeted periprocedural therapy, such as administration of iron chelators to remove excess
iron from intramyocardial tissue.

1.6.4 Research Objectives
The OBJECTIVES of this thesis include: 1) develop and validate cardiac
quantitative susceptibility mapping (QSM) in a cross-sectional and longitudinal study
with a large animal model of myocardial infarction, 2) investigate the association of
14

magnetic susceptibility with iron content and infarct pathophysiology, 3) compare QSM
to conventional cardiovascular magnetic resonance imaging such as relaxation time
mapping and late-gadolinium enhanced (LGE) MRI, 4) analyze the relationship between
relaxation rates and magnetic susceptibility of myocardial tissue, 5) determine the effect
of field strength and voxel size on magnetic susceptibility measurements, and 6) assess
the feasibility to acquire QSM in STEMI patients receiving PCI-therapy.

1.6.5 Overall experimental design
The experimental design of the thesis includes a large animal cross-sectional
longitudinal study of myocardial infarction to determine and validate if tissue magnetic
susceptibility is a sensitive biomarker of intramyocardial hemorrhage. The experimental
model was chosen to emulate human PCI reperfusion injury. The large animal model
preclinical study demonstrated the potential for clinical translation and formed the basis
of an observational, cross-sectional MRI study in humans.

Figure 1.8. Study design. Design, all swine (N=38) underwent coronary artery occlusion
and are partitioned into four groups: reperfusion at 45 (n=3), 90 (n=15) and 180 (n=5)
minutes after initiation of occlusion and permanent occlusion (n=4). Swine had a terminal
study 1-week post-infarction. Three additional groups were studied at 3 days (n = 3) and
8 weeks (n = 8) after a 90- or 180-min occlusion followed by reperfusion and a separate
15

set of controls without myocardial infarction (n = 5). In Aim 1, we investigated the
association between tissue magnetic susceptibility, myocardial infarction
pathophysiology, and iron content by implementing and validating cardiac quantitative
susceptibility mapping (QSM). In Aim 2, we compared quantitative susceptibility
mapping with conventional CMR techniques including transverse relaxation time (T2*)
and rate (R2*) mapping, late gadolinium enhanced (LGE) imaging at 3 T and expanded
the comparison by varying magnetic field strength and voxel size. In Aim 3, we assessed
the feasibility of implementing cardiac QSM in STEMI patients upon receiving PCItherapy.

1.6 Dissertation organization
This dissertation is organized as follows. Chapter 1 begins with the epidemiology,
diagnosis, treatment, and prognosis of ischemic cardiac disease. Then the chapter goes
into the complications associated with ischemic heart disease treatment, specifically
reperfusion injury. Next the chapter outlines the clinical impact of reperfusion injury and
the clinical need for non-invasive methods to assess reperfusion injury. Chapter 1 also
emphasizes the research rationale, specific aims, and hypotheses pertaining to each
chapter and overall experimental design of the thesis.
Chapter 2 will discuss the fundamentals of magnetic resonance imaging (MRI)
including the Nuclear Magnetic Resonance (NMR) phenomenon, Bloch equations, and
gradient echo imaging.
Chapter 3 will explain magnetic susceptibility imaging. First the classification of
materials will be discussed, including paramagnetism versus diamagnetism and how
magnetic susceptibility relates to hemoglobin byproducts. The chapter will also discuss
magnetic susceptibility imaging approaches including susceptibility weighted imaging
16

(SWI) and quantitative susceptibility mapping (QSM). The computation of magnetic
susceptibility is an ill-posed inverse problem, and the chapter will discuss how the
calculation of susceptibility through multiple orientation sampling (COSMOS) algorithm
can stabilize the inverse problem. A series of steps is required to solve the ill-posed
inverse problem through a minimization and regularization approach including phase
unwrapping and background field removal, which will also be discussed in the chapter.
Chapter 4 goes into detail about the complications of primary percutaneous
coronary intervention, specifically reperfusion injury, which is independently associated
with adverse tissue remodeling and adverse cardiac function. Quantitative susceptibility
mapping (QSM) was applied to the heart, where tissue regions containing iron caused a
paramagnetic shift. The paramagnetic shift in infarcts compared to remote myocardium
correlated with iron content and infarct pathophysiology. Evaluation of markers of iron
homeostasis showed a cellular response to elevation of iron concentration and
hemoglobin byproducts.
The findings in Chapter 4 culminated in a publication: Moon BF, Kamesh Iyer S,
Hwuang E, Solomon MP, Hall AT, Kumar R, Josselyn NJ, Higbee-Dempsey EM,
Tsourkas A, Imai A, Okamoto K, Saito Y, Pilla JJ, Gorman JH, Gorman RC, Tschabrunn
C, Keeney SJ, Castillero E, Ferrari G, Jockusch S, Wehrli FW, Shou H, Ferrari VA, Han
Y, Gulhane A, Litt H, Matthai W, Witschey WR. Iron imaging in myocardial infarction
reperfusion injury. Nature Communications, June 2020. 11(3273): DOI: 10.1038/s41467020-16923-0. Creative Commons license can be viewed at
http://creativecommons.org/licenses/by/4.0/.
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Chapter 5 compares quantitative susceptibility mapping (QSM) and relaxationbased mapping (T2*, R2*). Each imaging method provides a quantitative assessment and
image contrast based on the presence of iron found in hemorrhagic tissue. However,
magnetic susceptibility showed improved detection of regions containing sparse iron
concentration and was less influenced by confounding factors like edema and fibrosis.
Cardiac specimens of a reperfused and non-reperfused infarct model were imaged at 3 T
and 7 T magnetic field strength and show improved detection of hemorrhage and infarct
regions at 7 T in a large animal model correlating with infarct pathophysiology.
The findings in Chapter 5 culminated in a manuscript submitted and under review
for publication in Magnetic Resonance in Medicine (MRM) and currently under revision
for a resubmission with MRM as: Moon BF, Kamesh Iyer S, Josselyn NJ, Hwuang E,
Swago S, Keeney SJ, Castillero E, Ferrari G, Pilla JJ, Gorman JH, Gorman RC,
Tschabrunn C, Shou H, Matthai W, Wehrli FW, Ferrari VA, Han Y, Litt H, Witschey
WR. Magnetic susceptibility and R2* of myocardial reperfusion injury at 3 T and 7 T.
MRM, under review.
Chapter 6 discusses the multiple forms of iron including protein bound and labile
iron found in reperfusion injury of acute myocardial infarction (MI). The study showed
iron accumulation, iron form, and cellular response to reperfusion injury with respect to
the duration of wound-healing in a large animal model. An elevation in magnetic
susceptibility and R2* imaging biomarkers was associated with a significant increase in
infarct iron content in acute reperfusion injury that dissipates by 8-week post-infarction
and validate these findings with histology, iron concentration, and mRNA expression.
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Chapter 6 was presented at the annual meetings including Society for
Cardiovascular Magnetic Resonance (SCMR) and International Society for Magnetic
Resonance in Medicine (ISMRM) conferences in 2020. Specifically, the in vivo 1-week
and 8-week post-infarction imaging and iron validation studies were presented in the
Early Career Awards in Basic Science and Technical Developments Session at the 2020
Annual Meeting of SCMR as: Moon BF, Kamesh Iyer S, Hwuang E, Solomon MP, Hall
A, Kumar R, Josselyn NJ, Higbee-Dempsey E, Tsourkas A, Pilla JJ, Gorman JH, Gorman
RC, Tschabrunn C, Keeney SJ, Castillero EC, Ferrari G, Jockusch S, Ferrari VA, Han Y,
Litt HI, Matthai W, Witschey WR. Magnetic susceptibility and iron evolve during
myocardial infarction wound healing. SCMR 23rd Annual Scientific Sessions. Orlando,
FL. February 2020. In vivo and ex vivo 3-day, 1-week, and 8-week post-infarction
imaging and histopathology was presented at the 2020 Annual Meeting of International
Society for Magnetic Resonance in Medicine (ISMRM) as: Moon BF, Kamesh Iyer S,
Hwuang E, Josselyn NJ, Pilla JJ, Gorman JH, Gorman RC, Tschabrunn C, Keeney SJ,
Castillero E, Ferrari G, Jockusch S, Shou H, Higbee-Dempsey EM, Tsourkas A, Ferrari
VA, Han Y, Litt H, Witschey WR. Magnetic susceptibility, R2* and iron evolve during
reperfusion injury wound healing. ISMRM. Virtual Conference & Exhibition. August
2020. The 3-day post-infarction results presented are in preparation for a manuscript
submission with Journal of Cardiovascular Magnetic Resonance (JCMR) as: Moon BF,
Kamesh Iyer S, Hwuang E, Josselyn NJ, Swago S, Thompson E, Pilla JJ, Gorman JH,
Gorman RC, Tschabrunn C, Keeney SJ, Castillero E, Ferrari G, Jockusch S, Shou H,
Higbee-Dempsey EM, Tsourkas A, Ferrari VA, Han Y, Litt H, Witschey WR. Magnetic
susceptibility, R2* and iron evolve during reperfusion injury wound healing, in progress.
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Chapter 7 includes future work involving iron chelation as a therapeutic
intervention to remove iron found in reperfusion injury. This work was proposed as a
thesis sub-Aim at an annual thesis committee meeting in 2019. Unfortunately, due to the
COVID-19 pandemic in 2020, research experiments were halted and unable to be
implemented prior to defending and graduating in December 2020.
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________________________________________________________________________

Chapter 2
Fundamentals of MRI
________________________________________________________________________

2.1 Concepts of the NMR phenomenon
Nuclei with spin angular momentum have a magnetic moment that can be aligned
parallel to an applied magnetic field. In the absence of a magnetic field (𝐵0), the nuclear
spins are orientated randomly (Figure 2.1). Once the magnetic field is applied, a slight
majority of the nuclei will align themselves to 𝐵0 , this is referred to as the net
magnetization. The net magnetization is in the same direction as 𝐵0. The nuclei rotate at a
Larmor frequency and when an additional radiofrequency signal (𝐵1) is applied to the
system at the Larmor frequency, it causes the net magnetization to rotate. When 𝐵1 is
removed, the net magnetization returns to equilibrium and through this process emits
energy that can be detected with MRI technology.
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Figure 2.1. Protons in the presence of an external magnetic field. An external
magnetic field causes net magnetization.

2.1.1 Equation of motion for magnetization
All nuclei with a spin greater than zero have a magnetic moment and can be
detected with nuclear magnetic resonance (NMR) [55]. Throughout this thesis, I will
focus on the 1H nuclei. Protons spin about a magnetic field similarly to a gyroscope
precession around the gravity axis. The magnitude of a magnetic moment |𝜇⃗| remains the
⃗⃗ (Figure 2.2). The moment
same but the direction changes about the magnetic field 𝐵
⃗⃗ 𝑑𝑡, where 𝛾 is the gyromagnetic ratio
difference with respect to time is 𝑑𝜇⃗ = 𝛾𝜇⃗ × 𝐵
unique to a proton; for example, hydrogen protons have a gyromagnetic ratio of 42.58
⃗⃗, the distance from 𝐵
⃗⃗ to the tip of 𝜇⃗
MHz/T. When analyzing the plane defined by 𝜇⃗ and 𝐵
would be equal to 𝜇 sin 𝜃. Therefore, based on geometry

|𝑑𝜇⃗| = 𝜇 sin 𝜃 |𝑑𝜙|

22

(1)

Where |𝑑𝜇⃗| can be represented as

⃗⃗ |𝑑𝑡 = 𝛾𝜇𝐵 sin 𝜃 𝑑𝑡
|𝑑𝜇⃗| = 𝛾|𝜇⃗ × 𝐵

(2)

Equations (1) and (2) then result in |𝑑𝜙| = 𝛾𝐵|𝑑𝑡|, which when rearranged is the
Larmor equation.

𝑑𝜙
𝑑𝑡

= 𝜔 = 𝛾𝐵

Figure 2.2. Protons spin about a magnetic field. Figure published in [55].
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(3)

2.1.2 Bloch equations
From the analysis in section 2.1.1 the following coupled differential equations,
known as the Bloch equations, can be represented from

⃗⃗
𝑑𝜇
𝑑𝑡

⃗⃗ by assuming no
= 𝛾𝜇⃗ × 𝐵

proton relaxation and radiofrequency field, 𝐵 = 𝑧̂ 𝐵0 and 𝜔0 = 𝛾𝐵𝑧 .

𝑑𝑀𝑥
𝑑𝑡

𝑑𝑀𝑦
𝑑𝑡

= 𝛾(𝑀𝑦 𝐵𝑧 − 𝑀𝑧 𝐵𝑦 ) = 𝜔0 𝑀𝑦

(4)

= 𝛾(𝑀𝑧 𝐵𝑥 − 𝑀𝑥 𝐵𝑧 ) = 𝜔0 𝑀𝑥

(5)

𝑑𝑀𝑧
𝑑𝑡

= 𝛾(𝑀𝑥 𝐵𝑦 − 𝑀𝑦 𝐵𝑥 ) = 0

(6)

If a radiofrequency field 𝐵1 is applied to the system at the Larmor frequency, the proton
will rotate about the axis in the direction of 𝐵1 and the Bloch equations will become,

𝑑𝑀𝑥
𝑑𝑡

𝑑𝑀𝑦
𝑑𝑡

𝑑𝑀𝑧
𝑑𝑡

= 𝛾[𝑀𝑦 𝐵0 − 𝑀𝑧 𝐵1 sin(𝜔0 𝑡)] −

= 𝛾[𝑀𝑧 𝐵1 cos(𝜔0 𝑡) − 𝑀𝑥 𝐵0 ] −

𝑀𝑥

(7)

𝑇2

𝑀𝑦

(8)

𝑇2

= 𝛾(𝑀𝑥 𝐵1 sin(𝜔0 𝑡) − 𝑀𝑦 𝐵1 cos(𝜔0 𝑡)) −

𝑀𝑧 −𝑀0
𝑇1

(9)

Where T1 and T2 are the longitudinal and transverse relaxation rates, respectively.
Analyzing the equations with respect to the rotating frame of reference [56] results in the
following,
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𝑑𝑀𝑧
𝑑𝑡

𝑑𝑀𝑥
𝑑𝑡

𝑑𝑀𝑦
𝑑𝑡

=

𝑀0 −𝑀𝑧

(10)

𝑇1

= 𝜔0 𝑀𝑦 −

𝑀𝑥

= −𝜔0 𝑀𝑥 −

𝑇2

𝑀𝑦
𝑇2

(11)

(12)

The solutions to the Bloch equations with the assumption that the external magnetic field
is in the direction of the z-axis results in the following equations,

𝑀𝑧 (𝑡) = 𝑀𝑧 (0)𝑒 −𝑡⁄𝑇1 + 𝑀0 (1 − 𝑒 −𝑡/𝑇1 )

(13)

𝑀𝑥 (𝑡) = 𝑒 −𝑡/𝑇2 (𝑀𝑥 (0) cos 𝜔0 𝑡 + 𝑀𝑦 (0) sin 𝜔0 𝑡)

(14)

𝑀𝑦 (𝑡) = 𝑒 −𝑡/𝑇2 (𝑀𝑦 (0) cos 𝜔0 𝑡 + 𝑀𝑥 (0) sin 𝜔0 𝑡)

(15)

The equilibrium or steady state as 𝑡 → ∞ causes 𝑀𝑥 (∞) = 𝑀𝑦 (∞) = 0, and 𝑀𝑧 (∞) =
𝑀0 .
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Figure 2.3. Trajectory of proton precession about z-axis. (A) Through the process of
proton precession, there is a combination of (B) regrowth in the longitudinal
magnetization (T1 longitudinal relaxation) and (C) signal decay in the xy-plane (T2
transverse relaxation). Adapted from [55].

The complex representation of magnetization can be shown as,

𝑀+ (𝑡) = |𝑀+ (𝑡)|𝑒 𝑖𝜙(𝑡) = 𝑀⊥ (𝑡)𝑒 𝑖𝜙(𝑡)

(15)

𝑀⊥ (𝑡) = 𝑒 −𝑡⁄𝑇2 𝑀⊥ (0)

(16)

𝜙(𝑡) = −𝜔0 𝑡 + 𝜙(0)

(17)

and

Signal phase (𝜙) is the parameter of interest for magnetic susceptibility imaging and will
be the focus of the next chapters.
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2.2 MRI and how it works
The signal detected and measured in an MRI machine originates from the
precession of protons to equilibrium and subsequent release of energy in the form of a
time-varying magnetic flux, which induces a voltage that is detected by a receiver
radiofrequency (𝑟𝑓) coil [55] (Figure 2.4). The voltage, also known as electromotive
force (𝑒𝑚𝑓), induced in the receive coil can be represented as,

𝑑
⃗⃗⃗ ∙ 𝐵
⃗⃗𝑟𝑓 )𝑑3 𝑟
𝑒𝑚𝑓 = − ∮ 𝑑𝑡 (𝑀

(18)

⃗⃗𝑟𝑓 represents the static field in the receive coil per unit current and 𝑒𝑚𝑓 is
Where 𝐵
proportional to 𝜔0 𝑀0 , and the time dependence is dominated by the precession of the
proton. Altogether, the signal is proportional to the square of the external magnetic field
𝐵0.

𝑠𝑖𝑔𝑛𝑎𝑙 ∝

𝛾3 𝐵02 𝜌0
𝑇

(19)

This equation demonstrates the interest in acquiring MR images at high field strength
which would enhance the signal and lead to a higher signal-to-noise ratio (SNR). The
analysis and comparison between images acquired at 3 T versus 7 T will be shown in
Chapter 5.
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Figure 2.4. MRI Scanner Cutaway: components and functions. The MRI machine
consists of a radiofrequency coil, gradient coil, magnet, and the plastic covering of the
magnet.

2.2.1 Gradient Echo MRI
There are many sequences to-date that analyze and manipulate the different
components of proton precession including but not limited to T1 [57, 58], T1ρ [59-66],
T2 [39, 41, 67-72], T2* [19, 36, 50, 73], and phase (𝜙) [74-76]. There are also sequences
that detect the proton exchange with the surrounding environment, such as CEST [77-81],
or the fluid dynamics of protons through 4D phase contrast flow MRI [82, 83]. This
thesis will focus on the gradient echo (GRE) sequence and the data extracted including
T2*-weighted (T2*w) magnitude, phase, T2*-maps, R2*-maps, susceptibility weighted
imaging (SWI), and quantitative susceptibility mapping (QSM).
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T2 is the transverse relaxation time and is defined by the time constant for decay
of transverse magnetization (Figure 2.3, 2.4). T2 is affected by atomic or molecular
interactions, whereas T2* describes the signal decay from inhomogeneities originating
from the main magnetic field or susceptibility-induced field perturbations (Figure 2.5).
The relationship between T2 and T2* can be described by the equation,

1
𝑇2∗

1

1

= 𝑇2 + 𝑇2

𝑖

(20)

Where, T2* will always be less than or equal to T2, and 1⁄𝑇2𝑖 = 𝛾∆𝐵𝑖 is the relaxation
rate related to the field inhomogeneities across a voxel. As voxel size increases,
transverse relaxation rate would be expected to increase, this is further discussed in
Chapter 5.
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Figure 2.5 Proton reaction in a spin echo MRI experiment. In a spin echo sequence,
an RF pulse is applied in the x-axis direction and causes a 𝜋⁄2 rotation in the xy-plane.
Proton precession occurs and spins accumulate extra phase. Then a second RF pulse is
applied causing a 𝜋 rotation. The spins continue collecting extra phase until all spins
return to the y-axis, which causes an echo that can be detected by an RF coil. The echo
amplitude is reduced based on the inherent T2 transverse relaxation from equation
𝑀0 𝑒 −𝑇𝐸⁄𝑇2 , where TE is the echo time in the sequence. Figure published by [55].

T2 can be measured using a Spin-echo MRI pulse sequence [55]. An initial RF
𝜋⁄2-pulse is applied to rotate the protons from the z-axis into the xy-plane. The protons
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dephase from atomic and molecular interaction causing signal decay (Figure 2.6). Then a
second 𝜋-pulse is applied to rotate the protons in the xy-plane. The protons continue to
collect phase which causes them to coalesce in the y-axis and create an echo at time TE.

Figure 2.6 Spin echo (SE) sequence. The spin echo sequence shows the RF pulse that
initially cause the 𝜋⁄2 rotation in the xy-plane followed by signal dephasing. Then the
second RF pulse causes a 𝜋 rotation and the spins collect in the y-axis direction causing
an echo at time TE. Figure published by [55].

Spin echo (SE) sequences use pairs of RF pulses to create an echo, whereas
gradient echo (GRE) sequences use an initial RF pulse then gradients to create an echo.
In Figure 2.7, the gradient right after the RF pulse (α) causes signal dephasing until time
(τ). The second gradient has an area twice the size of the first gradient. After time (τ), the
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spins rephase and coalesce at time (2τ), then begin to dephase again. A gradient echo is
created at time (2τ).

Figure 2.7 Gradient echo (GRE) sequence. Figure presented in BE581 course, LSPFI,
University of Pennsylvania, 2017.

2.3 Detecting hemorrhagic myocardial infarction with CMR
The physiological and magnetic susceptibility properties of hemorrhagic
myocardial infarction have been studied using MRI relaxation time contrast and mapping
[39, 50, 58, 70, 84, 85]. Shortening of T1 relaxation time is caused by the dipole-dipole
interaction of a paramagnetic material such as gadolinium or hemoglobin byproducts.
The dipole-dipole interaction is dependent on the proximal distance between surrounding
water molecules and the paramagnetic center of a molecule. The protein structure of
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methemoglobin allows water molecules to approach and interact with the heme iron
causing T1 shortening. Whereas, the structure of deoxyhemoglobin limits the amount of
T1 shortening [84]. Shortening of T2 relaxation time is caused by the susceptibility
effects of the paramagnetic substance leading to dephasing and signal decay. However,
T2 is also increased by edema and fibrosis which could obscure the magnetic
susceptibility effects on MRI [19, 36, 71].
Shortening of T2* results from the contributions of T2, decay of the transverse
magnetization, and magnetic field inhomogeneities. Both paramagnetic (i.e. gadolinium)
and diamagnetic material (i.e. calcium) can be detected by the dephasing and signal
decay due to the shortening of T2* [19] making T2* mapping ideal for imaging
reperfusion injury in the heart, where regions containing iron would cause signal decay
and signal dephasing.
An imaging technique with positive contrast rather than signal decay could
provide more confidence in the presence of paramagnetic material (i.e. iron and
hemoglobin byproducts) within the tissue. It is known that susceptibility-induced
materials create a magnetic dipole [86] causing local tissue field inhomogeneity and
signal decay in surrounding voxels. Therefore, T2*-weighted imaging may overestimate
the area of reperfusion injury.

2.4 Relaxation times and the influence of contrast agents
Conventional MRI contrasts and mapping techniques such as T1 [58, 84, 87, 88],
T2 [39, 41, 67, 69, 70, 72], T2* [19, 36, 50, 73] and the MR signal phase (susceptibilityweighted imaging) [74-76] are used in CMR. However, the sensitivity, specificity, and
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spatial distribution to hemorrhage, edema, and fibrosis are currently active areas of
research. T2 and T2* MRI typically appear hypointense with hemorrhage, but the spatial
correspondence of T2 and T2* may not overlap and the relative contributions of
hemorrhagic injury, edema and fibrosis to the MR signal are unknown. T2 and T2* are
increased in edema and fibrosis [70] but appear to decrease in hemorrhagic infarction.
T2* is affected by imperfections in the MRI static magnetic field, background field
heterogeneity at the lung-myocardium interface, signal fluctuations due to cardiac and
respiratory motion, and fluctuations of the MR signal due to venous oxygen saturation.
The effect of hemorrhagic tissue iron on the MR signal phase is nonlocal, affecting
adjacent non-hemorrhagic tissue contrast and relaxation measurements.
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Figure 2.8. T2* imaging in a reperfused and non-reperfused myocardial infarction.
T2* imaging utilizes signal intensity to see hemorrhage but is affected by competing
factors like fibrosis and edema which increase T2*, therefore T2* could misrepresent the
amount of hemorrhage. Both a reperfused and non-reperfused infarct show microvascular
obstruction (white arrows) on LGE indicating a severe infarct. The reperfused infarct had
hypointense infarct regions, unlike the non-reperfused infarct. However, both infarcts had
signal dephasing indicating the presence of iron.

Late gadolinium enhanced (LGE) imaging is used to detect microvascular
obstruction (MVO) which has shown to be closely related with intramyocardial
hemorrhage [39]. The contrast seen in LGE images is influenced by infarction, fibrosis,
and altered perfusion of the gadolinium contrast agent. While longitudinal and transverse
relaxation-based MR techniques detect the endogenous effects of proton decay, LGE, and
relaxation-based MR are physiologically different with respect to intramyocardial
hemorrhage. Therefore, there may not be a direct correlation between MVO and
intramyocardial hemorrhage [67].

35

Figure 2.9. Serial LGE and T2* studies show that microvascular obstruction and
hemorrhage are related but distinct. Microvascular obstruction (MVO) on the acute
scan (red arrow) dissipates by the follow-up scan. In contrast, the T2* maps show a
decrease in T2* within the infarct region (red arrow) at both time points, indicating
hemorrhage is present in the acute scan and iron is retained within the tissue by the
follow-up scan. Adapted from [89].
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________________________________________________________________________

Chapter 3
Magnetic Susceptibility Contrast
________________________________________________________________________

3.1 Classification of materials
Magnetic susceptibility is a material property that explains how much a material
will become magnetized within an external magnetic field [55]. Molecules without
unpaired electrons contain no free electrons and therefore, these molecules are classified
as diamagnetic and are weakly repelled by the external magnetic field. Diamagnetic
material includes water, fat, calcium, and most biologic tissues. Paramagnetic molecules
have unpaired electrons, causing the molecule to become magnetized and attracted to an
external magnetic field. Paramagnetic material includes molecular 𝑂2, salts, chelates of
metals (Gd, Fe, Mn, Cu), and organic free radicals. Superparamagnetic and ferromagnetic
material have more unpaired electrons and are strongly affected by an external magnetic
field. Superparamagnetic material includes ferritin, hemosiderin, and superparamagnetic
iron oxide (SPIO) MR contrast agents. Ferromagnetic material includes iron and steel.
The induced magnetic field of each of these molecules influences neighboring protons
and causes faster T2* relaxation and ultimately intravoxel dephasing and signal decay.
The magnetization of a molecule can be described by equation, 𝑀 = 𝑀0 + 𝜒𝐻
where 𝑀 is the summation of the inherent magnetization of a molecule (𝑀0 ) and the
induced magnetization caused by an external magnetic field (𝐻). The variable 𝜒
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characterizes the magnetic susceptibility properties of a material, where a positive 𝜒
indicates paramagnetism and a negative 𝜒 indicates diamagnetism.

3.1.1 Paramagnetism
If a piece of magnetic material were examined on an atomic scale, there would be
tiny currents that originate from electrons orbiting around nuclei and electrons spinning
about their axes or orbits (Figure 3.1 A). On a macroscopic scale, these tiny current loops
are so small that they can be treated as individual magnetic dipoles. In the absence of an
external magnetic field, the dipoles cancel each other out because of the random
orientation of the atoms. However, when a magnetic field is applied there is a net
alignment of these magnetic dipoles, and the material becomes magnetically polarized or
magnetized.
This kind of current is different from the typical current discussed in
electromagnetism. A single charge does not travel around the entire perimeter of the
object instead (Figure 3.1 A), instead each charge moves only around a single atom [86].
Nevertheless, when analyzing all atoms in the object, the net effect is a macroscopic
current flowing over the surface of the magnetized object. This type of current behaves
in the same way as any other current does and produces a magnetic field.
In the case of a paramagnetic material, the magnetization of the object is parallel
with the external magnetic field. A magnetic dipole experiences a torque for the
magnetization of the material (𝑚) to become parallel to the external magnetic field (𝐵)
(Figure 3.1 B,C). There are two forces (𝐹) acting on the sides of the object causing a
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torque. The torque of the object (𝑁) is equal to the cross product of the magnetization
and the external magnetic field.

Figure 3.1. Paramagnetic material introduced to an external magnetic field. Adapted
from [86].

3.1.2 Diamagnetism
All atoms have electrons that revolve around the nucleus in an orbit. In absence of
an external magnetic field the electron orbits are randomly orientated, and the dipole
moments cancel each other out. However, in the presence of a magnetic field there is a
change in the velocity of the electrons (∆𝑣) and each atom picks up a little extra dipole
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moment. These increments are all antiparallel to the field causing the atom to be repelled
against an external magnetic field (Figure 3.2 A) [86]. This is the mechanism responsible
for diamagnetism. All atoms have the diamagnetic property. However, diamagnetism is
typically much weaker than paramagnetism. Therefore, usually atoms that lack the
paramagnetic property by having a paired even number of electrons exhibit a diamagnetic
response to an external magnetic field. Diamagnetism is a quantum phenomenon and is
not simply described by equations shown in Figure 3.2 B. The important distinction
between diamagnetic and paramagnetic material is that diamagnetic material induces a
dipole moment (𝑚) opposite to the main magnetic field (𝐵).

Figure 3.2. Diamagnetic material introduced to an external magnetic field. Adapted
from [86].
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3.2 The effect of myocardial iron on magnetic resonance signal
In the post-infarction period, there is continuous tissue remodeling during wound
healing affecting the distribution of iron, as well as its ionization state (Fe2+ or Fe3+) and
molecular form. Within the first week after ischemia reperfusion injury, intravascular
hemoglobin within red blood cells is released into the myocardial interstitial space and
converts into paramagnetic protein forms such as deoxyhemoglobin and methemoglobin
(4 and 5 free electrons) and then crystalizes into superparamagnetic hemichromes, ferritin
and hemosiderin (many unpaired electrons) [84, 86]. Magnetic susceptibility coefficient
(Δχ) is an inherent material property and defines how much a material becomes
magnetized. Paramagnetic substances become magnetized and are attracted to an external
magnetic field, whereas diamagnetic material (no unpaired electrons) has an induced
magnetic field antiparallel to an external magnetic field.

Figure 3.3. Hemoglobin byproducts. The hemoglobin molecule contains heme groups
with Fe+2 at the center. There are 6 potential coordination sites, four are occupied by
nitrogen, the fifth site is bonded to histidine group and the 6th site is where oxygen binds
to the iron, affecting its magnetic properties. The breakdown of the hemoglobin
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molecule affects the number of unpaired electrons in the entire molecule and therefore
the inherent magnetic susceptibility. Deoxyhemoglobin and methemoglobin have 4 to 5
unpaired electrons and are paramagnetic. Methemoglobin and hemichromes are broken
down, releasing iron, which then coalesce to form large superparamagnetic (many
unpaired electrons) iron-protein molecules (ferritin and hemosiderin). Adapted from MRI
questions – types of hemoglobin.

Acutely ischemic myocardium followed by reperfusion injury causes overlapping
regions of fibrosis [36], edema [19, 90, 91], necrosis and hemorrhage. The evolution of
wound healing will impact native longitudinal (T1) and transverse (T2, T2*) relaxation
times. Cardiac QSM has the potential to detect paramagnetic hemoglobin byproducts
without the influence of surrounding tissue properties.

3.3 Susceptibility weighted imaging
Susceptibility weighted imaging (SWI) is an image processing method of GRE
phase images which takes advantage of the signal dephasing caused by susceptibilityinduced material [74-76]. A weight term is assigned to each voxel based on the amount of
signal dephasing. When there is more signal dephasing, the weight is increased. The
weight of each voxel is then applied to the magnitude image causing regions containing
susceptibility-induced material to be hypointense. SWI allows better localization and
detection of susceptibility-induced regions. However, some of the limitations of T2*
mapping still exist in SWI, where the regions of interest have negative contrast
(hypointense) and regions surrounding the susceptibility-induced material are affected by
the local field inhomogeneity. SWI provides a qualitative assessment of susceptibilityinduced material. However, a quantitative assessment of the material could potentially
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provide information on the quantity and molecular form of susceptibility-induced
material, such as the various hemoglobin byproducts.

Figure 3.4. Susceptibility weighted imaging (SWI). (A) Magnitude image at long echo
time, corresponding high pass filtered (B) phase image and (C) susceptibility weighted
image. (D-F) Cross section of the veins (see arrows), which appear hypointense on SWI
due to deoxygenated hemoglobin and subsequent signal dephasing [92, 93]. Images
obtained at 1.5 T and published by [94].

3.1.3 Relation between induced field and susceptibility
The relationship between the induced magnetic field and susceptibility can be
expressed as the field equaling the kernel of a magnetic dipole (Figure 3.5) convolved by
the magnetic susceptibility of the material [95],

𝛿𝑓𝑟 (𝑟⃗) = 𝐵0 ∫𝑟≠𝑟́

3𝑐𝑜𝑠2 𝜃𝑟≠𝑟́ −1 3
𝑑 𝑟
4𝜋|𝑟−𝑟́ |3
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= 𝐵0 (𝜒 ⊗ 𝑑)(𝑟⃗)

(1)

where, 𝛿𝑓𝑟 is the induced field, 𝐵0 is the main magnetic field, 𝑑 is the dipole kernel in
image space. In the Fourier domain this equation is expressed as a multiplication
problem,

𝑓∗ = 𝐷 × 𝜒

1

𝑘2

𝐷 = 3 − 𝑘𝑧2

(2)

(3)

where D is the dipole kernel in Fourier space, 𝑘 is the magnitude of the coordinate vector
⃗⃗ , and 𝑘𝑧2 is the projection of the coordinate vector on the z axis (in the direction of the
𝑘
main magnetic field).
However, the field cannot be simply divided by the dipole kernel in order to
isolate the susceptibility due to the dipole kernel being equal to zero at the two conical
surfaces (Figure 3.5), which is the magnetic angle ≈ 54.7𝑜 between the external
magnetic field and the dipole field. This causes the inverse problem to be ill-posed and
ill-conditioned when discretized to avoid zeros [96, 97]. The inverse problem can be
stabilized by using Calculation of Susceptibility through Multiple Orientation Sampling
(COSMOS).
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Figure 3.5. Representative Magnetic dipole field (kernel). Adapted from [95].

3.4 Calculation of Susceptibility through Multiple Orientation Sampling
A way to stabilize the ill-posed inverse problem is to rotate an object with respect
to the main magnetic field. For example, an object at orientation 1 (Figure 3.6 a) is in the
direction of the main magnetic field, then the object is rotated about the x-axis
(orientation 2, Figure 3.6 b). The dipole kernel (Figure 3.6 c) is in the Fourier domain
and fixed with respect to the object. With two rotations there are still zeros along the
cones surface. To eliminate zeros from the dipole kernel function, the object must be
rotated at least in 3 different orientations.

Figure 3.6. Rotation of object corresponding dipole field. Adapted from [97].
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2
In the Fourier domain, the magnetic field equation is shown here, where 𝑘𝑧𝑝
is the

projection of the object coordinate vector onto the direction of the main magnetic field.

2

⃗ ) = (1 − 𝑘𝑧𝑝 ) ∙ 𝑋(𝑘
⃗)
Δ𝐵 (𝑘
3
𝑘2

(4)

2
In Eq. 4 we are rotating the object about the x-axis, 𝑘𝑧𝑝
can be represented as

cosines and sines, and the degree of rotation (θ) is with respect to the main magnetic
field. If the object is sampled at N different angles, then the multiple measurements can
be used to solve the susceptibility at one location. In other words, there are three
equations and one unknown.

1

( −
3

(𝑘𝑧 cos 𝜃1 +𝑘𝑦 sin 𝜃1 )
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( −
) ∙ 𝑋(𝑘
⃗ ) = [ Δ𝐵2 ]
3
𝑘2
...
...
Δ𝐵𝑁
2
(𝑘𝑧 cos 𝜃𝑁 +𝑘𝑦 sin 𝜃𝑁 )
1
)]
2
[( −
1

3

(𝑘𝑧 cos 𝜃2 +𝑘𝑦 sin 𝜃2 )

2

(5)

𝑘

A direct solution of the equation involves the inversion of a very large matrix
which can be time extensive. The forward problem does not require forming such a large
matrix and can utilize the fast Fourier transform, allowing an iterative solution. Because
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the system is usually well conditioned after oversampling using different orientations, the
iterative method converges rapidly to a reasonable solution.
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(6)

𝑘

𝑋 ∗ = 𝑎𝑟𝑔𝑋⃗ 𝑚𝑖𝑛‖𝑊 ∗ 𝐹𝑇 −1 (𝐶𝑋 − 𝛥𝐵 )‖2

(7)

Where in Eq. 7, 𝐶 was used to compute a condition number which was minimized to
decrease the error propagation and compute an optimal angle combination which was
found to be (0, 60, 120 degrees) [96, 97].
In an experiment performed by [97], a phantom constructed with conical tubes at
different concentrations of gadolinium was rotated at the optimal angles similarly to
Figure 3.7. In Figure 3.8, (a) is the magnitude of the GRE image, (b) is the relative
difference field, (c) is the reconstructed susceptibility from three orientations and (d),
shows excellent linear correlation between estimated and expected susceptibility.
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Figure 3.7. Rotation of object at optimal angles. Adapted from [98].
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Figure 3.8. Gd-water phantom experiment. Adapted from [97].

3.5 Phase unwrapping
Quantitative susceptibility mapping requires magnitude and phase images at
multiple echo times with a long duration between each echo time (~3.2 msec) allowing
optimal signal dephasing to generate a high-quality field map [99]. The amount of signal
dephasing (∆∅) is related to the change in echo time (∆TE) by the equation ∆∅ =
2πγB0 ∆TE, where ∆f = γB0 ∆TE is the change in field. The field map can be generated
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using a linear regression approach in tissue regions that lack fat, such as the brain.
However, outside the brain an additional of step fat/water separation using a nonlinear
approach is required to create a field map. The field map estimation with fat/water
separation is generally solved as an energy (𝐸0 ) minimization algorithm (Eq. 8). The
spatially varying unknowns are water (𝜌𝑊 ), fat (𝜌𝐹 ) with chemical shift (𝑓𝐹 ),
susceptibility induced field inhomogeneity (𝑓𝑆 ), and signal decay rate (𝑅2∗ ) [100-107].

∗

2

𝑅2 𝑇𝐸𝑛 𝑖2𝜋𝑓𝑠 𝑇𝐸𝑛
𝐸0 (𝜌𝑊 , 𝜌𝐹 , 𝑓𝑠 , 𝑅2∗ ) = ∑𝑁
𝑒
× (𝜌𝑊 + 𝜌𝐹 𝑒 𝑖2𝜋𝑓𝐹𝑇𝐸𝑛 )‖2
𝑛−1‖𝑠(𝑇𝐸𝑛 ) − 𝑒

(8)

In Eq. 8, 𝑠(𝑇𝐸𝑛 ) represents the acquired signal at echo time 𝑇𝐸𝑛 and N is the number of
echoes.
Optimal echo times (TEfirst = 2.7, TElast = 16.5, ∆TE = 3.2 msec) were selected
based on phantom studies of fat water separation and chemical shift removal for field
map estimation using the algorithms GlObally Optimal Surface estimation (GOOSE)
with variable projection (VARPRO) [100, 108] and Simultaneous Phase Unwrapping and
Removal of Chemical Shift (SPURS) Using Graph Cuts (Figure 3.9) [99-101, 108].
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Figure 3.9. Phantom developed to determine optimal echo times. (A) Phantom
construction included multiple 15 mL conical tubes with increasing gadolinium
concentration from tube 1 to 6, tube at the center had mixture of oil (fat) and water,
additional water (W) and fat (F) tubes were placed near the edges of the container. (B)
Field map and subsequent water and fat maps were generated from the GOOSEVARPRO algorithm developed by [100, 108]. Optimal echo times were TEfirst = 2.7,
TElast = 16.5 with ∆TE = 3.2 msec.

3.6 Background field removal
There are multiple algorithms that perform background field removal, including
Sophisticated Harmonic Artifact Reduction on Phase data (SHARP) [109],
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Regularization-enabled SHARP [110], Laplacian boundary value (LBV) [111], and
Projection onto dipole fields (PDF) [112].
Projection onto dipole fields (PDF) is a novel background field removal technique
developed by [112] and is the method used throughout this thesis. The theory behind PDF
is based on the orthogonality between the local field (𝑓𝐿 ) inside a region of interest (ROI).
The local field is created by the local susceptibility distribution (𝜒𝐿 ) within the ROI based
on the relationship 𝑓𝐿 = 𝑑 ⊗ 𝜒𝐿 , where 𝑑 is the dipole kernel that represents the
magnetic field generated by a unit dipole at the origin using Lorentz sphere correction
[55, 113, 114] and ⊗ denotes the mathematical convolution. The background field (𝑓𝐵 ) is
outside the ROI and affected by the background susceptibility distribution (𝜒𝐵 ) such as
oxygen at the air-tissue interface. The total field is a summation of the local and
background fields,

𝑓 = 𝑓𝐿 + 𝑓𝐵 = 𝑑 ⊗ [𝜒𝐿 + 𝜒𝐵 ]

(9)

Based on the projection theorem in Hilbert space [115] the measured total field inside the
ROI is projected onto the background field, allowing direct computation of 𝑓𝐵 through a
mathematical minimization approach described by [112]. By removing the background
field from the measured total field, 𝑓𝐿 can be computed.
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3.7 Quantitative susceptibility mapping pipeline
The principle of QSM is to estimate tissue magnetic susceptibility from the
measured MR gradient echo signal phase. The magnetic susceptibility (Δχ) is a material
property that determines how much a material is magnetized in an applied magnetic field.
Δχ represents the magnetic susceptibility difference from water (in parts-per-million ppm
of the main magnetic field, SI units). In the forward model, the relationship between Δχ
and the measured local tissue magnetic field (Φ) is 𝐹Φ = 𝐷𝐹𝛥𝜒, where F is the discrete
Fourier transform operator and D is the dipole kernel in the Fourier domain [116]. The
estimation of the local Δχ is inherently ill-posed due to the presence of zeros in the
Fourier domain representation of the dipole kernel [97]. Hence, estimation of the
susceptibility map using a direct inversion of the dipole kernel leads to artifacts. Bayesian
regularization is a common approach to remove the artifacts from the reconstructed
susceptibility maps, which consists of a combination of a least squares data fidelity term
and a data regularizing term, leveraging sparsity of the image in a suitable transformation
domain to remove artifacts. In this study, the morphology enabled dipole inversion
(MEDI) technique [96, 117-119] is used to reconstruct the magnetic susceptibility using
an unconstrained formulation

𝛥𝜒 = 𝑚𝑖𝑛𝛥𝜒 𝜆‖𝑀𝐺𝛥𝜒‖1 + ‖𝑊(𝐹 −1 𝐷𝐹𝛥𝜒 − Φ)‖22

(10)

where || ||1 is the L1 norm, || ||2 is the L2 norm, M is an edge map estimated from the
magnitude image, G is a spatial gradient operator, W is an estimate of the signal-to-noise
ratio at each voxel from the magnitude images, and λ is a Lagrangian weight, balancing
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data fidelity and total variation-based data regularization [120]. The cost functional in Eq.
10 is minimized using a conjugate-gradient based implementation.
QSM images are generated from multi echo gradient echo images as shown in
Figure 3.4 A,D. Phase images have signal aliasing and are unwrapped using the algorithm
simultaneous phase unwrapping and removal of chemical shift (SPURS) with graph cuts
[99]. The total field map is estimated using a linear least-squares fit to the signal phase,
the mask is generated by thresholding a T2* magnitude image, the tissue field map is
extracted using projection onto dipole fields (PDF) [112], and QSM images are estimated
from the local field using Eq. 10.

Figure 3.10. Generation of quantitative susceptibility maps from gradient echo MRI
data. (A) gradient echo phase images at several echo times. (B) phase images are
unwrapped to remove phase aliasing. (C) total field map is obtained by voxel-based
linear regression. (D) magnitude images are thresholded to remove image noise to
generate (E) a cardiac binary mask. (F) local fields are estimated using the projection
onto dipole field (PDF) background field removal algorithm and (G) quantitative
susceptibility maps are generated by morphology enabled dipole inversion (MEDI).
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3.8 Comparison between Susceptibility Imaging Methods
When a paramagnetic molecule is introduced to an external magnetic field, the
molecule becomes magnetized and has a dipole effect. There is a chemical-shift
shielding field that affects the protons inside the molecule and a magnetic-susceptibility
inhomogeneity field, affecting neighboring protons and causing intravoxel dephasing and
rapid T2* decay which can be seen in brain MR images (Figure 3.11). The cranial nuclei
contain a higher percentage of iron causing signal decay in the central portion of the
brain. In T2-weighted (T2w) imaging, atomic and molecular interactions influence image
contrast (Figure 3.11). In T2*-weighted (T2*w) imaging, the local field inhomogeneities
influence image contrast, T2* relaxation, signal decay, and dephasing. SWI improves the
detection of susceptibility sources. However, T2*w and SWI imaging are unable to
distinguish between diamagnetic and paramagnetic material because each material causes
signal decay and magnetic field blooming. QSM provides the opportunity to uncover the
local tissue magnetic susceptibility from T2* weighted images. Additionally, QSM
demonstrates the highest contrast to noise ratio.

Figure 3.11. Comparison between susceptibility imaging methods. Globus pallidus:
external segment (Gpe), subthalamic (STN), and substantia nigra (SN) are easily
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delineated by QSM as compared to other susceptibility methods. Figure published by
[95].

3.9 Applications of quantitative susceptibility mapping
3.9.1 Susceptibility as a Biomarker: Microbleeds and Calcifications
Microbleeds and calcium deposits in the brain both appear hypointense in T2*w
images with elevated R2* (relaxation rate) and cannot be distinguished based on contrast
(Figure 3.12). QSM can be used to distinguish between these regions. Microbleed regions
cause a paramagnetic shift in the tissue due to deoxygenated hemoglobin and hemoglobin
byproducts. Calcium deposits cause a diamagnetic shift in the tissue. Paramagnetic
material appears bright (hyperintense) on QSM, whereas diamagnetic material appears
dark (hypointense).
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Figure 3.12. Quantitative susceptibility mapping can distinguish between
diamagnetic and paramagnetic material. T2*w imaging shows both microbleeds
(white arrows) and calcium deposits (black arrows) as hypointense regions. Whereas in
the QSM maps, the paramagnetic blood in the microbleeds appears hyperintense and the
diamagnetic calcium appears hypointense. Figure published by [95].

3.9.2 Susceptibility as a Biomarker: Blood Oxygen Saturation
A study performed by [121] investigated the magnetic susceptibility properties of
human blood samples at different oxygen saturations. There was a linear increase in
magnetic susceptibility versus deoxygenated hemoglobin concentration (Figure 3.13).
This relationship can then be used to determine the blood oxygen saturation.
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Figure 3.13. Magnetic susceptibility versus deoxygenated hemoglobin. Adapted from
[121].

The blood volume susceptibility (χ) depends linearly on the oxygen saturation
(𝑆𝑂2) and can be estimated as follows, the equation ignores the contribution from blood
products other than oxyhemoglobin and deoxyhemoglobin.

𝜒 = 𝐻[(1 − 𝑆𝑂2 )4𝜒𝑑𝑒𝑜𝑥𝑦ℎ𝑒𝑚𝑒 + 𝜒𝑜𝑥𝑦ℎ𝑒𝑚𝑒 ]
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(11)

H is the heme concentration in the blood in micromole per mL, which is a subject
specific physiological parameter that can be measured or estimated. The factor of 4 is the
number of deoxyhemes contained in a fully desaturated deoxyhemoglobin. By
rearranging the equation and taking the difference in susceptibility in the LV and RV we
can estimate the difference in blood oxygenation (∆𝑆𝑂2 ).

∆𝑆𝑂2 = 4𝐻𝜒

−∆𝜒

𝑑𝑒𝑜𝑥𝑦ℎ𝑒𝑚𝑒

(12)

In a previous study [122], multi-slice GRE images were acquired in healthy
volunteers and QSM images were generated from the GRE dataset (Figure 3.14). A
limitation of cardiac QSM is misregistration, which can cause artifacts and poor quality
QSM. Four volunteers out of the 14 had a good image quality score of 3.
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Figure 3.14. Heart Chamber Oxygenation using QSM. Cardiac short axis images were
acquired from a healthy volunteer. The top image is the long axis registered T2*weighted image, and below are the short-axis T2*-weighted images, followed by the
corresponding QSM maps. There is an increase in susceptibility in the RV from an
increased concentration of deoxygenated hemoglobin compared to the LV. Figure
published by [122].
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Chapter 4
Iron imaging in myocardial infarction reperfusion
injury
________________________________________________________________________
This chapter was adapted from:
Moon BF, Kamesh Iyer S, Hwuang E, Solomon MP, Hall AT, Kumar R, Josselyn NJ, HigbeeDempsey EM, Tsourkas A, Imai A, Okamoto K, Saito Y, Pilla JJ, Gorman JH, Gorman RC,
Tschabrunn C, Keeney SJ, Castillero E, Ferrari G, Jockusch S, Wehrli FW, Shou H, Ferrari VA,
Han Y, Gulhane A, Litt H, Matthai W, Witschey WR. Iron imaging in myocardial infarction
reperfusion injury. Nature Communications, 2020. 11(3273). Creative Commons license can be
viewed at http://creativecommons.org/licenses/by/4.0/.

4.1 Abstract
Restoration of coronary blood flow after a heart attack can cause reperfusion
injury potentially leading to impaired cardiac function, adverse tissue remodeling and
heart failure. Iron is an essential biometal that may have a pathologic role in this process.
There is a clinical need for a precise non-invasive method to detect iron for risk
stratification of patients and therapy evaluation. Here we report that magnetic
susceptibility imaging in a large animal model shows an infarct paramagnetic shift
associated with duration of coronary artery occlusion and presence of iron. Iron
validation techniques used include histology, immunohistochemistry, spectrometry, and
spectroscopy. Further mRNA analysis shows upregulation of ferritin and heme
oxygenase. While conventional imaging corroborates the findings of iron deposition,
magnetic susceptibility imaging has improved sensitivity to iron and mitigates
confounding factors such as edema and fibrosis. Myocardial infarction patients receiving
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reperfusion therapy show magnetic susceptibility changes associated with hypokinetic
myocardial wall motion and microvascular obstruction, demonstrating potential for
clinical translation.

4.2 Introduction
Reperfusion injury is a complication of vascular reperfusion therapy for acute
myocardial infarction and is estimated to occur in up to 60% of patients [35, 123]. While
reperfusion remains the most effective strategy for reducing infarct size and substantially
improves myocardial salvage, reperfusion injury may be independently associated with
adverse left ventricular (LV) remodeling, increased risk of fatal arrhythmias and
hospitalization for heart failure [31, 32, 39-41, 43-45, 50, 123].
These findings highlight the need for non-invasive imaging techniques, specific to
the molecular components of reperfusion injury, to identify patients at high risk for
adverse LV remodeling and heart failure. High-risk patients could be treated more
aggressively, while allowing low risk patients to be confidently seen in follow-up less
frequently, improving cost-effectiveness, or patients could be enrolled in studies of
emerging preventative approaches such as stem cell and biomaterial therapy [51-53].
Imaging could be used to evaluate the effectiveness or the dose-optimization of
adjunctive therapies for reperfusion such as periprocedural glycoprotein IIb/IIIa inhibitor
[42], iron chelation therapy [46], and β1-adrenergic receptor antagonists [48].
Pathologic levels of iron are a manifestation of many different types of heart
disease including myocardial hemorrhage [50]. While iron is an essential biometal in
many normal metabolic reactions involving cardiac function, it also has a pathologic role
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in reperfusion injury [50], specifically the production of reactive oxygen species and
subsequent DNA damage. Magnetic resonance imaging (MRI) provides a noninvasive
approach to map myocardial iron. It applies a very strong magnetic field (~ 3 Tesla) that
induces an additional magnetic field (~µT) that depends on the tissue magnetic
susceptibility distribution and its orientation with respect to the applied field [113].
Quantitative susceptibility mapping (QSM) is a technique that quantifies the magnetic
susceptibility using the induced field and is measured directly using the MRI signal
phase. Biometals such as iron perturb the MRI magnetic field and can be detected using
this technique.
To investigate the role of iron in reperfusion injury, we used QSM and associated
it with coronary occlusion duration in a large animal model and in patients with
successful reperfusion after ST-elevation myocardial infarction. The feasibility of this
approach was recently shown in healthy subjects [122]. However, no prior studies have
investigated the relationship between magnetic susceptibility and myocardial tissue iron
content with myocardial infarction in animal models or patients. Magnetic susceptibility
might be a specific imaging biomarker of myocardial hemorrhage, unlike conventional
MRI relaxation time contrast or mapping, which is also affected in part by inflammation
and fibrosis.
The purpose of this study was to measure the magnetic susceptibility of
myocardial infarction and determine its association with infarct tissue iron. We
hypothesized that reperfusion injury in myocardial infarctions show a paramagnetic shift
of magnetic susceptibility caused by elevated tissue iron as independently determined
using histology and inductively coupled plasma optical emission spectrometry (ICP-
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OES), electron paramagnetic resonance (EPR) spectroscopy and RNA analysis of
markers for iron metabolism. To test this hypothesis, we performed a cross-sectional
study in a large animal model of reperfusion injury myocardial infarction and
investigated the effect of reperfusion time on tissue iron and magnetic susceptibility.
QSM was compared to conventional MRI tissue characterization methods (1H T2*
relaxation times and LGE) and correlated to infarct size and cardiac function. We also
sought to determine the evolution of iron and magnetic susceptibility following
infarction. Finally, we studied patients following reperfusion for ST-elevation myocardial
infarction to determine the feasibility of mapping reperfusion injury using QSM.

4.3 Methods
4.3.1 Animal Study Experimental Design
All swine underwent occlusion of the left anterior descending or circumflex
coronary artery branches and were partitioned into groups: reperfusion occurred at 45(n=3), 90- (n=10) and 180- (n=5) minutes after initiation of occlusion or permanent
occlusion (n=4) without reperfusion. Swine had a terminal study 1-week post-infarction.
Three additional groups were studied at 3-day (n=3) and 8-week (n=8) after a 90- or 180min occlusion followed by reperfusion and a separate set of controls without myocardial
infarction (n=5). The experimental model was chosen to emulate human postpercutaneous coronary intervention ischemia reperfusion injury and remodeling postinfarction [124-126].
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4.3.2 Animal Care
Yorkshire swine (N=38; 30-35 kg at baseline, 100% male) were studied according
to the protocols approved by the Institutional Animal Care and Use Committee of
University of Pennsylvania (Philadelphia, PA). During all procedures, sedation was
induced with 25-30 mg/kg ketamine intramuscularly, endotracheal intubation was
performed, and the animal was maintained with a mixture of isoflurane 0.5-5% and
oxygen was kept at 6 L during procedure; tidal volume was manipulated based on arterial
blood gas readings, generally maintained at 10-20 mL/kg (Drager anesthesia monitor,
North American, Dragor, Telford, PA). Anesthesia and animal temperature were
monitored during surgical and imaging procedures to maintain a constant physiologic
state. Arterial access was obtained at the carotid artery for measurement of
intraventricular pressure (Millar Instruments, Houston TX). Venous access was obtained
at the internal jugular veins for administration of medication. After each procedure, the
animal was weaned from anesthesia and transported to the recovery room. Upon
completion of the terminal MRI study, the animal was returned to the operating room for
euthanasia and cardiac tissue harvest.

4.3.3 Animal Cardiovascular Surgical Procedure
A prophylactic antiarrhythmic regimen of 150 mg amiodarone, 1 mg/kg lidocaine
and 1 g magnesium sulfate were administered intravenously. A left thoracotomy was
performed, and the pericardium was opened. One or more coronary snares were
positioned at the branches of the circumflex artery (n=4) or left anterior descending
(LAD) artery (n=34) to induce an infarction of approximately 20-30% of the LV size.
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Swine underwent open chest surgery (n=17) or balloon catheter ligation (n=16). For open
chest surgery, the dimensions of the infarction were determined by visible color changes
at the epicardium (Figure 4.1 A,B). The exact locations of the ligation sutures (Figure 4.2
C) were decided upon after gross inspection of arterial anatomy, unique to the animal.
Ischemia was confirmed by visible color changes in the ischemic region and ST segment
elevations on ECG. After 45-, 90- or 180-min of coronary artery occlusion, the coronary
snare was removed, an intercostal nerve block was performed with bupivacaine at the
surgical site, and the chest was closed in muscle layers. For permanent occlusions (nonreperfused), the coronary snare was not removed. For balloon catheter occlusion, a 6Fr
Hockey-stick guide catheter (Cordis Corporation, Fremont, CA) was positioned in the left
main ostium under fluoroscopic guidance. A 0.18”, 180cm Choice-PT angioplasty wire
(Boston Scientific, Marlborough, MA) was carefully advanced into the LAD coronary
artery. A rapid-exchange 2.5x12mm angioplasty balloon (Apex, Boston Scientific,
Marlborough, MA) was placed over the angioplasty wire into the mid-LAD. Serial
coronary angiography was performed to position the angioplasty balloon immediately
distal to the second diagonal branch of the LAD. The angioplasty balloon was inflated
and maintained at 10-12 atm throughout the infarct procedure. After initial balloon
inflation, repeat coronary angiography was performed to confirm adequate distal
occlusion of the LAD. Uninterrupted coronary occlusion was maintained for 90, or 180
minutes with confirmation of acute MI by ST segment elevation in the precordial ECG
leads [125].

66

Figure 4.1. Generation of the animal model. Myocardial infarct generation in one
animal with 90 minutes of coronary artery occlusion followed by reperfusion. (A)
Schematic of the left ventricle coronary artery anatomy (red cross indicates suture sites
for coronary occlusion). (B) Myocardial ischemia observed by direct inspection of visual
discoloration of heart muscle to the affected area. White arrows indicate suture points for
coronary occlusion in apical view. Solid black line indicates the infarct border zone. (C)
Medial view (D) echocardiogram shows hypokinetic wall motion (black arrows) at
diastole and (E) systole. (F) electrocardiogram (ECG) observed at baseline (G) STelevation myocardial infarction at 90-min of coronary occlusion with limited definition of
QRS complex (H) partial restoration of QRS complex 30 minutes after reperfusion. LAD
= left anterior descending coronary artery. D1-4 = first through fourth diagonal branches
of LAD. OM1-OM6 = obtuse marginal branches of the left circumflex artery. LA = left
atrium. LV = left ventricle.

4.3.4 Animal Cardiovascular Magnetic Resonance Protocol
MRI studies were performed on a 3 T whole-body system (Trio; Siemens
Healthcare, Erlangen, Germany) with 40 mT/m gradients and 18 channel RF receiver
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arrays. Intraventricular pressure was interfaced to physiological monitoring software and
filtered to facilitate dual respiratory and cardiac gating (LabView, National Instruments,
Inc., Austin Texas). All 2D images were acquired in the short-axis during apnea and 3D
with dual cardiac and respiratory gating. Apnea was achieved by temporarily disabling
the animal ventilator.
In vivo retrospective, short axis, multi-slice cine MRI was performed with a TR =
41 msec, TE = 2.84 msec, FOV = 34 x 20 cm2, spatial resolution = 1.3 x 1.3 mm2, slice
thickness = 6 mm, number of slices = 18-20, flip angle = 12°, bandwidth = 399 Hz/pixel,
parallel imaging acceleration factor = 2, NEX = 1 and 3-4 slices with 60 cardiac phases
per slice were acquired during a breath hold of 20 sec followed by a 1 min break between
each breath hold. The animals received a 0.1 mmol/kg intravenous injection of
gadolinium contrast for LGE imaging (MultiHance; Bracco Diagnostics, Inc; Princeton,
NJ). Imaging was performed 10 minutes after injection of the contrast agent using an
inversion time (TI) scout sequence to determine the optimal inversion time to null normal
myocardial tissue signal. LGE MRI was obtained using a cardiac and respiratory gated
3D multishot phase-sensitive inversion recovery (PSIR) bSSFP sequence with a TR =
443 msec, TE = 2.42 msec, FOV = 35 x 219 cm2, voxel size = 1.4 x 1.4 x 4 mm3, number
of slices = 26, flip angle = 20°, bandwidth = 244 Hz/pixel, parallel imaging acceleration
factor = 2, NEX = 2 and total acquisition time ranged from 7-9 min. Respiratory and
cardiac gated 2D T2*-weighted single-echo gradient-echo images were obtained using
TR = 160 msec, TE = 10 msec, FOV = 24.0 x 17.3 cm2, spatial resolution = 0.9 x 0.9
mm2, slice thickness = 4 mm, number of slices = 10-15, flip angle = 13°, bandwidth =
260 Hz/pixel, parallel imaging acceleration factor = 2, NEX = 12 and each slice was
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acquired during a breath hold of 60 sec followed by a 3 min break between each breath
hold.
Ex vivo imaging at 1-week, animals were euthanized, their hearts were excised
and bathed in non-1H magnetic susceptibility-matched fluid (Fomblin), and T2*-weighted
multi-echo gradient-echo images of whole heart specimens were obtained using TR = 42
msec, 5 TEs = 3.3-16.1 with ΔTE = 3.2 msec, FOV = 23 x 23 cm2, voxel size = 0.9 x 0.9
x 0.9 mm3, flip angle = 16°, bandwidth = 610 Hz/pixel, NEX = 1 and total acquisition
time was 30 min.

4.3.5 Eligibility Criteria in Humans
Patients (n = 7, age = 61 ± 9 years, 1 female, 6 male) enrolled in this study had
ST-elevation acute myocardial infarctions and were treated by primary percutaneous
coronary intervention (PCI). The trial was conducted in accordance with the Declaration
of Helsinki and the Guidelines for Good Clinical Practice. The trial protocol was
approved by the Institutional Review Board of the University of Pennsylvania
(Philadelphia, PA, USA). The full trial protocol can be accessed through
ClinicalTrials.gov with trial registration number, NCT03531151. Patients were recruited
and imaged at the Penn Presbyterian Medical Center during the time period of March to
June 2018. Eligibility criteria included: (1) between the ages of 18 and 80, (2) must be
able to read and understand English and sign the informed consent form, (3) elevated and
delayed peak creatine kinase-MB and troponin I (cTnI) and troponin T (cTnT) in blood
serum, (4) no contraindications to magnetic resonance imaging such as claustrophobia,
(5) adequate renal function, as determined by glomerular filtration rate >30 mL/min, (6)
69

no presence of cardiac pacemaker or implanted cardioverter defibrillator, (7) were not
pregnant, (8) did not have a personal or family history of hypertrophic cardiomyopathy,
(9) did not have a history of seizure disorder. The indications for PCI were based on
electrocardiogram criteria showing 1 mm ST elevation in precordial leads or 0.5 mm ST
elevation in limb leads in at least 2 contiguous leads. A minority of patients received
thrombolytic therapy. The indications for PCI in these cases were: (1) lack of resolution
of ECG changes, as determined by >50% resolution of ST elevation from maximum
elevation, (2) significant resolution of chest pain, as assessed by verbal confirmation with
the patients, and (3) hemodynamic instability, as determined by non-invasive blood
pressure measurement, heart rate changes on ECG and clear lungs.

4.3.6 Human Cardiovascular Magnetic Resonance Protocol
MRI studies were performed on a 1.5 T whole-body system (Aera; Siemens
Healthcare, Erlangen, Germany) with 40 mT/m gradients and 48 channel RF receiver
arrays. Electrocardiograms were obtained during MRI and used for gating using a
wireless ECG monitor. All 2D images were acquired in the short-axis during breathholding and 3D with dual cardiac and respiratory gating. All patients were in a head first
supine position.
Retrospective, short axis, cardiac gated, breath held, multi-slice cine MRI was
performed with a TR = 33.4 msec, TE = 1.09 msec, FOV = 30 x 40 cm2, spatial
resolution = 2.1 x 2.1 mm2, slice thickness = 8 mm, number of slices = 10-15, flip angle
= 55°, bandwidth = 930 Hz/pixel, parallel imaging acceleration factor = 2, NEX = 1 and
3-4 slices with 30 cardiac phases per slice were acquired during breath hold of 10 sec
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followed by a 45 sec break between each breath hold. LGE imaging was performed 10
minutes after intravenous injection of 0.15 mmol/kg gadolinium contrast (Dotarem;
Guerbet USA, LLC; Princeton, NJ). Imaging was performed 10 minutes after injection of
contrast agent using an inversion time (TI) scout sequence to determine the inversion
time to null myocardial tissue signal. LGE MRI was obtained using a 3D multishot
phase-sensitive inversion recovery (PSIR) turboflash sequence with navigator respiratory
gating with TR = 882 msec, TE = 1.1 msec, FOV = 24 x 32 cm2, voxel size = 2 x 2 x 8
mm3, number of slices = 12 -15, flip angle = 40°, bandwidth = 1080 Hz/pixel, NEX = 1
and total acquisition time ranged from 5-6 min. Breath held cardiac gated 2D T2*weighted single-echo gradient-echo images were obtained using TR = 192 msec, TE = 15
msec, FOV = 23 x 30 cm2, spatial resolution = 1.6 x 1.6 mm2, slice thickness = 3 mm,
number of slices = 10-15, flip angle = 25°, bandwidth = 400 Hz/pixel, parallel imaging
acceleration factor = 2, NEX = 1, each slice was acquired during breath hold of 12-18 sec
followed by a 1 min break between each breath hold. All patients were in the MRI for a
maximum duration of 1 hour to acquire all protocol sequences.

4.3.7 QSM Image Analysis
Remote myocardium was defined as the regions showing no hyperintensity
(isointensity) on T2*-weighted images. The ROIs for healthy myocardium (isointense,
iso), infarct (hypointense, hypo) and infarct (hyperintense, hyper) were obtained by
segmenting the T2*-weighted images acquired at the last echo (TE = 16.1 milliseconds)
using thresholding active contour segmentation (ITK-SNAP 3.4, University of
Pennsylvania) [127]. Ex vivo infarct ROI measurements (Figure 5.1) included both
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hypointense and hyperintense regions. In vivo infarct ROI measurements included
hypointense regions. Statistical analysis was performed from the whole heart (multi-slice)
ROI basis for each animal.

4.3.8 MRI Parametric Mapping
T2* mapping was performed in Matlab-R2017B (MathWorks, Natick, MA, USA)
𝑇𝐸

using a 2-parameter model 𝑆 = 𝐴e−𝑇2∗ , where A is a free parameter. The T2* GRE
magnitude images had signal decay across five echo times (TE). The 2 parameters (A and
T2*) were estimated using least squares minimization and error maps were computed to
validate the accuracy of the fit.
The principle of QSM is to estimate tissue magnetic susceptibility from the
measured MR gradient echo signal phase. The magnetic susceptibility Δχ is a material
property that determines how effectively it is magnetized in an applied magnetic field.
Δχ represents the magnetic susceptibility difference from water (in parts-per-million ppm
of the main magnetic field, SI units). In the forward model, the relationship between Δχ
and the measured local tissue magnetic field (Φ) is 𝐅𝛷 = 𝐃𝐅𝛥𝜒, where 𝐅 is the discrete
Fourier transform operator and 𝐃 = 1⁄3 −

𝐤 2𝐳⁄
𝐤 2 is the dipole kernel in the Fourier

domain [116]. The estimation of the local Δχ is inherently ill-posed due to the presence of
zeros in the Fourier domain representation of the dipole kernel [97]. Hence, estimation of
the susceptibility map using a direct inversion of the dipole kernel leads to artifacts. A
common approach for removing the artifacts from the reconstructed susceptibility maps
is the use of Bayesian regularization, which consists of a combination of least squares
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data fidelity term and a data regularizing term, leveraging sparsity of the image in a
suitable transformation domain to remove artifacts. Tikhonov and the total variation (TV)
[120] constraints are well known data regularizers that penalize the gradient of the image
to enforce a piecewise-constant/smooth model [116, 117]. Here, the Morphology enabled
dipole inversion (MEDI) technique [96, 117-119] was used to reconstruct the magnetic
susceptibility using an unconstrained formulation
2

𝛥𝜒 = 𝑚𝑖𝑛𝛥𝜒 𝜆‖𝐌𝐆𝛥𝜒‖1 + ‖𝐖(𝐅 −𝟏 𝐃𝐅𝛥𝜒 − 𝛷)‖2

[1]

where || ||1 is the L1 norm, || ||2 is the L2 norm, M is an edge map estimated from the
magnitude image, G is a spatial gradient operator, W is an estimate of the signal-to-noise
ratio at each voxel from the magnitude images, and λ is a Lagrangian weight, balancing
data fidelity and total variation-based data regularization. The cost functional in Eq. 1
was minimized using a conjugate-gradient based implementation.
QSM images are generated from multi echo gradient echo images as shown in
Figure 3.3. Phase images have signal aliasing and are unwrapped using the algorithm,
simultaneous phase unwrapping and removal of chemical shift (SPURS) with graph cuts
[99]. The total field map is estimated using a linear least-squares fit to the signal phase,
mask is generated by thresholding a T2* magnitude image, the tissue field map is
extracted using projection onto dipole fields (PDF) [112], and QSM images are estimated
from the local field using Eq. 1.
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4.3.9 Cardiac Function
Cine MRI image series was used to calculate LV mass (Mass), end-diastolic
volume (EDV), end-systolic volume (ESV), ejection fraction (EF) cardiac output (CO),
wall thickening (WT), wall motion (WM) and wall thickness at end systole (WTES). Epiand endocardial contours were drawn manually at ED and ES using standard techniques
(Qmass 7.5, Medis, Leiden, The Netherlands).

4.3.10 Infarct Size Determination
Infarct volume and transmurality were assessed using full width at half maximum
(FWHM) thresholding with visible enhancement on LGE MRI (Qmass 7.5, Medis,
Leiden, The Netherlands). After defining the infarct region with FWHM, microvascular
obstruction (MVO) regions were defined as a hypointense core within a hyperintense
region on LGE and were manually segmented. Infarct volume included hyperintense
regions in LGE, selected based on FWHM and hypointense MVO regions that were
manually segmented.

4.3.11 Isolation of Tissue Samples and Histology
The excised heart from each animal was sliced (2 mm thickness) using a 330M
13" Prosciutto Meat Slicer (Berkel; Troy, OH). Infarct regions were sectioned into 1.5 to
2.5 cm2 samples from short-axis cardiac slices. Similarly, from each swine cardiac
specimen, at least four samples of viable myocardium were isolated from the tissue
opposite of the infarct region. Contiguous tissue samples were collected for both

74

histology, inductively coupled plasma optical emission spectrometry (ICP-OES) iron
measurements, Electron paramagnetic resonance spectroscopy (EPR) and gene
expression analysis.
For histology, 5 μm sections were obtained from a representative sample from
each of the infarct and remote regions from every animal. These sections were stained
with Hematoxylin and Eosin stain for cell viability, Masson Trichrome stain for fibrosis,
and Prussian Blue stain for iron and sections were digitally imaged at 40x magnifications
and viewed with Aperio ImageScope [v12.3.2.8013] (Leica Biosystems, Wetzlar,
Germany) software. Color adjustment of Prussian Blue digital images were performed
(parameters: sharpness 25%, brightness -38%, contrast 85%, saturation 400%,
temperature 6500-6700). Immunohistochemistry (IHC) was done using the Dako
Envision+ Peroxidase Based System (Agilent Technologies; Santa Clara, CA).
Hemoglobin, MHC class II antigen-presenting cells and newly recruited macrophages
were detected using a Hemoglobin Beta antibody (LSBio: LS‑C755633, 1:100 dilution),
Cathepsin-S antibody (GeneTex: GTX114350) and a MAC-387 antibody (Abcam:
ab22506), respectively. Tissue fiducial markers (ie. RV insertion and papillary muscles)
were used to correlate MR images with histology.

4.3.12 Inductively Coupled Plasma Optical Emission Spectrometry
The total amount of iron deposited within each myocardial sample ([Fe] in
milligrams per gram of tissue) was measured using inductively coupled plasma optical
emission spectrometry (ICP-OES). Stored samples were thawed from -80oC, blotted,
weighed and placed in individual borosilicate glass centrifuge tubes (VWR International,
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Radnor, Pennsylvania, USA) with PTFE-lined caps (MedSupply Partners, LLC, Atlanta,
GA, USA). Sample weights ranged from 50-300 mg. 75 μL of nitric acid (Fisher
Scientific, Hampton, NH, USA) and 225 μL of hydrochloric acid (Fisher Scientific,
Hampton, NH, USA) were added to the samples. The samples were then placed in a
water bath overnight at a temperature of 50 oC. The digested samples were cooled down
to room temperature, diluted with ultrapure water to a volume of 6 mL, and then filtered
through 0.2 μm Nalgene syringe-filters (Thermo-Fisher Scientific, Waltham, MA, USA)
and the filtrates were collected in individual 15 mL metal-free polypropylene tubes
(Thermo-Fisher Scientific, Waltham, MA, USA). A set of standards with concentrations
ranging from 0ppm to 100 ppm was prepared using a 1000 ppm iron stock solution
(Inorganic Ventures, Christiansburg, VA, USA).
All samples were analyzed using a Genesis ICP-OES (Spectro Analytical
Instruments GMBH; Kleve, Germany). Sample selection occurred automatically via an
ASX-260 autosampler (CETAC, Omaha, NE, USA); sample introduction occurred via
peristaltic pump at a rate of ~1.5 mL/min through a modified Lichte nebulizer with a
cyclonic spray chamber. Data was acquired using the dedicated SmartAnalyzer Vision
software. Fe content measured within each sample was averaged between three
duplicates and expressed as mg of Fe per L of sample by using the weight of the tissue
sample and volume dilution the concentration was calculated to be μg of Fe per g of
tissue.
ICP-OES was performed on multiple contiguous tissue samples of viable
myocardium and infarct regions and measurements were averaged from each region
within 90-, 45-, 180-min, and permanent ligation animal models. In all (n=327) total iron
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concentration measurements were analyzed, at 1-week post-infarction: remote (n=141)
tissue samples, 45-min (n=24), 90-min (n=32), 180-min (n=37), permanent (n=50) infarct
tissue samples, at 8-week post-infarction: remote (n=20) tissue samples and 90-min
(n=23) infarct tissue samples.

4.3.13 Electron Paramagnetic Resonance spectroscopy
Electron Paramagnetic Resonance (EPR) spectroscopy was performed with a
modified method based on the study by Yegorov et al [128]. Frozen samples (30-90 mg)
were weighed and homogenized in 500 μl of sterile saline with a TissueRuptor (ThermoFisher). Aliquots were saved for colorimetric iron measurements (Sigma MAK025).
Decreasing concentrations of a stock solution of 10 mM FeSO4 in 0.2 mM HCl (100 μM
- 12.5 μM) were diluted in saline to be used as standards. 200 μl of each homogenate and
FeSO4 standards were treated for 16 hours with 200 µl of 10 mM desferrioxamine
(Sigma). Desferrioxamine oxidizes Fe2+ to Fe3+, hence the desferrioxamine-bound iron
detected by EPR corresponds to both original Fe3+ in the homogenate and Fe2+ converted
into Fe3+. For EPR measurements, samples, standards and saline as blank (80 μl) were
placed in 1/8” teflon tubes (Cole-Parmer) and frozen in liquid nitrogen (77 K). EPR
spectra of samples, standards and saline in liquid N2 were recorded using a Bruker EMX
spectrometer under the following conditions: microwave frequency 9.47 GHz; power, 20
mW; modulation amplitude, 1.0 millitesla. EPR signal was measured at g ~ 4.3 to
estimate desferrioxamine-iron concentration. Fe content measured within each sample
was averaged between at least two duplicates and expressed as mg per g of tissue. EPR
was performed on multiple contiguous tissue samples of viable myocardium and infarct
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regions. Representative measurements from each infarct group were averaged together, in
all remote (n=25) and infarct (n=43) tissue samples were analyzed. The EPR technique is
not without error in tissue, as the isolation may mobilize or dilute catalytic iron. All tissue
was processed under the same conditions, making any mobilization or dilution of labile
iron during the isolation process comparable in all samples. However, it is possible that
the actual concentration (mg/g) of labile iron in the original tissue differs from the values
of our results.

4.3.14 Gene Expression of Iron Handling Markers
Total mRNA was isolated from frozen samples (remote, n=20, infarct, n=24)
using the RNeasy mini kit (Qiagen) and a TissueRuptor (Thermo). Total RNA
concentration and purity were measured on a Denovix spectrophotometer (Denovix).
cDNA synthesis was performed using 100 ng of RNA with Maxima H Minus First Strand
Kit (Thermo Scientific). Real-time PCR for quantification of mRNA was performed on a
Piko Real 96 (Thermo Scientific) by using a SYBR-Green protocol. Results were
expressed as fold changes in expression when compared with the average of remote
samples from all time points using the cycle threshold 2(ΔΔCT) method with GAPDH
and HPRT as reference genes. Primers producing a PCR product smaller than 200 bp
were designed using NIH Primer Blast with spanning an exon-exon junction when
possible. The corresponding sequences were: porcine GAPDH forward, 5’ccctgcgctctctgctc-3’; porcine GAPDH reverse, 5’- gccagagttaaaagcagccc-3’; porcine
HPRT forward, 5’- agccccagcgtcgtgatta-3’; porcine HPRT reverse, 5’acatctcgagcaagccgttc-3’; porcine FLC forward, 5’- ctcatggctggtcggcaata-3’; porcine FLC
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reverse 5’- tgtttggacggaacagaccc-3’; porcine FTH1 forward, 5′- ttgggtctgcagcttcatca-3′;
porcine FTH1 reverse, 5′-gccagaactaccaccaggac-3′; porcine DMT1 forward, 5’ccaggatctagggcatgtgg-3’; porcine DMT1 reverse, 5’- actggtggcttcttcagtcag-3’; porcine
ACO1 forward, 5’- accattgccaacatgtgtcc -3’, porcine ACO1 reverse, 5’agtctgggtcttgagaggagt -3’, porcine HO1 forward, 5’- gtaccgctcccgaatgaaca-3’ and porcine
HO1 reverse, 5’- tggtccttagtgtcctgggt-3’.

4.3.15 Statistical Analysis
Statistics were performed in Matlab-R2017B (MathWorks, Natick, MA, USA)
and R-3.6.3 (Vienna Austria). Descriptive results are reported as mean±SD or
interquartile range. Comparisons between two groups were performed using two-tail
student’s two-sample t-test. Comparisons between more than two groups were performed
using a one-way analysis of variance (ANOVA) with Tukey’s HSD post hoc multiple
comparisons test or a nonparametric Kruskal-Wallis test when appropriate. Comparisons
between multiple groups and two factors were performed using a two-way ANOVA with
Tukey’s HSD post hoc multiple comparisons test. Receiver operating characteristic
(ROC) curves were computed for each predictor variable with binary response variable as
infarct equal to 1 and remote myocardium equal to 0. The data was fit to a logistic
regression model. Area under the ROC curve (AUC) and Youden’s index were
computed. Sensitivity and specificity were measured at the optimal operating point.
Linear regression was performed to determine if there was a significant correlation
between two measures and the P-value was generated by testing whether the slope was
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zero using a Wald test. Results were found to be significant for P<0.05. *P<0.05 and
**P<0.001.

4.4 Results
4.4.1 Animal model of myocardial reperfusion injury
A swine model of reperfused and permanent myocardial infarction was generated
by occlusion of the left anterior descending or circumflex coronary arteries or their
branches [59, 129]. To investigate the association between iron, magnetic susceptibility
and severity of infarction, coronary occlusion was performed in swine for varying
duration: 45- (n=3), 90- (n=5), 180- (n=5) minutes and permanent occlusion (n=4) at 1
week after infarction. After mapping the affected territory (Figure 4.1 A), animals
showed discoloration of the myocardium upon visual inspection during surgical ligation
(Figure 4.1 B,C), hypokinetic wall activity on echocardiogram (Figure 4.1 D,E), and STelevation myocardial infarction (STEMI) on electrocardiogram (ECG) (Figure 4.1 F-H).
At 1 week after occlusion, cine MRI showed that all animals had comparable enddiastolic and end-systolic volumes (EDV and ESV), ejection fraction (EF) and left
ventricle (LV) mass (Table A.1), which suggests that animals did not show early LV
remodeling or substantial myocardial hypertrophy. Late gadolinium enhanced (LGE)
MRI showed that longer time-to-reperfusion was associated with larger infarct size
(P=0.05), greater microvascular obstruction (MVO) (P=0.05) and increased infarct
transmurality (P=0.02), as detailed in Appendix Figure A.1 and Appendix Table A.1.
Representative LGE MR images from each group are shown in Figure 4.3 A.
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4.4.2 Association of infarct magnetic susceptibility and iron
To determine the magnetic susceptibility of infarcted myocardium, we performed
cardiac QSM of whole heart ex vivo specimens at 1 week after coronary artery occlusion.
Quantitative susceptibility maps were generated from magnitude and phase gradient echo
MRI of explanted swine hearts at 0.2 mm3 voxel size immediately following in vivo MRI
as detailed (Figure 4.2). The magnetic susceptibility of each infarct group was Δχ45 = 0.03
± 0.05, Δχ90 = 0.07 ± 0.04, Δχ180 = 0.06 ± 0.03 and ΔχP = 0.03 ± 0.01 ppm compared to
remote myocardium 0.003 ± 0.02 ppm. There was a significant paramagnetic shift in
magnetic susceptibility in infarcted regions compared to remote myocardium in 90-min
(P=0.012) and permanent (P=0.025) infarct groups (Figure 4.3 B).
To determine if magnetic susceptibility was associated with iron content, we
quantified total iron using inductively coupled plasma optical emission spectrometry
(ICP-OES). Iron concentrations in infarct regions were elevated compared to remote
myocardium in all infarct groups ([Fe]45 = 0.08 ± 0.04, [Fe]90 = 0.11 ± 0.07, [Fe]180 =
0.18 ± 0.07, [Fe]P = 0.12 ± 0.14 mg/g, and [Fe]remote = 0.04 ± 0.02 mg/g) and colorimetric
assay of total and Fe2+ iron revealed the same trend (Figure 4.3 C and Appendix Figure
C.3).
Histologic evaluation was performed to investigate the spatial distribution of iron
in the myocardium. Spatial correspondence between histological hematoxylin and eosin
staining (H&E) and quantitative susceptibility maps was achieved using fiducial
landmarks including the RV insertion, papillary muscle shape, length of the LV and
distance to the apex. Swine reperfused after 90 minutes showed non-transmural infarcts
with dense peripheral extracellular matrix, a central zone of non-viable cardiomyocytes,
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and red blood cells. There was iron accumulation at the transition zone between necrotic
myocytes and mixed viable myocytes suggesting an active immune response originating
outside the infarct core (Figure 4.3 D). Permanently infarcted myocardium showed
extensive fibrosis, transmural injury, and substantially less positive iron staining (Figure
4.3 E) indicating a difference in wound healing and tissue remodeling. Viable
myocardium did not show positive iron staining, fibrosis, myocardial cell death or
hemoglobin (representative histology from each infarct group and remote myocardium
are shown in Appendix Figures C.1 and C.2).

Figure 4.3. Infarct magnetic susceptibility is associated with elevated tissue iron
content. At 1 week post-infarction (A), late gadolinium enhanced (LGE) MRI shows
hyperintense signal in the infarct region corresponding to uptake of gadolinium contrast
82

agent. In total, 90, 180 min, and permanent infarcts were larger with microvascular
obstruction, as indicated by hypointense regions in the infarct core (white arrows).
Images show views of the infarct region and left ventricular short axis (insets). Infarcts
show a paramagnetic shift in ex vivo quantitative susceptibility maps (QSM) for each
infarct group compared with remote (myo) regions. (B) There was a significant infarct
paramagnetic shift in 90 min (P =0.012) and permanent (P =0.025) infarct groups.
Magnetic susceptibility measurements in 45 min (n= 3), 90 min (n = 5), 180 min (n = 3),
and permanent (n = 4) infarct groups were from independent whole heart ex vivo
specimens, regions of interest (ROI) were compared using a two-tailed two-sample t test
for each infarct group. (C) Infarct total iron concentration was significantly elevated in 90
min (P =0.001), 180 min (P < 0.0001), and permanent (P = 0.015) infarcts compared with
remote myocardium. In total, 45 min (n = 31, 24), 90 min (n= 32, 32), 180 min (n = 48,
37), and permanent (n = 30, 50) measurements were from independent tissue samples
(myo, infarct), tissue regions and infarct groups were compared using two-way analysis
of variance (ANOVA) with Tukey’s HSD post-hoc test. (D) Representative histological
findings in a 90 min reperfused infarct. Trichrome stain shows a nontransmural infarct,
fibrosis, and nonviable myocytes at the core of the infarct. Prussian blue staining shows
iron accumulation (black arrows) at the transition zone between necrotic myocytes and
mixed viable myocytes suggesting an active immune response originating outside the
infarct core. (E) Representative histological findings in a permanent occlusion infarct.
Trichrome stain shows fibrosis and transmural infarct. Prussian blue shows iron deposits
at the peripheral infarct fibrotic regions. Histology was repeated independently on
multiple tissue sections (n > 5) for each whole heart specimen (n = 15) showing similar
histopathological findings for each infarct group. The results are reported as mean ± SD.
#P = 0.094 and significance *P < 0.05 and **P < 0.001.

We further investigated the nature of elevated iron using electron paramagnetic
resonance (EPR), gene expression assays and immunohistochemistry. Iron was
significantly increased in the infarct region as shown by total iron measurements from
ICP-OES (P=7e-22) and desferrioxamine-chelatable labile iron from EPR (P=3e-4)
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(Figure 4.4 A and Appendix Figure C.3 B). To confirm the increase of iron, we tested the
gene expression of cellular iron metabolism markers in infarct (n=24) and remote
myocardium (n=20) tissue samples. Ferritin is a scavenger of intracellular labile iron,
arresting its redox activity. Ferritin light chain (FLC) expression significantly increased
in the infarct (infarct, 1137.2% Myo vs. remote myocardium, 88.1% Myo, P=0.002) and
ferritin heavy chain (FTH1) expression was not significantly modified in infarct vs.
remote area in any of the conditions studied (Figure 4.4 B). The expression of the
intracellular iron sensor Iron Regulatory Protein 2 (IRP1, also known as ACO1) was
significantly decreased in the infarct region (infarct, 61.4% Myo vs. remote myocardium,
102.4% Myo, P=0.035) (Figure 4.4 C). Divalent metal transporter 1 (DMT1), which
transports iron into the labile iron pool, was significantly decreased in the infarct region
(infarct, 53.7% Myo vs. remote myocardium, 99.1% Myo, P=0.002) (Figure 4.4 D).
Heme oxygenase-1 (HO1) transcription is activated in response to increased intake of
heme proteins, and its expression was significantly increased (infarct, 1300% Myo vs.
remote myocardium, 100% Myo, P=2e-4) (Figure 4.4 E). There was increased
hemoglobin staining by immunohistochemistry in reperfused and permanently occluded
animals, compared to remote myocardium (Figure 4.4 F,G and Appendix Figure C.2),
which contributed to the increased HO1 expression.
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Figure 4.4. Ex vivo iron content and expression of cellular markers of iron
homeostasis. (A) Infarcts had significantly increased total iron (P= 7e−22) and labile iron
(P= 3e−4) concentration compared with remote (myo) regions. Myo (n = 188) and infarct
(n = 216) total iron ICP-OES and myo (n = 25) and infarct (n = 43) labile iron EPR
measurements were from independent tissue samples. (B) Ferritin light chain (FLC)
expression was significantly increased in infarct regions (P= 0.002) and ferritin heavy
chain (FTH1) expression was not significantly modified (P= 0.15). (C) The expression of
the intracellular iron sensor iron regulatory protein 2 (IRP1, also known as ACO1) (P =
0.035), and (D) divalent metal transporter 1 (DMT1), which transports iron into the labile
iron pool (P = 0.002), were significantly decreased in infarct regions. (E) Heme
oxygenase-1 (HO1) expression was significantly increased in infarct regions (P = 2e−4).
Total mRNA was isolated from myo (n = 20) and infarct (n= 24) independent frozen
tissue samples and real-time PCR for quantification of mRNA was performed by using an
SYBR-Green protocol. The results are expressed as fold changes in expression when
compared with the average of remote samples from all time points using the cycle
threshold 2(ΔΔCT) method with GAPDH and HPRT as reference genes. Total and labile
iron, FLC, FTH1, IRP1, DMT1, and HO1 measurements were compared between myo
and infarct regions using a two-tailed two-sample t test. (F) Representative 90 min
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reperfused infarct at 1 week post-infarction shows a lack of cell viability (H&E) and
positive hemoglobin (Hb) beta staining (HBB IHC). (G) Representative permanently
occluded infarct at 1 week post-infarction shows similar dark Hb β staining, with less
concentrated areas of positive staining. The darker staining may reflect extracellular or
uptake of Hb β from past hemorrhage. Histology was repeated independently on multiple
tissue sections (n > 5) for all reperfused and permanent infarcts which showed similar
histopathological findings within each infarct group. The results are reported as mean ±
SD. Significance is indicated by *P < 0.05 and **P < 0.001, region of interest (ROI).
Analysis is across all reperfusion groups.

4.4.3 Magnetic susceptibility imaging versus conventional MRI
To investigate the relationship between magnetic susceptibility and conventional
MRI biomarkers in ischemic myocardium, we compared LGE MRI, T2*-weighted
images (T2*w), T2*-maps, phase images and susceptibility maps in Figure 4.5 A
(Appendix Figures B.1, B.2, and B.3). Three regions were classified from T2*w images:
(1) isointense (iso) regions were remote myocardium, (2) hyperintense (hyper) and (3)
hypointense (hypo) regions infarct regions. T2*w images and maps showed hypointense
regions after 90- and 180-min of coronary artery occlusion but not after 45-min or in
permanently infarcted myocardium. Susceptibility maps showed increased susceptibility
in T2*w hypointense regions at 1-week after 90- (P=7e-4) and 180-min (P=0.003) of
coronary artery occlusion compared to isointense regions (Figure 4.5 B). As expected,
hypointense regions seen at 1-week after 90 and 180-min of coronary artery occlusion
correlated with a decrease in T2* relaxation times and a paramagnetic shift (Figure 4.5
C). In contrast, the absence of both T2*w hypointensity and decrease in T2*, permanent
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infarcts also showed a significant paramagnetic shift in magnetic susceptibility compared
to remote regions (P=0.025).
Receiver operating characteristic (ROC) curves were computed for each predictor
variable (magnetic susceptibility, T2* relaxation time, R2* relaxation rate) with binary
response variable as infarct equal to 1 and remote myocardium equal to 0 (Appendix
Figure B.4). Magnetic susceptibility had increased area under the ROC curve (AUC) and
showed superior balance between sensitivity and specificity at classifying infarct versus
remote viable myocardium compared to T2* and R2*.
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Figure 4.5. Comparison of conventional MRI with magnetic susceptibility imaging.
(A) In vivo late gadolinium enhanced (LGE), and ex vivo T2*-weighted (T2*w), T2*
maps, gradient-echo phase images, and quantitative susceptibility maps (QSM) obtained
1 week after 45, 90, 180 min, and permanent coronary occlusion. In distinction to the 45
min infarct group, 90, 180 min, and permanent infarcts showed a hypointense signal on
LGE MRI corresponding to delayed uptake of the contrast agent (white arrows). T2*w
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and T2* maps show hypointense regions after 90 and 180 min of coronary occlusion, but
not after 45 min and permanent coronary occlusion. This suggests elevated iron content
in reperfused infarcts with longer coronary occlusion time. Gradient echo phase images
show local signal dephasing in the infarcted myocardium in all infarct groups and
corresponds to elevated susceptibility seen in QSM. (B) Magnetic susceptibility from iso,
hyper, and hypo regions of interest (ROI) on T2*w images. In total, 90 min reperfused
infarcts showed substantially elevated magnetic susceptibility in hypo compared with
hyper (P =0.006) and iso (P = 7e−4) regions. In total, 180 min infarcts were elevated in
hypo compared with hyper (P = 0.003) and iso (P = 0.003) regions, and permanent
infarcts were elevated in hyper compared with iso (P = 0.025) regions. (C) T2* relaxation
times from iso, hyper, and hypo ROI on T2*w images. Together, (B) and (C), show
elevated magnetic susceptibility in all infarct groups despite increased T2* relaxation
times in 45 min and permanent infarcts. This suggests that low levels of iron may be
undetectable by T2* when edema and fibrosis changes are present. Magnetic
susceptibility and T2* measurements in 45 min (n = 3), 90 min (n = 5), 180 min (n =3),
and permanent (n = 4) infarct groups were from independent whole heart ex vivo
specimens. ROIs were compared for each infarct group using one-way ANOVA with
Tukey’s HSD post-hoc test. The results are reported as mean ± SD. Significance is
indicated by *P < 0.05 and **P < 0.001. T2*w and phase images are at echo time (TE)
16.1 ms.

4.4.4 Detection of an active immune response and iron
To investigate if tissue magnetic susceptibility and iron content was associated
with inflammation at 1-week after reperfusion injury, we performed histology of
ischemic tissues. Representative images of 180-min and permanent occlusion myocardial
infarcts are shown in Figure 4.6. All animals showed regions of iron accumulation at the
transition zone between myocyte necrosis and mixed myocyte viability colocalized with
MHC class II antigen-presenting cells and newly recruited macrophages. H&E stains
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showed tissue damage, cell viability and an active immune response (Appendix Figure
C.1). The central core of the infarcts had autolyzed myocytes with preserved cell
membrane but showed pale or absent nuclei and pale cytoplasm with loss of sarcomere
cross striations. Reperfused infarcts showed significantly more iron deposition compared
to the permanent infarcts. Dense iron deposition was predominantly found in the
transition zone of the infarction. Permanent infarcts had reduced erythrocyte
extravasation and less iron deposition at the transition zone, although clusters of iron
were found at the border of the fibrotic region of the infarct (Figure 4.3 E and Figure 4.6
B,C), indicating an active immune response with newly recruited macrophages (Figure
4.6 B) and iron containing MHC class II antigen-presenting cells (Figure 4.6 C) at the
periphery of the fibrotic region. The elevation in iron concentration (Figure 4.3 C) along
with a reduced positive Prussian blue staining in the permanent infarct group indicates
intracellular iron released from autolyzed myocytes at the core of the permanent infarct
and an active immune response originating outside the infarct region.
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Figure 4.6. Immune response and iron deposition in reperfused and permanent
infarcts. (A) Representative 180 min reperfused infarct at 1 week post-infarction shows
regions of iron accumulation at the transition zone between myocyte necrosis and mixed
viable myocytes (Prussian blue, black, and blue arrows) colocalized with MHC class II
antigen-presenting cells (Cathepsin-S, black arrows) and newly recruited macrophages
(MAC-387, blue arrows). (B, C) Representative permanently occluded infarct at 1 week
post-infarction also had heterogeneous macrophage aggregation with newly recruited
macrophages (MAC-387, blue arrows) and MHC class II antigen-presenting cells
(Cathepsin-S, black arrows) colocalized with iron accumulation (Prussian blue, black,
and blue arrows). Histology was repeated in independent tissue sections for 90 (n =2),
180 min (n =2) reperfused, and permanent (n = 2) infarcts which showed similar
histopathological findings within reperfused and permanent infarct groups. A and B are at
×40 magnification and C is at ×100 magnification.
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4.4.5 Magnetic susceptibility and iron evolve in wound healing
To investigate how magnetic susceptibility and iron progress after infarction, we
performed a cross-sectional MRI study in control animals without myocardial infarction
(n=5) and at 1-week (n=15) and 8-weeks (n=8) after infarction. Cardiac structural and
functional data were obtained using cine and LGE MRI, and show changes in wall
thickening, end-systolic wall thickness, and wall motion between remote and infarct
regions and between controls, 1- and 8-weeks (Appendix Table A.2). In vivo QSM was
acquired at 1-week (n=11) and 8-weeks (n=8) post-infarction. LGE, T2*-weighted and
QSM images from one swine imaged serially at 1- and 8-weeks post-infarction are
displayed in Figure 4.7 A (additional pigs shown in Appendix Figure B.5). At 1-week
there was a significant paramagnetic shift within the infarct region (Δχ = 0.055 ± 0.039
ppm) compared to the remote myocardium (Δχ = -0.011 ± 0.020 ppm) (P=2e-4) (Figure
4.7 B). This was associated with elevated total iron concentration, measured by ICP-OES
(infarct samples n=68, [Fe] = 0.15 ± 0.08 mg/g vs. remote myocardium samples n=80,
[Fe] = 0.04 ± 0.01 mg/g, P<0.0001) (Figure 4.7 C). By 8-week post-infarction there was a
significant decrease in both infarct magnetic susceptibility (Δχ = -0.019 ± 0.034 ppm,
P=1e-4) and total iron concentration (n=23, [Fe] = 0.06 ± 0.04 mg/g, P<0.0001). There
was a significant association between MVO versus magnetic susceptibility (R2=0.31,
P=0.048) and a significant association between total iron concentration and ex vivo tissue
magnetic susceptibility (R2=0.48, P=7e-4) (Appendix Figure C.4 A,C).
Histology (Figure 4.7 D,E) showed the evolution of fibrosis and necrosis between
1- and 8-weeks post-infarction. Erythrocyte and hemoglobin deposition were seen at 1week. Prussian blue shows iron accumulation at the transition zone between necrotic
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myocytes and mixed viable myocytes plus an active immune response. At 8-weeks postinfarction there was a lack of erythrocytes and immune cells. Prussian blue showed
sparse iron accumulation localized at the infarct core and there was a lack of positive
hemoglobin staining (representative histology from each post-infarction time point are
shown in Appendix Figures C.1 and C.2).
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Figure 4.7. Magnetic susceptibility and iron evolve from 1 to 8 weeks postinfarction. (A) In vivo late gadolinium enhanced (LGE), T2*-weighted (T2*w), T2*
maps, and quantitative susceptibility maps (QSM) from a reperfused 90 min animal
imaged serially. In vivo LGE, reperfused infarcts at 1 week postinfarction had
microvascular obstruction (MVO) indicated by hypointense regions (white arrows),
MVO is no longer present at 8 weeks post-infarction. QSM shows an infarct
paramagnetic shift (red arrows) compared with viable myocardium (myo). (B) At 1 week,
reperfused infarcts had a significant paramagnetic shift (P = 2e−4) associated with (C) a
significant elevation in infarct iron concentration (P < 0.0001). From 1 to 8 weeks postinfarction there was a significant decrease in infarct magnetic susceptibility (P= 1e−4)
and iron concentration (P < 0.0001). Magnetic susceptibility was measured in vivo at 1
week (n= 11) and 8 weeks (n =8) post-infarction from independent animals. Total iron
ICP-OES measurements at 1 week (n = 80, 68) and 8 weeks (n = 20, 23) were from
independent tissue samples (myo, infarct). Two-way ANOVA with Tukey’s HSD posthoc tests were used to compare across tissue regions and post-infarction time points. (D)
Representative 90 min 1 week post-infarction histology shows extensive fibrosis
(Trichrome), erythrocyte deposition (H&E, inset), and iron accumulation (Prussian blue,
inset) at the transition zone between autolyzed necrotic myocytes (H&E) and mixed
viable myocytes. Immunohistochemistry shows positive staining for hemoglobin (HBB
IHC). (E) Representative 90 min 8 weeks post-infarction histology shows dense collagen
deposition (Trichrome), lack of cell viability (H&E), sparse regions of iron accumulation
(Prussian blue, inset) within the infarct core and there was a lack of positive hemoglobin
staining (HBB IHC). Histology was repeated independently on multiple tissue sections (n
> 5) for each post-infarction time point which showed similar histopathological findings
within each group. The results are reported as mean ± SD. Significance is indicated by
**P < 0.001. T2*w images are at echo time (TE) 10 ms.
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4.4.6 Magnetic susceptibility in STEMI patients
The large animal model preclinical findings demonstrated the potential for clinical
translation and formed the basis of an observational, cross-sectional MRI study in
humans. Seven STEMI patients (mean±SD, age = 61 ± 9 years, 1 female, 6 males;
Appendix Table A.4) treated by primary percutaneous coronary intervention with
successful reperfusion and without a previous myocardial infarction underwent
cardiovascular MRI at 1.5 T. All subjects gave informed consent to participate in a
research study approved by the Institutional Review Board of the University of
Pennsylvania. The examinations were performed at 2.9 ± 1.5 days following primary
reperfusion and included T2*w, T2* relaxation time mapping, cardiac QSM, and late
gadolinium enhanced (LGE) MRI.
Four of 7 patients had hemorrhagic myocardial infarction as determined by >1 g
of hypointense region on T2* MRI. Representative LGE, T2*w, and QSM are shown in 3
subjects (Figure 4.8, all subjects appear in Appendix Figure B.6, reproducibility analysis
in Appendix Figure B.7 and MRI findings in Appendix Table A.3). Hemorrhage was
observed at least once in the right coronary artery (n=2), left anterior descending artery
(n=3), and left circumflex artery (n=1). All patients (n=3) with TIMI grade 0/1 prior to
revascularization had myocardial hemorrhage while 3 of 4 patients with TIMI grade 2/3
did not have hemorrhage. After intervention, all patients had successful reperfusion with
TIMI grade 3 flow. Infarct size and regions of microvascular obstruction tended to be
larger in patients with hemorrhage (45.9 g [IQR = 38.6, 52.8] g) compared to those
without (31.9 g [IQR = 14.0, 43.9]). The magnetic susceptibility of the infarct in the
hemorrhage group (n=4, 0.16 ± 0.09) was significantly elevated compared to the remote
95

myocardium in all patients (n=7, -0.01 ± 0.06 ppm, P=0.005). The duration from
symptom onset to reperfusion was 303.7 min in the no hemorrhage group and 695.5 min
in the hemorrhage group (Appendix Table A.3). Three of 4 patients who showed a
magnetic susceptibility alteration had transmurality>75% and MVO> 5% LV mass. Of
the patients who we did not detect a change in magnetic susceptibility, none had
transmurality >75% and only 1 had MVO>5%.

Figure 4.8. Imaging of ST-elevation myocardial infarction patients after reperfusion
therapy. (A) Patient had a nontransmural infarction with microvascular obstruction
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(LGE, white arrows), hemorrhage, and elevated magnetic susceptibility (QSM, red
arrows). (B) Patient had substantial transmural infarction with microvascular obstruction,
and significant hemorrhage and increases in magnetic susceptibility. (C) Patient shows a
nontransmural infarction, minimal microvascular obstruction, and no substantial increase
in magnetic susceptibility in the infarct region. All patients were reported to have TIMI
grade 3 flow (no flow defects) following reperfusion and were imaged within 48 h after
reperfusion therapy. T2*w images are at echo time (TE) 10 ms.

4.5 Discussion
This study investigated the association between reperfusion therapy and magnetic
susceptibility, an endogenous imaging biomarker of tissue iron, in a clinically relevant
large animal model of hemorrhagic myocardial infarction and in patients after reperfusion
therapy for acute myocardial infarction. We found that there was a paramagnetic shift in
tissue magnetic susceptibility corresponding to the affected coronary vascular bed and
this was associated with spatially elevated tissue iron content. Tissue magnetic
susceptibility was closely associated with the duration of coronary artery occlusion; yet
while animals with longer time-to-reperfusion showed significant changes in magnetic
susceptibility, also animals that did not undergo reperfusion after myocardial infarction
showed magnetic susceptibility changes and elevated tissue iron content in comparison to
remote myocardium.
The development of methods to image myocardial ischemia reperfusion injury
non-invasively is essential to improve our understanding of pathophysiology, and
prognostication to determine risk factors for adverse left ventricular remodeling and
arrhythmias. In this study, we assessed reperfusion injury in a large animal model using
quantitative susceptibility mapping and associated it with time-to-reperfusion in patients.
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Elevated magnetic susceptibility shown on QSM was associated with accumulation of
post-infarction tissue iron, increased desferrioxamine-chelatable iron and active cellular
iron homeostasis response, which were independently validated with histology and
inductively coupled plasma optical emission spectrometry, electron paramagnetic
resonance and gene expression analysis by real-time PCR. The combination of
susceptibility maps with LGE MRI and relaxation time mapping may substantially
improve our understanding of the distribution of iron in myocardial ischemia, allowing
for more robust and reliable quantification and interpretation of the results. We
investigated this combined approach in a preliminary study of seven patients with STelevation myocardial infarction and showed that some, but not all patients, had regions of
elevated magnetic susceptibility that were spatially consistent with the area of infarction
reported by ECG, cardiac catheterization and LGE MRI. While all patients were
successfully reperfused as assessed by coronary TIMI flow grade, not all patients had
hemorrhage or elevated infarct magnetic susceptibility. However, the patient’s infarct
size ranged from 10-45% of the LV. This may indicate that despite adequate coronary
flow, there was still myocardial tissue ischemia without successful blood perfusion
causing extensive fibrotic regions in these patients (patients 3-5) resembling the
physiology seen with permanent occlusion infarcts. These differences among patients
may be attributed to their individual anatomic coronary collateral vessels.
In distinction to remote myocardium, permanently occluded animals had elevated
iron content, suggesting that there was elevated tissue iron even in the absence of
hemorrhagic reperfusion injury. We found that moderately elevated magnetic
susceptibility in permanently occluded animals did not cause substantial signal loss on
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T2*-weighted images or relaxation time decreases on T2* maps. The reason for the
discrepancy between T2* compared to total iron/magnetic susceptibility measurements is
not yet fully clear and may be caused by technical factors such as field strength [130] and
voxel size [131] or an incomplete understanding of the physical mechanisms underlying
T2* contrast in their relation to infarct pathophysiology. There was only a moderate
association between transverse relaxation rate (R2* [sec-1]) and iron (R2 = 0.19,
P=0.011), but this improved when excluding the 45-min and permanent infarct groups
(R2 = 0.58, P<0.0001) (Appendix Figure C.4 D,E). It has been observed that there is an
association between the duration of ischemia, mobilization of iron in and out of cells and
the labile iron fraction [132-134], and time since the initial event. A difference in R2*
could occur if, in the reperfused group, there were an alteration in the rate of water
exchange with protein-bound iron or labile iron within cells. Alternately, differences in
the clustering or aggregation of iron post-infarction may result in altered relaxation times.
It was recently shown in patients that the amount of hemorrhage peaks on day 2 postinfarction using T2* MRI [123], which suggests an underlying pathophysiologic change
such as the accumulation of protein-bound iron in macrophages that contributes
substantially more to the transverse relaxation rate R2* (1/T2*). However, technical
factors such as image spatial resolution affect T2* relaxation times and must also be
taken into consideration.
In comparing QSM to conventional gadolinium and relaxation time contrasts,
there were several interesting findings. All animals with permanent infarcts and 90- and
180-min reperfused infarcts had hypointense regions within the hyperintense infarct on
LGE MRI, which indicates more severe infarctions and microvascular obstruction. In the
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permanent infarct group, all animals showed microvascular obstruction without
hypointense regions on T2*. In reperfused animals at 90- and 180-min, T2*-weighted and
T2*-maps of reperfused infarcts had hypointense regions attributed to hemorrhage.
However, the sensitivity, specificity and spatial distribution of conventional MRI
contrasts and mapping techniques such as T1 [58, 84, 87, 88], T2 [39, 41, 67-72] and T2*
[19, 36, 50, 73] and the MR signal phase (susceptibility-weighted imaging) [74-76] to
hemorrhage, edema and fibrosis are currently active areas of investigation. T2 and T2*
MRI typically appear hypointense with hemorrhage, but the spatial correspondence of T2
and T2* may not overlap and the relative contributions of hemorrhagic injury, edema and
fibrosis to the MR signal are unknown. T2 and T2* are increased in edema and fibrosis
[70], but appear to decrease in hemorrhagic infarction. T2* is affected by imperfections
in the MRI static magnetic field, background field heterogeneity at the lung-myocardium
interface, signal fluctuations due to cardiac and respiratory motion, and fluctuations of
the MR signal due to the intravascular blood oxygen level-dependent (BOLD) effect and
venous oxygen saturation. Moreover, the effect of hemorrhagic tissue iron on the MR
signal phase is nonlocal, affecting adjacent non-hemorrhagic tissues, and the presence
and spatial extent of hemorrhage may be underestimated or overestimated and
confounded by other tissue changes.
There has been some progress toward isolating the contribution of microvascular
obstruction (MVO) or hemorrhage to worsening of heart disease after myocardial
infarction. In a study of more than 200 patients, myocardial hemorrhage was associated
with adverse remodeling and hemorrhage, but not MVO. Hemorrhage was also
associated with a composite hazard outcome of cardiovascular cause of death or heart
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failure event post discharge [123]. In an additional 30 patients who underwent serial
imaging, MVO and hemorrhage showed a distinct time course post-infarction.
Myocardial iron appears to be retained in some patients for months after the acute event
and 13 or 15 patients had evidence of residual iron deposition using T2* imaging at 5
months after infarction even in the absence of MVO [89, 135]. We found that all animals
that underwent permanent coronary occlusion showed significant MVO, yet the spatial
distribution of iron deposition as observed on T2* or QSM did not match MVO on LGE
(Appendix Figure B.1). In two patients we also found limited MVO and no apparent
hemorrhage (patients 4 and 5, Appendix Figure B.6). Given these findings, it is apparent
that MVO and hemorrhage are distinct pathophysiologic traits that sometimes appear
coincident. LGE contrast shows the accumulation of a T1 contrast agent (gadolinium)
within the extracellular space of the myocardium. Pathology that limits transport of
gadolinium to the myocardium, such as an obstructed artery or microvascular obstruction
are expected to manifest the same patterns of contrast. QSM is a non-gadolinium-based
contrast and is sensitive to changes in the MR signal phase. Myocardial deposition of
gadolinium-based contrast agents appears to have limited influence on the MR signal
phase relative to iron found in hemorrhagic MI. We found that significant phase changes
were present in hemorrhagic myocardium even in the absence of gadolinium contrast
agent in one animal (Appendix Figure B.1).
Our analysis showed several aspects of iron accumulation and cellular handling in
reperfusion injury, where there was an elevation in total iron concentration and positive
Prussian blue staining in reperfused and permanent infarcts. In assessing the underlying
biological processes of iron, we focused on (1) intracellular and (2) extracellular iron.
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During homeostasis, most of the intracellular iron is bound to ferritin and is redoxinactive. A small fraction of intracellular iron belongs to the labile iron pool to be used in
intracellular reactions [132]. The iron in the labile pool is redox active, and has the
potential of generating free radicals upon injury [133, 134]. IRP1/ACO1 acts as an
intracellular sensor of iron levels: in low intracellular iron conditions it enhances DMT1
expression to increase iron uptake and accumulation in the labile iron pool and represses
ferritin expression; in high intracellular iron conditions, it inhibits DMT1 and derepresses iron responsive elements in the ferritin genes, increasing their expression [133].
EPR analysis revealed significantly increased infarct chelatable iron compared to remote
myocardium. Desferrioxamine-bound tissue iron detected by EPR likely corresponds to
loosely bound iron, which has the potential of catalyzing hydroxyl radical formation. The
expression of ferritin light chain was significantly increased in infarct regions, suggesting
an effective cellular response towards sequestration of intracellular labile iron by
increased ferritin. Ferritin light chain transcription has been reported to be more
responsive to high iron levels than the heavy chain FTH1 [136], which was not
significantly modified within infarcts. Unlike iron-storage tissues like the liver in which
light chain-rich ferritin is more abundant, in the heart the ferritin heavy chain is the
dominant subunit. A study in a mouse model of iron overload showed that while FTH1
mRNA levels were constitutively higher in the heart than FLC mRNA, FLC expression
was more sensitive to increased cardiac iron levels [137]. Increased expression of ferritin
light chain in the infarct area may potentially change the composition, as well as the
functional role, of cardiac ferritin following ischemia reperfusion. A significant decrease
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in DMT1 in infarct regions suggests increased intracellular iron, which would induce
IRP1/ACO1-mediated inhibition of DMT1 translation to decrease iron uptake.
For extracellular iron, immunostaining of hemoglobin showed that leftover
hemoglobin from hemorrhage is present at 1-week (90-, 180-min) and declines by 8weeks after reperfusion injury, indicating a clearance of hemoglobin during wound
healing. Permanent infarct groups showed similar positive hemoglobin, with less
concentrated areas of positive staining. The darker IHC staining contrast may reflect
extracellular or uptake of hemoglobin from past hemorrhage. Hemoglobin may be an
important source of magnetic susceptibility and iron content of the tissue, especially in
the 90- and 180-min infarct groups. Significantly increased HO1 within infarct regions
suggests cellular clearance of extracellular hemoglobin and subsequent increased
denatured hemoglobin requiring heme ring degradation and iron release. Hemoglobin
converts into paramagnetic protein forms such as deoxyhemoglobin and methemoglobin
and then crystalizes into hemichromes, ferritin and hemosiderin. Of these forms,
deoxyhemoglobin and methemoglobin are paramagnetic (4 and 5 free electrons) and
ferritin and hemosiderin are superparamagnetic (many unpaired electrons). The ionization
state, Fe2+ or Fe3+, as well as the molecular form of protein-bound iron, is expected to
affect the magnetic susceptibility density and measured QSM.
There are several challenges to the accurate estimation of myocardial magnetic
susceptibility in humans. There are errors caused by cardiac motion, respiratory motion,
blood flow and imperfections in local tissue field estimation. These cause artifacts in the
magnetic susceptibility images and hinder accurate estimation. A combination of ECG
gating, apnea and magnetic field gradient flow compensation helped mitigate the ill103

effects of cardiac motion, respiratory motion and blood flow, respectively. A major
source of artifacts was the presence of large significant background magnetic field
gradients at the myocardium-lung interface. While these artifacts were readily identified
in both patients and animals, it is necessary to develop methods that limit these effects
across the heart muscle. We addressed these issues of background field heterogeneity and
motion in animals by embedding the whole heart tissue explants in a susceptibilitymatched fluid. Additionally, we showed the feasibility to perform cardiac susceptibility
mapping and detect regions of altered magnetic susceptibility in patients, spatially
corresponding to the areas of infarction on late gadolinium enhanced magnetic resonance
imaging. There may be differences between the 1-week time point in animals compared
to the subacute (3-day) period in humans that limit extrapolation of the findings. We
investigated magnetic susceptibility in swine (n=3) 3 days after reperfusion and found
these changes were replicated in both animals and humans (Appendix Figure B.5).
Additionally, while many of the patients showed changes in magnetic susceptibility,
some did not; this may be in part explained by possibly less severe infarctions, which was
represented in part by 45 min animal group. Although in principle magnetic susceptibility
is field-independent, differences in field strength between animals (3 T) and humans (1.5
T) may result in measured differences in susceptibility, since the induced magnetic field
is stronger at higher field, altering the sensitivity of magnetic susceptibility imaging to
different MRI measurement parameters such as echo time. Misregistration between slices
was a potential source of artifacts found in the patient QSM images [122]. To mitigate
this issue, we minimized the breath-hold time for each slice (<20 sec) to limit cardiac and
respiratory motion across the cardiac slice direction. Free-breathing cardiac-gated GRE

104

acquisitions using respiration gating may have the potential to further improve image
quality [138].
In conclusion, we investigated the magnetic susceptibility of acute myocardial
infarction using magnetic susceptibility imaging in a large animal model and showed the
feasibility to detect regions of magnetic susceptibility changes in patients. These noninvasive imaging methods, specific to iron, could be used to evaluate the effectiveness of
therapies for reperfusion injury. This technique may also provide reperfusion injury
diagnosis and prognostication for acute myocardial infarction patients.
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________________________________________________________________________

Chapter 5
Magnetic susceptibility and R2* in myocardial
reperfusion injury at 3 T and 7 T
________________________________________________________________________
This chapter was adapted from:
Moon BF, Kamesh Iyer S, Josselyn NJ, Hwuang E, Swago S, Keeney SJ, Castillero E, Ferrari G,
Pilla JJ, Gorman JH, Gorman RC, Tschabrunn C, Shou H, Matthai W, Wehrli FW, Ferrari VA,
Han Y, Litt H, Witschey WR. Magnetic susceptibility and R2* of myocardial reperfusion injury
at 3 T and 7 T. MRM, under review.

5.1 Abstract
Purpose: Magnetic susceptibility (Δχ) alterations have shown association to
myocardial infarction (MI) iron deposition, yet there remains limited understanding of the
relationship between relaxation rates and susceptibility or the effect of magnetic field
strength. We sought to compare Δχ and R2* in MI at 3 T and 7 T.
Methods: Subacute MI was induced by coronary artery ligation in male
Yorkshire swine. 3D multiecho gradient echo imaging was performed at 1-week
postinfarction at 3 T and 7 T. Quantitative susceptibility maps (QSM) images were
reconstructed using a morphology-enabled dipole inversion. R2* maps and QSM were
generated to assess the relationship between R2*, Δχ, and field strength. Infarct
histopathology was investigated.
Results: Magnetic susceptibility was not significantly different across field
strengths (7 T: 126.8±41.7 ppb; 3 T: 110.2±21.0 ppb, P=NS), unlike R2* (7 T:
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247.0±14.8 Hz ; 3 T: 106.1±6.5 Hz, P<0.001). Additionally, infarct Δχ and R2* were
significantly higher than remote myocardium. Magnetic susceptibility at 7 T versus 3 T
had a significant association (β=1.02, R2=0.82, P<0.001), as did R2* (β=2.35, R2=0.98,
P<0.001). There was spatial correspondence between imaging and infarct
pathophysiology.
Conclusion: We found that R2* showed dependence and Δχ showed
independence of field strength. There was spatial correspondence between R2*, Δχ, and
histology.

Keywords: ∎ myocardial infarction ∎ hemorrhage ∎ iron ∎ magnetic susceptibility ∎
R2* ∎ 7 T

5.2 Introduction
Patients suffering from acute myocardial infarction (MI) often undergo primary
percutaneous coronary intervention to restore blood flow to the ischemic tissue [33, 139].
Revascularization can lead to additional microvascular damage and hemorrhage
(reperfusion injury) [34, 50, 85, 140] and has been reported in 41-54% [17, 42] of
patients. The presence and extent of reperfusion injury on cardiovascular magnetic
resonance (CMR) may be prognostic for long-term patient outcomes, with higher
incidence of adverse left ventricular (LV) remodeling, impaired LV function, and fatal
arrhythmias [17, 41-43, 141].
Ultra-high field MRI (7 T and higher) is becoming more widely explored as an
imaging tool for cardiovascular disease. At higher fields, there is a larger induced
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magnetic field than at lower fields. This physical principle is shown by the equation 𝐵𝑖 =
𝜒𝐵0, where the induced magnetic field 𝐵𝑖 is proportional to the magnetic susceptibility 𝜒
and the main magnetic field strength 𝐵0. In principle, the magnetic susceptibility should
be independent of field strength, however the larger induced field may affect T2*
relaxation times because of its potential to increase MR phase dispersion within a voxel
[131]. A better understanding of these relationships may improve our ability to apply
CMR methods at ultra-high field strength.
T2* relaxation time mapping can detect elevated myocardial iron associated with
hemorrhagic MI but is also affected by myocardial edema and fibrosis [19, 70, 142].
Quantitative Susceptibility Mapping (QSM) uses the MR signal phase to quantify tissue
magnetic susceptibility and may be a useful marker of myocardial iron deposition in MI.
QSM alterations have been associated with elevated tissue iron content in reperfusion
injury and appears to be less sensitive to edema and fibrosis than T2* [143], yet there
remains limited understanding of the relationship between relaxation times and
susceptibility and the effect of magnetic field strength on these measurements.
The purpose of this study was to measure and compare magnetic susceptibility
and R2* at 3 T and 7 T in remote and infarcted myocardium. We hypothesized that the
larger induced magnetic field gradients at 7 T would increase infarct R2* (= 1/T2*) [130]
and that magnetic susceptibility would be similar at both field strengths [144]. We
anticipated there would be improved sensitivity and detection of hemorrhage in infarct
regions at higher field strength. To test this hypothesis, we compared cardiac QSM and
R2* in a large animal model of MI at 3 T and 7 T. We also explored the relationship
between infarct pathophysiology and MRI at 3 T and 7 T.
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5.3 Methods
5.3.1 Overview
To investigate the association of tissue magnetic susceptibility (Δχ), T2* and R2*
with varying voxel sizes and field strengths, whole heart specimens were imaged at 3 T
and 7 T. After imaging, tissue samples were extracted from the heart specimens to assess
infarct pathophysiology.

5.3.2 Animal Study Experimental Design
All swine underwent occlusion of the left anterior descending (LAD) artery
branches. Animals had reperfusion either at 90 (n=11) or 180 (n=3) minutes after
initiation of occlusion, or the artery was permanently occluded (n=2), as shown in
Appendix Figure D.1. Terminal imaging studies were performed at 1 week after MI. The
experimental model was chosen to emulate human post-percutaneous coronary
intervention ischemia reperfusion injury and subacute remodeling postinfarction, where
longer ischemia time causes reperfusion injury [124-126].

5.3.3 Animal Care
All animal studies (Yorkshire swine, N=16; 30-35 kg at baseline, 100% male)
followed protocols approved by the Institutional Animal Care and Use Committee of
University of Pennsylvania (Philadelphia, PA). For each surgical procedure, sedation was
first induced with 25-30 mg/kg ketamine intramuscularly along with endotracheal
intubation. Then the animal received a mixture of isoflurane 0.5-5%, and oxygen (6 L)
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for the duration of the study. Tidal volume was maintained at 10-20 mL/kg (Draeger
anesthesia monitor, North American, Draeger, Telford, PA) and adjusted based on
arterial blood gas readings. Anesthesia and temperature of the animal were monitored.
Arterial access was obtained at the carotid or femoral artery to measure intraventricular
pressure (Millar Instruments, Houston TX). Medication was administered through the
internal jugular vein. All animals were weaned from anesthesia and recovered from
surgery. At the terminal time point, the animal was euthanized followed by harvesting the
cardiac specimen.

5.3.4 Animal Cardiovascular Surgical Procedure
During the cardiovascular surgical procedure, each animal received a prophylactic
antiarrhythmic regimen of 150 mg amiodarone, 1 mg/kg lidocaine, and 1 g magnesium
sulfate intravenously. Swine underwent open chest surgery (n=6) or balloon catheter
ligation (n=10). For open chest surgery, a left thoracotomy was performed, and the
pericardium was opened. One or more coronary snares were positioned at the branches of
the LAD to induce an infarction of approximately 20-30% of the LV size [59, 124]. The
dimensions of the infarction were determined by visible color changes at the epicardium.
Ischemia was confirmed by ST segment elevations on ECG. After MI in some animals
the coronary snare was removed, and bupivacaine was used at the surgical site for
intercostal nerve block followed by chest closure in muscle layers. For balloon catheter
occlusion, a 6 Fr Hockey-stick guide catheter (Cordis Corporation, Fremont, CA) was
positioned in the left main ostium under fluoroscopic guidance. A 0.18”, 180 cm ChoicePT angioplasty wire (Boston Scientific, Marlborough, MA) was carefully advanced into
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the LAD. A rapid-exchange 2.5 mm x 12 mm angioplasty balloon (Apex, Boston
Scientific, Marlborough, MA) was placed over the angioplasty wire into the mid-LAD.
Serial coronary angiography was performed to position the angioplasty balloon
immediately distal to the second diagonal branch of the LAD. The angioplasty balloon
was inflated with a pressure maintained at 10-12 atm throughout the infarct procedure.
After initial balloon inflation, repeat coronary angiography was performed to confirm
adequate distal occlusion of the LAD. Uninterrupted coronary occlusion was maintained
with confirmation of acute infarction by ST segment elevation in the precordial ECG
leads [125]. Following the terminal CMR procedure, the cardiac specimens were
explanted, and bathed in non-1H magnetic susceptibility-matched fluid (Fomblin).

5.3.5 Image acquisition
CMR studies were performed on 3 T (Trio; Siemens Healthineers, Erlangen,
Germany) using a receive-only head coil and 7 T whole-body systems (Terra; Siemens)
using a 32 receive and 1 transmit coil. Gradient mode was monopolar for all imaging and
Siemens adaptive coil combine method was used at 3 T and sum of squares at 7 T. 3D
multi echo gradient echo images of whole heart specimens were obtained at 3 T using TR
= 31 ms , 5 echo times (TE) = 2.7-16.5 ms, ΔTE = 3.4 ms, FA = 16 degrees, BW = 610
Hz/pixel, NEX = 1 and at 7 T using TR = 24 ms, 3 TEs = 2.8-9.6 ms, ΔTE = 3.4 ms, FA
= 28 degrees, BW = 725 Hz/pixel, NEX = 3. To correct for Rician noise bias in R2*
measurements, truncation was performed at 7 T, where signal measured at the first 3 TEs
were used to create R2* maps instead of 5 TEs. T2*-weighted (T2*w) images, R2* maps,
chi-square error maps and measured signal versus echo time are shown in Appendix
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Figure D.2 and Figure 5.2. At 1 week postinfarction, ex vivo whole heart specimens were
imaged at varying voxel volumes at 3 T: 0.42 (n=5), 0.72 (n=12), 1.13 (n=2), 1.72 (n=2)
mm3 and at 7 T: 0.03 (n=8), 0.13 (n=5), 0.42 (n=5), 0.72 (n=1) mm3.

5.3.6 Image analysis
T2* and R2* maps were obtained using a 2-parameter fit 𝑆 = 𝐴exp(−TE⁄𝑇2∗ ),
where A is the amplitude at TE=0, T2* (= 1/R2*) is the transverse relaxation time, and S
is signal intensity. T2* GRE signal intensity was measured across 5 TEs and the 2
adjustable parameters (A and T2*) were estimated using least squares minimization. Error
maps were computed to validate the accuracy of the fit. QSM images were reconstructed
using the morphology-enabled dipole inversion toolbox
(http://pre.weill.cornell.edu/mri/pages/qsm.html) [96, 99, 112, 117-119, 143]. An
overview of these cardiac QSM post-processing steps are shown in Figure 5.1.

Figure 5.1. Experimental design and processing of QSM images. Generation of QSM
from multiecho gradient echo MRI data at 3 T and 7 T. Phase (𝜙) images were
unwrapped to remove phase aliasing [99]. Local field (Δ𝑓) maps were estimated using
the projection onto dipole field (PDF) background field removal algorithm [112]. In the
forward model, the relationship between Δχ and the measured local tissue magnetic field
(Δ𝑓) is 𝐅Δf = 𝐃𝐅𝛥𝜒, where 𝐅 is the discrete Fourier transform operator and 𝐃 = 1⁄3 −
112

𝐤 2𝐳 ⁄𝐤 2 is the dipole kernel in the Fourier domain [116]. However, this problem is illposed and requires regularization to solve for a unique solution. Magnetic susceptibility
was computed using morphology enabled dipole inversion (MEDI) [96, 117-119], where
|| ||1 is the L1 norm, || ||2 is the L2 norm, M is an edge map estimated from the magnitude
image, G is a spatial gradient operator, W is an estimate of the signal-to-noise ratio at
each voxel from the magnitude images, and λ is a Lagrangian weight, balancing data
fidelity and total variation-based data regularization. The cost functional was minimized
using a conjugate-gradient based implementation. Yorkshire swine whole heart
specimens were used in all experiments and imaged 1 week after infarction.

Three volumes-of-interests (VOI) were obtained from T2*-weighted (T2*w)
images using threshold active contour segmentation (ITK-SNAP, University of
Pennsylvania [127]) including remote myocardium: (1)-isointense (iso), infarct: (2)hyperintense (hyper), (3)-hypointense (hypo) (‘hemorrhage’). To have similar contrast at
both field strengths for T2*w segmentation, the echo times were selected based on the
amount of signal dephasing (∆∅) being proportional to change in echo time (∆TE) and
B0. From equation, ∆∅ = 2πγB0 ∆TE, echo time of 6.2 ms was selected at 7 T, which was
closest to 3/7 of the echo time 16.5 ms at 3 T. Relaxivity enhancement (RE) was analyzed
based on the equation (R2*(7.0T) – R2*0(7.0T)) = RE(R2*(3.0T) – R2*0(3.0T)), where
R2*0 was measured in the remote myocardium at 3 T and 7 T [145, 146].
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Figure 5.2. Multiecho T2*w images from a reperfused infarct. (a) Representative
T2*w short axis slice from a 3D GRE dataset from a single cardiac specimen acquired at
3 T and 7 T with five echo times (TE). Isointense remote regions appear to have similar
contrast across all TEs with an R2* = 22.6 ± 3.2 Hz at 3 T and 35.5 ± 6.6 Hz at 7 T.
Hypointense infarct regions appear to have a decrease in signal as TE increases with an
R2* = 109.8 ± 32.8 at 3 T and 175.9 ± 52.8 Hz at 7 T. Hyperintense infarct regions
appear to have a relative consistent signal intensity across TEs at 3 T with a R2* = 18.6 ±
6.3 Hz, whereas at 7 T signal intensity decreases as TE increases with a R2* = 59.7 ±
36.6 Hz. (b) Representative 3 T and 7 T T2*w long axis 4 chamber and 2 chamber views
from the same cardiac specimen with corresponding volumes of interest, segmented with
ITK-snap. Short axis slice selection is shown in the long axis views (dashed green line).
R2* VOI measurements were computed from the representative cardiac specimen shown
here. All images were acquired at 0.75 mm isotropic resolution.

5.3.7 Isolation of Tissue Samples and Histology
The excised heart from each animal was sliced in the short axis direction. Infarct
regions were then sectioned into 1.5 to 2.5 cm2 samples, and at least 4 samples of
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infarcted myocardium were isolated. Similarly, from each swine cardiac specimen, at
least 4 samples of remote myocardium were isolated from the tissue opposite of the
infarct region. Contiguous tissue samples were collected for histology.
For histology, 5-μm sections were obtained from infarct and remote tissue
samples from each animal and digitally imaged at 40x magnification. These sections
were stained with Hematoxylin and Eosin (H&E) for cell viability, Masson Trichrome for
fibrosis and Prussian Blue for iron. Color adjustment of Prussian Blue digital images was
performed (parameters: sharpness 25%, brightness -38%, contrast 85%, saturation 400%,
temperature 6500-6700). Tissue fiducial markers (RV insertion and papillary muscles)
were used to correlate MR images with histology. Histology was repeated independently
on multiple tissue sections (n>3) for each whole heart specimen showing similar
histopathological findings for each infarct group.

5.3.8 Statistical analysis
Statistics were performed in Matlab-R2017B (MathWorks, Natick, MA, USA)
and R-3.6.3 (Vienna Austria) from whole heart (multi-slice) VOI measurements for each
animal. Descriptive results for magnetic susceptibility and R2* are reported as mean ±

standard deviation (SD). Histograms show a normal distribution of R2* and magnetic
susceptibility based on voxel measurements in hypointense, hyperintense, and isointense
VOIs. Therefore, a normal distribution was assumed for parametric testing throughout the
manuscript. Comparisons between two groups were performed using two-tailed student’s
two-sample t-test. Comparisons between multiple groups and two factors were performed
using a two-way analysis of variance (ANOVA) with Tukey’s HSD post hoc multiple
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comparisons test. A simple linear regression was performed to determine if there was a
significant association between two measures and the p-value was generated by testing
whether the regression coefficient (β) was zero (no effect) using a Wald test. Results
were found to be significant for P < 0.05 and indicated by *P < 0.05 and **P < 0.001 or
non-significance indicated by P = NS.

5.4 Results
5.4.1 Tissue magnetic susceptibility and R2* in myocardial infarction at
3 T and 7 T
T2*w images, T2* maps, R2* maps, and quantitative susceptibility maps (QSM)
from a representative animal at 3 T and 7 T are shown in Figure 5.3. R2* was
significantly higher at 7 T than at 3 T. The differences in R2* between 7 T and 3 T were
iso = 17.7 ± 4.7 Hz (P = 0.05), hyper = 39.2 ± 10.7 Hz (P < 0.001), and hypo = 140.9 ±
14.9 Hz (P < 0.001) (Figure 5.4b). However, there were not significant differences in
magnetic susceptibility between 7 T and 3 T; iso = 5.2 ± 12.5 ppb (P = NS), hyper = 12.4
± 34.1 ppb (P = NS), and hypo = 16.6 ± 29.3 ppb (P = NS) (Figure 5.4c). There was
excellent correlation between R2* at 7 T versus 3 T (β = 2.35, R2 = 0.98, P = 8e-12,
Figure 5.5a). Δχ had excellent correlation at 7 T versus 3 T (β = 1.02, R2 = 0.82, P = 4e-6,
Figure 5.5b). To analyze the relationship of relative enhancement across field strengths,
(R2*(7.0T) – R2*0(7.0T)) versus (R2*(3.0T) – R2*0(3.0T)) was fit to a line, where the
relaxivity enhancement (RE) was found to be close to 7/3 (β = 2.20, R2 = 0.98, P = 2e-8,
Appendix Figure D.3).
When comparing different regions within the heart, we found R2* was
significantly higher in hypointense infarct regions compared to hyperintense infarct and
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isointense remote myocardium at 3 T (hypo = 106.1 ± 6.5 Hz vs. hyper = 22.6 ± 3.2 Hz,
P < 0.001 and iso = 24.9 ± 2.5 Hz, P < 0.001) and 7 T (hypo = 247.0 ± 14.8 Hz vs. hyper
= 61.8 ± 13.1 Hz, P < 0.001 and iso = 42.5 ± 7.1 Hz, P < 0.001) as shown in Figure 5.4.
Likewise, magnetic susceptibility was significantly more paramagnetic in hypointense
regions at 3 T (hypo = 110.2 ± 21.0 ppb vs. hyper = 25.0 ± 28.3 ppb, P < 0.001 and iso =
1.36 ± 16.7 ppb, P < 0.001) and 7 T (hypo = 126.8 ± 41.7 ppb vs. hyper = 37.3 ± 28.8
ppb, P < 0.001 and iso = 6.56 ± 10.6 ppb, P < 0.001). While hyperintense infarct regions
had elevated R2* compared to isointense regions at 7 T (61.8 ± 13.1 Hz vs. 42.5 ± 7.1
Hz, P = 0.029), we could not detect a difference at 3 T (22.6 ± 3.2 Hz vs. 24.9 ± 2.5 Hz,
P = 0.998).
In the reperfused infarction, there was a strong association between R2* and
magnetic susceptibility at 7 T (β = 1.45 Hz per ppb, R2 = 0.81, P = 5e-6) and 3 T (β =
0.69 Hz per ppb, R2 = 0.81, P = 4e-6) (Figure 5.5c). When excluding hypointense
regions, interestingly, there was a greater association at 7 T (β = 0.33 Hz per ppb, R2 =
0.37, P = 0.06), compared to 3 T (β = 0.03 Hz per ppb, R2 = 0.05, P = 0.53).
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Figure 5.3. Relaxation mapping and quantitative susceptibility maps (QSM) in MI
at 3 T and 7 T. Shown left to right are T2*w magnitude and phase images, T2* maps,
R2* maps, and QSM. Imaging was performed 1 week after 90 minutes of percutaneous
occlusion of the LAD coronary artery and subsequent reperfusion. 3 T and 7 T images
were obtained 2-4 hours post-mortem from the same cardiac specimen. Representative
T2*w and phase images are at TE = 16.1 and 6.2 ms at 3 T and 7 T, respectively. All
images were acquired at 0.75 mm isotropic resolution.

Figure 5.4. Comparison of R2* and magnetic susceptibility in MI at 3 T and 7 T. (a)
Representative T2*w (7 T, TE = 6.2 ms) short axis slice from a 3D GRE dataset. Three
volumes-of-interests (VOI) were obtained from T2*w images using manual
segmentation: remote-isointense (blue), and active contour segmentation: infarcthyperintense (yellow) and infarct-hypointense (red). (b) R2* was significantly different
between 3 T and 7 T for each VOI, whereas (c) magnetic susceptibility was not
significantly different (P = NS). At 3 T, there were substantially elevated R2* and
magnetic susceptibility in hypo compared to hyper and iso regions. The same relationship
was seen at 7 T with the addition of a significantly elevated R2* in hyper compared to iso
regions. Significance is indicated by *P < 0.05 and **P < 0.001 or non-significance
indicated by P = NS. All data was extracted from R2* maps and QSM with 0.75 mm
isotropic resolution.
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Figure 5.5. Correlation between R2* and magnetic susceptibility at 3 T and 7 T. (a)
Correlation between R2* at 7 T versus 3 T. (b) Correlation between magnetic
susceptibility at 7 T versus 3 T. (c) Correlation between R2* versus magnetic
susceptibility at 3 T (triangles) and 7 T (circles). There were two overlapping wholeheart hyperintense magnetic susceptibility and R2* measurements, approximately 37 ppb
and 24 Hz, respectively. T2*w VOI: remote myocardium (isointense), infarct
(hyperintense) and hemorrhagic myocardium (hypointense). The linear effect (β) was
significant if P < 0.05. All data was extracted from R2* maps and QSM with 0.75 mm
isotropic resolution.

5.4.2 Effect of spatial resolution on R2* and magnetic susceptibility
We next sought to investigate the effect of voxel size on R2* and magnetic
susceptibility at 3 T and 7 T. Upon visual inspection, QSM images showed more detail
and infarct conspicuity as resolution and field strength increased (Figure 5.6). In
hypointense regions at 7 T, there was a significant change in R2* with image resolution.
R2* was higher at 0.42 mm3 (247.0 ± 14.8 Hz) than at 0.13 mm3 (214.9 ± 15.4 Hz, P =
0.05) or 0.03 mm3 (187.9 ± 34.1 Hz, P < 0.001, Figure 5.7a) causing an increasing trend
of R2* versus voxel size (β = 140.7 Hz per mm3, R2 = 0.94, P = 0.15, Appendix Figure
D.4a). Unlike R2*, in hypointense regions at 7 T, magnetic susceptibility was not
significantly higher at 0.42 mm3 (126.8 ± 41.7 ppb) compared to 0.13 mm3 (128.1 ± 18.9
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ppb, P = NS) and 0.03 mm3 (137.1 ± 24.3 ppb, P = NS) (Figure 5.7b). However,
regression analysis that includes measurements from 3 T hypointense regions at 0.42
mm3 and 0.72 mm3 showed a significant decreasing trend of magnetic susceptibility with
increasing voxel size (β = -52.0 Hz per mm3, R2 = 0.83, P = 0.03, Appendix Figure D.4b).
Altogether, these results show that R2* depends on field strength and voxel size, whereas
tissue magnetic susceptibility appears to have relatively consistent measurements
between field strength and a declining trend with respect to increasing voxel size.
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Figure 5.6. Relationship between tissue magnetic susceptibility (Δχ), R2*, and voxel
size. QSM and R2* maps with varying voxel size in a single cardiac specimen. T2*w
images showed hypointense infarct regions corresponding to elevated R2* and magnetic
susceptibility. T2*w images at 3 T and 7 T were obtained at echo time (TE) 16.1 and 6.2
ms, respectively. Representative cardiac specimen was not imaged at 0.03 mm3 voxel
size due to scan time constraint.

Figure 5.7. Tissue magnetic susceptibility (Δχ) and R2* at varying voxel size. (a) At 7
T, R2* and (b) magnetic susceptibility were significantly elevated in hypo VOI compared
to hyper and iso regions at each voxel size. R2* also showed a significant difference
between hyper and iso regions at 0.42 and 0.72 mm3 voxel size. Hypo VOI measurements
at 0.42 mm3 had a significantly elevated R2* compared to hypo regions at 0.13 and 0.03
mm3 voxel size, whereas magnetic susceptibility did not show a significant change
between voxel sizes. Graphs (a) and (b) exclude 0.72 mm3 voxel size due to small sample
size (n < 2).

5.4.3 R2* and magnetic susceptibility in non-reperfused myocardial
infarction
To investigate R2* and magnetic susceptibility in ischemic myocardium without
hemorrhagic injury, we performed imaging on the explant hearts of animals without
reperfusion. We found that non-reperfused infarcts (n = 2) showed elevated R2* and a
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greater paramagnetic shift in hyperintense infarct regions compared to isointense viable
myocardium at 7 T with high resolution (0.03 mm3 voxel size; R2*: hyper = 41.1 ± 0.6,
iso = 34.5 ± 0.6 Hz; Δχ: hyper = 10.2 ± 9.3, iso = 1.95 ± 0.78 ppb). At 3 T with lower
resolution (0.72 mm3 voxel size), R2* was relatively the same in hyperintense infarct
regions compared to isointense regions (R2*: hyper = 21.7 ± 1.7, iso = 21.6 ± 0.4 Hz),
whereas magnetic susceptibility remained elevated in hyperintense regions (Δχ: hyper =
29.5 ± 7.6, iso = 18.5 ± 8.8 ppb). Specifically, non-reperfused infarctions had a decrease
in T2*w signal intensity at the epicardium, which corresponded to elevated R2* and
magnetic susceptibility at 7 T (Figure 5.9 and Appendix Figure D.1).

5.4.4 Magnetic susceptibility alterations were associated with tissue iron
We next sought to compare MRI with histological findings in animals with
(Figure 5.8) and without reperfusion (Figure 5.9). As expected, high resolution 7 T
showed more detail and better infarct conspicuity than at 3 T. Reperfused infarcts had a
heterogeneous appearance on T2*w MRI corresponding to regions of cellular necrosis
and fibrosis interspersed with regions of viable myocardium. Iron deposits were found at
the transition zone of myocyte necrosis. Also, erythrocytes were detected in the infarct
region. Both iron and erythrocytes corresponded to regions that showed a paramagnetic
shift on QSM.
In non-reperfused infarcts, there was also spatial correspondence between MRI
and histology (Figure 5.9). Unlike reperfused infarctions, hypointense regions were not as
conspicuous. However, there were visible regions of hypointensity observed at 7 T that
were not seen at 3 T. Additionally, the endocardium showed hyperintense regions, which
correspond to cellular necrosis. The epicardium had decreased signal intensity, where
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more erythrocytes and iron deposition were seen compared to endocardium. Specifically,
iron deposits were found in the transition zone of myocyte necrosis coinciding with a
paramagnetic shift on QSM. Necrotic regions had a lack of a paramagnetic shift, which
corresponded to sparse histologic iron deposition.

Figure 5.8. Magnetic susceptibility, R2*, and histopathology in reperfused MI.
Reperfused infarcts had a heterogeneous appearance on T2*w MRI extending from the
endocardium (Endo) to the epicardium (Epi). MRI (dashed box) was matched to
histology from gross pathology fiducial markers (RV insertion, papillary muscles, and
length of LV). Histology shows myocyte necrosis (H&E, black arrows), viable
myocardium (H&E, blue arrows) and extensive fibrosis (Trichrome, yellow arrows).
Increased iron content was observed at the transition zone between necrotic and viable
myocytes (Prussian blue, red arrows) and regions of trapped red blood cells (RBCs)
(H&E, red arrows). Magnetic susceptibility, R2* maps, and histology were obtained from
the same cardiac specimen. 3 T MR images were acquired at 0.9 mm isotropic resolution
and 7 T MR images were acquired at 0.5 mm isotropic resolution.
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Figure 5.9. Magnetic susceptibility, R2*, and histopathology in non-reperfused MI.
MRI (dashed box) was matched to histology from gross pathology fiducial markers.
Histology shows a transmural infarct with myocyte necrosis (H&E, black arrows) and
extensive fibrosis (Trichrome, yellow arrows). Magnetic susceptibility and R2* were
elevated at the epicardium (Epi) indicating the presence of iron content. Regions of
necrosis towards the endocardium (Endo) had a lack of a paramagnetic shift and elevated
R2*. Increased iron content was observed at the boundary of myocyte necrosis and
fibrosis (Prussian blue, red arrows) and regions of trapped red blood cells at the
epicardium (RBCs) (H&E, red arrows). Magnetic susceptibility, R2* maps, and
histology were obtained from the same cardiac specimen. To compare, reperfused and
non-reperfused infarcts at 3 T and 7 T the same range of R2* and magnetic susceptibility
were kept constant for each group. 3 T MR images were acquired at 0.9 mm isotropic
resolution and 7 T MR images were acquired at 0.5 mm isotropic resolution.

5.5 Discussion
This study investigated the relationship between R2*, QSM and field strength in a
large animal model of MI at 3 T and 7 T. We analyzed R2* and magnetic susceptibility in
the hemorrhagic and nonhemorrhagic infarction and in the remote myocardium. In all
three regions, R2* was higher at 7 T than at 3 T, however there was not a significant
124

difference in magnetic susceptibility. There was excellent correlation between R2* at 3 T
and 7 T and there was also excellent correlation between magnetic susceptibility at these
field strengths. Additionally, we found that hypointense infarct regions had a
significantly elevated R2* at increased voxel size, whereas magnetic susceptibility did
not change significantly across voxel sizes. Finally, we found spatial correspondence
between magnetic susceptibility and histologic evidence of iron.

5.5.1 Relationship between magnetic susceptibility, R2*, and field
strength
Magnetic susceptibility was in agreement with previously reported infarct and remote
myocardium measurements at 3 T [143]. As previously reported [50, 143], we found that
R2* was significantly higher in hemorrhagic regions than in non-hemorrhagic MI or
remote myocardium. However, all studies reported slightly different R2* measurements,
which could be attributed to field strength and voxel size variations. In remote
myocardium, we observed that R2* increased with field strength, which was within the
range of the R2* previously reported [130], where microscopic magnetic field gradients
would be amplified at higher field strengths and the macroscopic gradient field would
increase at larger voxel size causing an overall elevation in R2*. Hyperintense regions
also had slightly higher R2* than remote myocardium. This was somewhat paradoxical
since there was higher signal intensity than the remote regions on T2*w MRI. However,
infarcted myocardium may have higher water content and therefore may have higher
signal intensity at short echo times than remote myocardium. Higher relaxation times and
diffusivity may be attributed to edema or fibrosis and has been observed on T2 and T1ρ
CMR in acute and subacute MI [124, 147]. The increased diffusivity observed on
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diffusion images has also been attributed to higher water content in MI. Altogether, the
higher R2* and signal intensity in hyperintense regions may suggest a combination of
increased water and iron content, representative T2*w images from a reperfused infarct at
each TE are shown in Figure 5.2. As expected, hypointense regions had the highest R2*
of all regions, which was consistent with intramyocardial hemorrhage and significantly
higher iron content than other regions [143, 148]. Relaxivity enhancement (RE) was
found to be close to 7/3 (RE=2.20) when analyzing R2* measurements at 7 T versus 3 T,
demonstrating that R2* scales with field strength as shown in previous work [145, 146].
The relationship between R2* and magnetic susceptibility is similar to that reported
in the human brain [149]. Regions containing high iron concentration (globus pallidus)
clustered at higher magnetic susceptibility and R2*, whereas low iron concentration
regions (hippocampus) clustered at low magnetic susceptibility and R2*. This
relationship was seen in our study, where hypointense regions containing high iron
content had a significant elevation in R2* and magnetic susceptibility compared to
isointense regions with low iron content.

5.5.2 Relationship between magnetic susceptibility, R2*, and voxel size
While T2* and R2* are sensitive to iron induced microscopic magnetic fields, they
are also affected by macroscopic magnetic field gradients [131, 150]. There are several
possible causes of macroscopic magnetic field gradients such as differences in magnetic
susceptibility between lung and myocardium or imperfections in magnet design. Since
the macroscopic magnetic field gradients can also cause higher R2*, it is important to
mitigate these macroscopic effects as much as possible. We sought to reduce
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macroscopic effects by imaging whole-heart specimens in a magnetic susceptibility
matched fluid. However, even after minimizing macroscopic field gradients, R2* showed
a dependence on voxel size, suggesting that there remained a relaxation enhancement
effect of microscopic magnetic fields.
We found that hypointense regions at 0.75 mm isotropic resolution had slightly
higher magnetic susceptibility than previously reported at 3 T [143]. In the previous
study, the slightly lower magnetic susceptibility may be explained in part by physiologic
variation and differences in voxel size. Voxel size influence on magnetic susceptibility
may be attributed to a partial volume effect; regions with high iron content are lumped
together in the same voxel with surrounding regions of lower iron content, causing an
overall decrease in magnetic susceptibility. Similar results were found by Karsa et al.
[131], where increasing slice thickness and reduced FOV coverage decreased magnetic
susceptibility in the human brain and in numerical phantom simulations. The globus
pallidus, which is known to have higher iron content than other brain regions [130, 151,
152], had the most substantial decrease in magnetic susceptibility as slice thickness was
increased. Brain regions that did not show a paramagnetic shift (putamen) or that were
slightly diamagnetic (white matter) showed alterations in magnetic susceptibility [131].

5.5.3 Magnetic susceptibility is more specific to iron
In addition to T2* changes, ischemic myocardium shows more signal dephasing
than remote myocardium [74, 143]. The signal dephasing is nonlocal and can be
attributed to underlying tissue magnetic susceptibility distribution. While iron has a
strong effect on the MR signal phase, the phase appears to be less sensitive to edema or
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fibrosis compared to signal intensity and relaxation time mapping [19, 153]. For this
same reason, magnetic susceptibility may be considered more specific to iron-related
pathology than relaxation time mapping. Indeed, there is evidence that edema and fibrotic
pathologies have the effect of increasing relaxation times in the myocardium, absent
underlying elevated iron [19, 70, 90, 91, 143]. In ischemic myocardium, these
pathologies may increase or decrease relaxation times, depending on the predominant
pathology.

5.5.4 Relationship between CMR and Pathology
In this study, we found good spatial correspondence between high resolution 7 T
QSM and infarct pathophysiology. Reperfused infarcts had regions of dense fibrosis with
patches of viable myocardium, which corresponded to heterogeneous T2*w signal
intensity. Reperfused infarcts also had iron deposition at the transition zone of myocyte
necrosis and mixed viable myocytes, which was detected as a paramagnetic shift seen
with QSM. Magnetic susceptibility and R2* alterations were seen in non-reperfused
infarcts at 7 T, which were not visible at 3 T. With larger iron-induced magnetization and
increased spatial resolution at 7 T, there may be enhanced sensitivity to regions
containing sparse iron distribution. Multiple sources of iron may be contributing to the
elevated magnetic susceptibility [154, 155]. In previous work [143], labile (non-protein
bound) iron was another form of iron observed in MI. Labile iron is available for catalytic
reactions and has the potential of producing damaging hydroxyl radicals following tissue
injury [132-134].
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5.5.5 Limitations
There are some limitations to this study. Relaxation time mapping and QSM was
performed on whole-heart explants and there may be differences from live animals and
humans. The feasibility of implementing in vivo cardiac QSM was recently shown in
healthy patients [122], a swine model of myocardial infarction reperfusion injury [143],
and ST-elevation MI patients [143]. These studies were conducted at 3 T or 1.5 T. Based
on the findings in this study, we would expect to see differences in vivo at 7 T.
From previous work [156, 157], it may be difficult to extrapolate the relationship
between R2* and magnetic susceptibility at low concentrations of iron or at low field
strength. Where regions containing high iron concentration would cause a linear
increasing trend between R2* and magnetic susceptibility. At higher field strength there
would be increased sensitivity to iron. However, with low iron concentration the
relationship between R2* and magnetic susceptibility becomes more complex.
Diamagnetic tissue properties influence magnetic susceptibility and confounding factors
such as edema and fibrosis influence R2*. Altogether, R2* versus magnetic
susceptibility is predicted to have a nonlinear relationship at low iron concentration and
low field strength as seen in isointense and hyperintense regions at 3 T (Figure 5.5c).
As discussed earlier, imperfections in the magnet design or challenges solving the
QSM inversion problem may lead to inaccurate estimation of magnetic susceptibility. At
7 T, the heterogeneity of the macroscopic gradient fields is enhanced, further increasing
the difficulty when shimming and removing background magnetic field gradients.
Matching MRI with histology is challenging and is an active area of research
[148, 150, 158]. MRI was performed on fresh whole-heart specimens, whereas histology
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samples were cut, fixed, embedded in paraffin, sectioned with a microtome, plated, and
stained. Despite the differences in tissue form, MRI and histology were matched using
fiducial landmarks such as long-axis ventricular dimension, infarct appearance,
trabeculae, and RV insertion point geometry. There are advantages to imaging fresh
tissue. Fresh tissue contrast, relaxation time and susceptibility measurements resemble
more closely to in vivo conditions, whereas fixation changes relaxation times as shown
by [159]. Reperfused infarcts had tissue heterogeneity detected through imaging and
validated with histology. Permanent infarcts were unique in the fact that there was a lack
of hypointensity and positive iron staining (Prussian blue) despite elevated susceptibility
indicating another source of iron, such as labile iron [143].

5.5.6 Conclusions
R2* was higher at 7 T than at 3 T in MI and in remote myocardium, however
there was not a significant difference in magnetic susceptibility. There was excellent
correlation between R2* and magnetic susceptibility at 3 T and 7 T and spatial
correspondence between magnetic susceptibility and histologic evidence of iron. This
work improves our understanding of the distribution of iron after MI and its effect on
CMR markers of ischemic heart disease.
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________________________________________________________________________

Chapter 6
Magnetic susceptibility, R2*, and iron evolve
during reperfusion injury wound healing
________________________________________________________________________
Parts of this chapter have been adapted from:
Moon BF, Kamesh Iyer S, Hwuang E, Solomon MP, Hall AT, Kumar R, Josselyn NJ, HigbeeDempsey EM, Tsourkas A, Imai A, Okamoto K, Saito Y, Pilla JJ, Gorman JH, Gorman RC,
Tschabrunn C, Keeney SJ, Castillero E, Ferrari G, Jockusch S, Wehrli FW, Shou H, Ferrari VA,
Han Y, Gulhane A, Litt H, Matthai W, Witschey WR. Iron imaging in myocardial infarction
reperfusion injury. Nature Communications, 2020. 11(3273). Creative Commons license can be
viewed at http://creativecommons.org/licenses/by/4.0/.

6.1 Abstract
There are multiple forms of iron including protein bound and labile iron found in
reperfusion injury of acute myocardial infarction (MI). This study investigated iron
accumulation, iron form, and cellular response to reperfusion injury with respect to the
duration of wound-healing, in a large animal model. We demonstrate with magnetic
susceptibility and R2* imaging biomarkers that there is a significant increase in infarct
iron content in acute reperfusion injury which dissipates by 8-week post-MI, and validate
these findings with histology, iron concentration, and mRNA expression.

6.2 Introduction
Reperfusion injury is a complication seen in 40-60% of acute myocardial
infarction (MI) patients receiving primary percutaneous coronary intervention therapy
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[17, 35]. While reperfusion substantially improves myocardial salvage, ischemia and
microvascular damage can cause extravasation of RBCs (extracellular iron) and elevation
in iron content including protein bound and labile (“free”) iron. Under iron homeostasis
conditions (Figure 6.1) [154, 155], extracellular iron can be imported into the cell and
enter the intracellular labile iron pool. Labile iron can be utilized by the cell through
multiple pathways including metabolism, energy production, heme synthesis, and Fe-S
biogenesis. Labile iron can also be stored by Ferritin proteins. Labile iron can also act as
a catalyst in the production of reactive oxygen species through the Fenton/Haber–Weiss
reaction cycle leading to cellular DNA damage [133, 160].
In previous studies, a paramagnetic shift in reperfusion injury at 1-week post-MI
was associated with elevated iron content [161]. There remains limited understanding of
the alteration of myocardial tissue and iron content throughout wound healing and the
association to MRI biomarkers (magnetic susceptibility, R2*). The objectives of this
study were to 1) evaluate the progression of wound healing through quantitative
susceptibility mapping (QSM), R2*-mapping, histology, iron concentration and 2) to
investigate the molecular form of iron and mRNA expression of cellular markers of iron
homeostasis in reperfusion injury.

132

Figure 6.1. Cell diagram of iron homeostasis. The simplified diagram of iron
homeostasis demonstrates a subset of pathways of iron in a single cell. Extracellular iron
includes hemoglobin byproducts which are imported into the cell and go into a labile iron
pool. There are multiple pathways intracellular labile iron can take, including metabolic
utilization and energy production; iron can be stored within larger proteins like Ferritin;
iron has the potential to cause free radicals and ultimately DNA damage; and iron can be
exported from the cell. Figure was adapted from [154, 155].

6.3 Methods
MI was induced by coronary surgical ligation and released after 90- or 180-min in
male Yorkshire swine. In a cross-sectional study, CMR was performed in controls (N=5),
3-day (N=6), 1-week (N=11) and 8-weeks (N=8) post-MI at 3T (Trio, Siemens
Healthcare). Cardiac function, volumes and remodeling parameters were obtained using
cine MRI and LGE. In a subset of swine, in vivo GRE images were acquired at 1- (N=6)
and 8-weeks (N=6) (voxel size=0.9x0.9x4.0 mm3, TR/TE=160/10 ms, FA=13 degrees,
FOV=24.0x17.3 cm2, BW=260 Hz/pixel, NEX=12).
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Ex vivo multi-echo gradient-echo image acquisition of whole heart specimens
occurred at 3-day (n=2), 1-week (n=6) and 8-week (n=2) post-MI. Scan parameters
include 7 T and 3 T 0.75 mm isotropic resolution, TR = 24/42 msec, TEfirst = 2.8/3.3
msec, TElast = 16.5/16.1 msec, ΔTE = 3.4/3.2 msec, FA=28,16 degrees, BW=725,610
Hz/pixel, NEX=3,1 (7 T parameters are bold italics). R2*-maps were obtained using a 2parameter fit with least squares minimization. QSM was reconstructed using the MEDI
image processing pipeline [96, 112]. Two volumes-of-interest (VOIs) were obtained from
T2*-weighted (T2*w) images using threshold active contour segmentation (ITK-SNAP
[127]) including remote myocardium (“isointense”) and infarct (“hyperintense” and
“hypointense”).
Tissue experiments included histology staining (Prussian blue, Trichrome, H&E,
Hemoglobin-beta immunohistochemistry (HBB IHC)), total iron concentration from
inductively coupled plasma-optical emission spectrometry (ICP-OES), labile iron
concentration from electron paramagnetic resonance (EPR) spectroscopy. Statistics
included linear regressions and student’s t-test comparison between infarct and remote
myocardium regions.

6.4 Results
6.4.1 Magnetic susceptibility in acute to chronic infarcts
To further investigate how magnetic susceptibility and iron progress after
infarction, we expanded the cross-sectional MRI study in Chapter 4 [143] to include postinfarction time point 3-day (n=6) after infarction in comparison to 1-week (n=11) and 8weeks (n=8) after infarction. The cross-sectional longitudinal swine study showed
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magnetic susceptibility evolved during wound healing. At 3 days post-infarction there
was an increase in microvascular obstruction volume (3.23±3.73 g, Figure 6.2 and
Appendix Figure A.2) that significantly declined by 8 weeks (0.46±0.43 g, P=0.02),
shown with the yellow arrows. At 1-week post-infarction, microvascular obstruction
remained present (1.81±1.49 g). At 3 days post-infarction, hypointense regions on T2*w
imaging (red arrows) corresponded to an infarct paramagnetic shift on QSM (infarct:
177.3±51.9, myo: 33.2±91.2 ppb, P=0.075) indicating the presence of iron. At 1-week
post-infarction, there was a significant infarct paramagnetic shift (infarct: 55.2±38.9,
myo: -10.5±19.6 ppb, P=0.01). By 8 weeks post-infarction, microvascular obstruction
declined significantly (0.46±0.43 g, P<0.001), ejection fraction declined (3 day:
41.0±7.83%, 8-week: 33.1±8.35%, P=0.29), and there was a lack of hypointensity within
the infarct region with significant decline in magnetic susceptibility (infarct: -18.7±33.7
ppb) compared to 1-week (P=0.007) and 3-days (P<0.001) post-infarction.
Cardiac function, volumes, and remodeling parameters were analyzed with cine
and LGE MRI (Appendix Table A.5). There was a significant decrease in ejection
fraction (EF) during the wound healing process from 3 days to 8 weeks post-infarction,
which is a marker for adverse cardiac function (Appendix Figure A.2). Left ventricle
remodeling index (LVRI=LV mass/EDV) was significantly lower in infarct groups
compared to the control group, indicating adverse tissue remodeling and subsequent LV
dilation.
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Figure 6.2. In vivo LGE, T2*w, and QSM acquired during myocardial infarct
wound healing reflects changes in tissue magnetic susceptibility and MVO. (A) 3day, 1-week infarcts had elevated microvascular obstruction (MVO) and (A,B) Δχ that
dissipated by 8-week. ROI arrows: LGE MVO (yellow), T2*w isointense (blue), T2*w
hypointense (red).

6.4.2 Magnetic susceptibility and iron decline during wound healing
The in vivo results were confirmed with ex vivo imaging, where 3-day and 1-week
post-infarction demonstrated hypointense infarct regions, and by 8-week post-infarction
there was a lack of hypointensity (Figure 6.3). Infarct regions at 3-day and 1-week had a
significant elevation in R2* (3-day: 139.2±15.3 Hz, 1-week: 123.1±24.5 Hz) and
magnetic susceptibility (3-day: 93.3±14.0 ppb, 1-week: 69.7±10.9 ppb) compared to
remote myocardium (R2*: 43.5±6.91 Hz, P<0.001, ∆χ: 2.88±10.7 ppb, P<0.001). At 8weeks post-infarction, there was a lack of hypointensity within the infarct with only slight
elevation in magnetic susceptibility (27.8±19.0 ppb) compared to the remote myocardium
(-3.6±9.57 ppb, P=0.009) and an insignificant difference in R2* measurements (infarct:
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47.2±7.93 Hz, myo: 44.5±6.44 Hz, P=0.99). Overall, there was a significant decline in
magnetic susceptibility (P<0.001) and R2* (P<0.001) over time from 3-day to 8-week
post-infarction indicating a decline in iron content within the infarct region.
Total iron concentration was measured using ICP-OES, which showed significant
elevation in infarct regions compared to remote myocardium at 3-days (infarct: 0.09±0.04
mg/g, myo: 0.05±0.01 mg/g, P=0.0003) and 1-week (infarct: 0.11±0.07 mg/g, myo:
0.04±0.003 mg/g, P<0.001) post-infarction, and an insignificant elevation at 8-weeks
(infarct: 0.06±0.04 mg/g, myo: 0.04±0.01 mg/g, P=0.76). There was a significant decline
in infarct iron concentration over time from 1-week to 8-weeks post-infarction (P<0.001),
similar to the imaging findings.

Figure 6.3. Ex vivo T2*w, R2*, and QSM reflects changes in tissue magnetic
susceptibility and iron content. (A) 3-day and 1-week infarcts had hypointense regions
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corresponding to elevated (B) R2* and (C) Δχ that dissipated by 8-week. T2*w arrows:
isointense-remote (blue), hypointense-infarct (red).

6.4.3 Infarct pathophysiology and iron content
Histology was performed to assess infarct pathophysiology during wound healing
and to determine the association with R2* and QSM at 3-day, 1-week, and 8-week postinfarction (Figure 6.4). There was initial fibrosis (Trichrome) at 3-day that became dense
collagen scar tissue by 8-week post-infarction. At 3-day and 1-week, lysed myocytes and
RBCs were present with an active immune response at the transition zone of myocyte
necrosis (H&E). By 1-week, the active immune response extended toward the
endocardium suggesting infiltrative immune cells originating outside the infarct. At 1week, regions containing ferric iron (Fe3+) were at the transition zone (Prussian blue)
which may correspond to engulfment of iron by immune cells. Positive hemoglobin
staining (HBB IHC) was present at 3-day and 1-week, which contributes to the
paramagnetic shift seen in QSM. By 8-week, RBCs, immune cells, iron, and hemoglobin
had dissipated.
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Figure 6.4. T2*w, R2*, and QSM correspond to infarct pathophysiology findings.
MR images were matched to gross tissue by fiducial markers (blue circles, lines). Tissue
sections (dashed green lines) were stained. Collagen density increases from (A) 3-day,
(B) 1-week, to (C) 8-week (Trichrome). Immune response (H&E), extensive RBCs
(inset), iron (Prussian blue, inset) and hemoglobin-beta deposition (HBB IHC)
dissipate by 8-week. T2*w arrows: isointense (blue), hypointense (red), hyperintense
(yellow).

There was a linear relationship between iron vs magnetic susceptibility (Δχ:
slope=1.30 mg/g of total iron per 1 ppm increase in tissue magnetic susceptibility,
R2=0.48, P<0.001) and iron vs transverse relaxation rate (R2*: slope=2.29 mg/g of total
iron per 1 msec-1 increase in R2*, R2=0.58, P<0.001).

Figure 6.5. Relationship between tissue magnetic susceptibility, R2* and total iron
concentration at 3-day, 1-week and 8-week post-MI. Infarct (90-, 180-min) and remote
myocardium total iron concentration vs corresponding ex vivo VOI (A) magnetic
susceptibility and (B) R2* measurements from whole heart specimens (n=10).

Labile iron, a fraction of total iron measured, was significantly increased in infarct
compared to remote regions (0.019± 0.016 vs. 0.008±0.007 mg/g; P<0.001) (Figure 6.6).
Ferritin light chain (FLC) expression was significantly increased in the infarct vs. remote
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myocardium (1137.2 vs. 88.1 %Myo), unlike ferritin heavy chain (FTH1). The
expression of the intracellular iron sensor Iron Regulatory Protein 2 (IRP2, also known as
ACO1) was significantly decreased in the infarct region vs. remote myocardium (61.4 vs.
102.4 %Myo). Divalent metal transporter 1 (DMT1), which transports iron into the labile
iron pool, was significantly decreased in the infarct region vs. remote myocardium (53.7
vs. 99.1 %Myo). Heme oxygenase-1 (HO1) transcription is activated in response to
increased intake of heme proteins, and its expression was significantly increased in the
infarct region vs. remote myocardium (1350.3 vs. 100.5 %Myo), which corresponds to
elevated hemoglobin seen with HBB IHC.

Figure 6.6. Ex vivo iron measurements and mRNA expression of cellular markers of
iron homeostasis. (A) Infarcts had increased total and labile iron concentration compared
to remote myocardium (myo) regions. (B) FLC expression was increased in infarct
regions, unlike FTH1. (C) IRP2/ACO1 and (D) DMT1 were decreased in infarct regions.
(E) HO1 expression was increased in infarct regions. Iron concentration and real-time
PCR data was collected from all post-MI groups. Results are reported as mean±SD.
Significance is indicated by * for P<0.05 and ** for P<0.001. Figure 6.6 was adapted
from Figure 4.4.
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6.5 Discussion
Our analysis showed several aspects of iron accumulation and cellular handling in
reperfusion injury. There was an elevation in total iron concentration and positive
Prussian blue staining in acute reperfusion injury (3-day, 1-week) that dissipated by 8week post-MI (chronic reperfusion injury). During homeostasis, most of the intracellular
iron is bound to ferritin. A small fraction of intracellular iron belongs to the labile iron
pool [132] and is redox active with the potential of generating free radicals upon MI
injury [133, 134]. In high intracellular iron conditions such as MI, IRP2/ACO1 is down
regulated, inhibiting DMT1 and increasing ferritin gene expression [133]. The expression
of FLC was significantly increased in infarct regions, suggesting an effective cellular
response towards labile iron sequestration [136]. Significantly increased HO1 within
infarct regions suggests cellular clearance of extracellular hemoglobin, where HBB IHC
showed hemoglobin cleared during wound healing by 8-week post-MI. The ionization
state as well as the molecular form of protein-bound iron is expected to change
throughout wound healing, affecting the magnetic susceptibility.

6.6 Conclusion
Infarct iron content appears to evolve during wound-healing. After reperfusion
injury, there was an infarct paramagnetic shift associated with increased iron at 1-week
post-MI. After 8-weeks, magnetic susceptibility and iron declined. This study increases
our understanding of the pathologic role of iron after reperfusion injury and the
mechanistic underpinnings of MR contrast during the post-MI period.
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Figure A.1. Infarct transmurality, size and microvascular obstruction. Infarct data is
displayed by (A-C) time-to-reperfusion (45-, 90-, 180-min and permanent occlusion) at
1-week post-infarction and by (D-F) post-infarction time point (3-day, 1-week, 8-week)
after a 90-, 180-min coronary occlusion. Infarct properties from animals as determined by
late gadolinium enhanced MRI (n=31), (A,D) infarct transmurality, (B,E) infarct size,
(C,F) microvascular obstruction (MVO). Two animals (of 33 total) did not undergo LGE
MRI. Results are reported as mean±SD.
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Figure A.2. Ejection fraction and microvascular obstruction declines during
myocardial infarction wound healing. Ejection fraction (EF) is displayed by (A) postMI time point (3-day, 1-week, 8-week) after a 90-, 180-min coronary occlusion. (B)
Microvascular obstruction size was determined by late gadolinium enhanced MRI
(n=25). Results are reported as mean±SD.
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Table A.1. Swine cardiac function and infarct data by occlusion time at 1-week postinfarction.
45 min
(n=3)

90 min (n=5)

180 min
(n=5)

Per (n=4)

P*

79.9±7.6

84.8±10.3

95.3±29.9

86.9±17.4

0.87

EDV (mL)

105.4±12.5

107.0±22.3

104.5±17.2

114.4±20.9

0.64

ESV (mL)

57.8±4.0

58.8±16.8

53.2±10.5

60.9±19.0

0.73

EF (%)

45.0±2.7

45.7±4.6

47.6±17.3

47.4±10.7

0.85

CO (mL/min)

5.0±0.1

5.5±0.6

5.6±2.6

6.0±1.0

0.73

Function (Cine MRI)
LV mass (g)

Infarct (LGE MRI) ‡
Infarct size (g)

0.1±0.1

9.1±8.1

17.3±6.0

15.2±10.0

0.05

Transmurality
(%)

5.1±7.1

54.3±12.1

72.6±8.6

79.4±15.1

0.02

MVO (g)

0.0±0.0

1.2±1.3

3.2±1.9

2.1±1.8

0.05

Magnetic susceptibility (QSM) §
Iso Δχ(SI)

0.007±0.024 -0.003±0.031

0.009±0.006 0.004±0.017 0.9

Hypo Δχ(SI) #

NA

0.093±0.038

0.095±0.03

NA

Hyper Δχ(SI)

0.03±0.049

0.021±0.015

0.01±0.009

0.038±0.013 0.58

P†

0.51

<0.001

0.004

0.02

0.96

Relaxation time mapping (T2*)
Iso T2* [msec]

46.0±2.2

47.5±4.3

46.4±0.6

45.1±2.6

0.72

Hypo T2*
[msec] €

NA

14.0±2.9

14.1±2.8

NA

0.96

Hyper T2*
[msec]

54.3±17.4

55.2±13.8

68.7±3.63

53.3±12.7

0.36

P†

0.46

<0.001

<0.001

0.07

Iron (ICP-OES) ‖
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Remote
myocardium
[Fe]

0.038±0.006 0.0354±0.003 0.038±0.008 0.063±0.037 <0.001**

Infarcted
myocardium
[Fe]

0.075±0.041 0.108±0.068

0.184±0.066 0.119±0.145 <0.001

P†

NS

<0.001

<0.001

<0.001

*Kruskal-Wallis test by occlusion time (45-, 90-, 180-min and permanent infarction) and
by †location (infarct/remote or iso/hyper/hypo). Results are reported as mean±SD. Source
data are provided as a Source Data file.
‡One animal in the 90-min coronary occlusion group did not undergo LGE MRI.
§Two animals in the 180-min coronary occlusion group did not undergo explant MRI due
to unavailability of the MRI scanner.
‖Two animals in the 90-min coronary occlusion group did not have ICP-OES analysis due
to unavailability of the equipment.
#Hypointense regions were not observed in 45-min or permanent infarcts.
**Excluding the permanent infarction group the single-factor ANOVA results in P-value
= 0.15.
LV = left ventricle, EDV = end diastolic volume, ESV = end systolic volume, EF =
ejection fraction, CO = cardiac output, MVO = microvascular obstruction, Per =
permanent ligation.
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Table A.2. Swine cardiac function and infarct data by post-infarction time point.
baseline
(n=5)

1 week
(n=15)

8 week
(n=8)

*

LV mass (g)

82.9±18.7

85.4±14.2

128.7±15.7

<0.01

EDV (mL)

57.8±7.5

101.7±16.0

138.6±13.0

<0.01

ESV (mL)

25.5±9.1

62.4±13.2

97.0±14.3

<0.01

EF (%)

56.7±10.5

38.1±12.9

30.3±5.6

0.01

CO (L/min)

4.3±0.7

4.3±1.8

3.9±0.6

0.73

LVRI (L/min)

1.5±0.4

0.8±0.1

0.9±0.1

<0.01

50.2±9.3

34.7±15.4

42.5±15.1

0.18

Infarct

9.9±13.9

15.4±17.3

0.64

†

0.00

0.01

7.6±1.0

9.8±1.5

0.04

Infarct

7.5±1.1

6.6±0.9

0.01

†

0.95

<0.01

10.1±1.0

13.6±1.7

<0.01

Infarct

7.8±1.6

7.5±1.2

0.04

†

<0.01

<0.01

4.5±1.6

5.3±1.1

0.34

Infarct

2.3±1.3

2.5±1.0

0.72

†

<0.01

<0.01

P

Function (Cine MRI)

Wall thickening (%)
Remote

P

ED wall thickness (mm)
Remote

8.9±1.8

P

ES wall thickness (mm)
Remote

13.2±3.1

P

Wall motion (mm)
Remote

P

5.4±1.4

Infarct (LGE MRI)
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Infarct size (g)

19.3±12.5

27.4±5.4

0.19

Transmurality (%)

61.6±12.1

52.9±3.1

0.11

MVO (g)

2.0±1.7

0.3±0.3

<0.01

myo (ppm)

-0.01±0.02

-0.01±0.04

0.13

‡

inf (ppm)

0.06±0.05

-0.01±0.04

0.01

†

P

0.01

1.00

Remote myocardium [Fe]

0.04±0.01

0.04±0.01

1

Infarcted myocardium [Fe]

0.15±0.08

0.06±0.04

<0.001

†

<0.001

0.99

Magnetic susceptibility (Δχ)

Iron (ICP-OES) ‖

P

*Indicates results of significance testing at p=0.05 level of significance using a KruskalWallis test by post-infarction MRI time point and by †location (infarct/remote or
iso/hyper/hypo).
‡Indicates region of elevated magnetic susceptibility inside the area of enhancing signal
on late gadolinium enhanced MRI.
‖Seven animals in the 1-week time point group did not have ICP-OES analysis due to a
subset of the animals being in a serial study and six animals in the 8-week time point
group did not have ICP-OES due to unavailability of the equipment.
Results are reported as mean±SD.
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Table A.3. Clinical and angiographic characteristics for all patients by presence of
hemorrhagic infarctionª (n=7).
All Patients
(n=7)

No myocardial
hemorrhage (T2*
core negative, n=3)

Myocardial
hemorrhage (T2*
core positive, n=4)

Age, y

61 [55,67]

61.7 [55.0, 69.0]

60.5 [55.5, 63.5]

Male sex, n (%)

6

2 (66)

4 (100)

BMI, kg/m2

27.4
[25.3, 27.9]

28.3 [25.2, 30.1]

26.8 [22.8, 27.6]

Hypertension, n (%)

5

2 (67)

3 (75)

Current smoker, n (%)

2

1 (33)

1 (25)

Hypercholesterolemia, n
(%)

4

3 (100)

1 (25)

Diabetes mellitus†, n (%)

2

1 (33)

1 (25)

Previous angina, n (%)

2

2 (66)

0 (0)

Previous myocardial
infarction, n (%)

1

1 (33)

0 (0)

Previous PCI, n (%)

0

0 (0)

0 (0)

Heart rate, bpm

78.7
[70.0, 86.0]

84 [74, 96]

74.8 [70.0, 77.2]

Systolic bp, mmHg

129.7
[121.5, 136.5]

135.7
[126.0, 143.5]

125.2
[118.5, 134.8]

Diastolic bp, mmHg

79.1
[73.5, 81.5]

80.7 [71.0, 87.0]

78.0 [75.3, 80.8]

Time from symptom
onset to reperfusion,
minb

527.6
[186.5, 370.0]

303.7
[267.0, 369.0]

695.5
[164.8, 812.2]

Clinical

History

Presenting characteristics
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Ventricular fibrillation‡,
n (%)

1

0 (0)

1 (25)

0

5

2

3

I/II

1

1

0

III/IV

1

0

1

NYHA heart failure class

Number of diseased arteries§, n (%)
1

5

3 (100)

2 (50)

2

1

0 (0)

1 (25)

3

1

0 (0)

1 (25)

TIMI coronary flow grade before PCI, n (%)
0/1

3

0

3

2/3

4

3

1

TIMI coronary flow grade after PCI, n (%)
0/1

0

0

0

2

0

0

0

3

7

3

4

ACEI or ARB

3

2 (67)

1 (25)

Beta blocker

3

1 (33)

2 (50)

1st Troponin -T

2.44
[0.06, 1.86]

0.30 [0.08, 0.41]

4.0 [0.04 5.6]

LV mass, g

164.0
[140.5, 186.5]

146.7
[118.5, 169.5]

177.0
[158.5, 185.0]

EDV, mL

160.6
[144.5, 181.0]

135.3
[111.0, 168.0]

179.5
[167.8, 189.8]

EDVI, mL/m2

79.3
[74.5, 91.5]

69.3 [58.0, 81.5]

86.8 [82.5, 91.8]

Medical Therapy

MRI
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b

EF, %

51.7
[44.5, 55.0]

49.7 [48.0, 53.0]

53.3 [45.0, 59.8]

SV, mL

71.4
[57.5, 87.0]

66.0 [51.0, 87.5]

75.5 [71.0, 83.5]

Infarct size, g

39.9
[21.7, 57.7]

31.9 [14.0, 43.9]

45.9 [38.6, 52.8]

Transmurality, %

20.6 [3.4, 25.3] 48.8 [46.7, 51.6]

75.7 [65.9, 94.3]

MVO, g

6.0 [1.3, 9.5]

2.2 [0.3, 3.4]

8.9 [6.4, 12.0]

Magnetic susc. (rem.
myocardium), ppm

-0.01
[-0.05, -0.2]

0.04 [0.02, 0.06]

-0.04 [-0.06,-0.03]

Magnetic susc. (hem.
myocardium), ppm

0.16
[0.11, 0.23]

NA

0.16 [0.11 0.23]

Time-to-reperfusion self-reported by patient in the emergency room.

ªHemorrhage was visually defined as a hypointense area >1 g tissue in T2*-weighted
image corresponding to the region of myocardial infarction as assessed by late
gadolinium enhanced MRI.
†Diabetes mellitus was defined as a history of diet-controlled or treated diabetes.
‡Successfully electrically converted ventricular fibrillation at presentation or during
emergency PCI procedure.
§Multivessel coronary artery disease was defined according to the number of stenoses of
at least 50% of the reference vessel diameter, by visual assessment and whether or not
there was left main involvement.
LV = left ventricle, EDV = end diastolic volume, EDVI = end diastolic volume index, EF
= ejection fraction, SV = stroke volume, MVO = microvascular obstruction.
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Table A.4. Cardiac function and infarct data for all patients (n=7).
Subject
ID

LV
mass, g

EDV,
mL

EDVI,
mL/m2

EF,
%

SV,
mL

Infarct
size, g (%)

transmurality
(%)

1

145

137

78

57

78

23.5 (14.6)

36.0

2

170

178

84.0

46

80

43.6 (32.2)

75.9

3

136

184

92

53

96

19.9 (12.9)

43.4

4

203

152

71

43

65

67.9 (42.6)

53.2

5

101

70

45

53

37

8.0 (10.1)

50.0

6

230

225

94

42

94

68.8 (38.9)

93.0

7

163

178

91

68

50

47.5 (44.5)

98.0

Subject
ID

Hemorrhage
(yes/no)

Remote myocardium
magnetic susceptibility
(ppm)

Hemorrhagic myocardium
magnetic susceptibility
(ppm)

1

Yes

0.006±0.2

0.14±0.23

2

Yes

-0.08±0.4

0.22±0.6

3

No

0.01±0.9

NA

4

No

0.02±0.5

NA

5

No

0.09±0.4

NA

6

Yes

-0.05±0.3

0.03±0.2

7

Yes

-0.04±0.3

0.24±0.4

LV = left ventricle, EDV = end diastolic volume, EDVI = end diastolic volume index, EF
= ejection fraction, CO = cardiac output, MVO = microvascular obstruction. Hemorrhage
was visually defined as a hypointense area >1 g tissue in T2*-weighted image
corresponding to the region of myocardial infarction as assessed by late gadolinium
enhanced MRI. Magnetic susceptibility results are reported as mean±SD.
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Table A.5. Swine cardiac function and infarct data by post-infarction time point
including 3-day.

Control
(n=5)

3-day
(n=9)

1-week
(n=21)

8-week
(n=11)

P-value

LV mass [g]

82.9±18.7

121.2±17.5

93.3±20.5

127.1±17.1

<0.001

EF [%]

56.7±10.5

41.02±7.83

39.0±11.1

33.1±8.35

0.001

EDV [mL]

57.8±7.45

129.2±26.6

108.9±23.7

135.2±13.5

<0.001

ESV [mL]

25.5±9.07

75.5±16.3

65.9±16.3

91.2±18.0

<0.001

SV [mL]

32.3±4.15

53.6±17.6

43.0±15.8

44.0±7.7

0.06

CO [L/min]

4.26±0.75

4.69±1.49

4.33±1.6

4.12±0.85

0.83

LVRI

1.45±0.41

0.96±0.13

0.86±0.11

0.94±0.11

<0.001

Infarct size
[g]

32.7±5.44

21.6±10.0

25.7±5.3

0.007

Infarct size
[%]

29.1±4.04

24.2±10.4

23.4±5.18

0.26

Transmurality
[%]

52.3±7.65

59.2±11.8

52.6±2.66

0.094

MVO [g]

5.48±4.83

1.82±1.49

0.46±0.43

<0.001

MVO [%]

4.57±3.49

2.12±1.81

0.41±0.36

0.001
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Figure B.1. Ex vivo MRI data from all animal models. Short axis cardiac images are
displayed by time-to-reperfusion (45-, 90-, 180-min, permanent occlusion) and postinfarction time point (3-day, 1-week, 8-week). Late gadolinium enhanced (LGE) MRI
(column 1), T2*-weighted images (TE=16.1 msec) (column 2), T2*-maps (column 3),
quantitative magnetic susceptibility maps (column 4).
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Figure B.2. Basal to apical consecutive ex vivo quantitative susceptibility maps.
Representative quantitative susceptibility maps from 90-min occlusion and reperfusion
(first row) and permanent occlusion (second row) animal models at 1-week postinfarction.
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Figure B.3. Classification of infarct versus remote myocardium. The predictor
variables were (A) tissue magnetic susceptibility (Δχ), (B) transverse relaxation time
(T2*) and (C) transverse relaxation rate (R2*) measurements that had a binary response
variable as infarct (n=22) equal to 1 and remote myocardium (n=22) equal to 0 and were
fit to a logistic regression model. Δχ provided the receiver operating characteristic (ROC)
curve with an area under the curve (AUC) = 0.92, Youden’s index = 0.77 and at the
optimal operating point (red circle) sensitivity = 0.91 and specificity = 0.86. T2* and
R2* ROC analysis provided an AUC= 0.71, Youden’s index = 0.56 and at the optimal
operating point sensitivity = 0.65 and specificity = 0.90. Δχ showed superior balance
between sensitivity and specificity at classifying infarct versus remote viable
myocardium compared to T2* and R2*.
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Figure B.4. In vivo MRI data from 90-, 180-min reperfused animal models. Short
axis cardiac images are displayed by time-to-reperfusion (90-, 180-min occlusion) and
post-infarction time point (3-day, 1-week, 8-week) and a subset of corresponding ex vivo
MRI. In vivo: late gadolinium enhanced (LGE) MRI (column 1), T2*-weighted images
(column 2, TE=10 msec), quantitative magnetic susceptibility maps (column 3), ex vivo:
T2*-weighted images (column 4, TE=16.1 msec), quantitative magnetic susceptibility
maps (column 5). Each row shows the MRI from a single animal.
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Figure B.5. Magnetic resonance imaging from all STEMI patients (n=7). Late
gadolinium enhanced MRI (first row), T2*-weighted MRI (second row), quantitative
susceptibility maps (QSM) (third row). * Patients are represented in Figure 6.
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Figure B.6. Reproducibility of magnetic susceptibility in STEMI patients. BlandAltman and intra-class correlation coefficient show no significant bias and good
correlation between two raters. Remote and infarct myocardium magnetic susceptibility
was measured in seven STEMI patients. Source data are provided as a Source Data file.
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Figure C.1. Microscopy images from each animal model group. Representative
histology from each animal model group is displayed by time-to-reperfusion (45-, 90-,
180-min, permanent occlusion) and post-infarction time point (3-day, 1-week, 8-week)
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(n=7). Hematoxylin and eosin stain (column 1), Masson’s trichrome stain (column 2),
Prussian blue stain (column 3).
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Figure C.2. Hemoglobin beta immunohistochemistry from each animal model
group. Representative Hemoglobin beta (HBB) immunohistochemistry (IHC) HBB IHC
from each animal model group is displayed by time-to-reperfusion (45-, 90-, 180-min,
permanent occlusion) and post-infarction time point (3-day, 1-week, 8-week) in select
animals (n=7). (A) 45-min 1-week infarct has darker staining in the infarct area without
obvious concentration areas of positive HBB staining. (B) 90-min 1-week and (C) 180min 1-week infarcts have concentration areas of positive HBB staining. The darker
staining may reflect uptake and extracellular hemoglobin from past hemorrhage.
Additionally, there are areas that show granular accumulation of hemoglobin
corresponding to red blood cells. (D) Similar dark staining in the permanent infarct, with
less concentrated areas of positive HBB staining. (E) 90-min 3-day infarct has positive
HBB staining with granular accumulation of hemoglobin. The area of positive HBB
declined by 8-week post-infarction as shown in (F) 90-min 8-week infarct, indicating a
clearance of hemoglobin during wound healing. (G) Remote myocardium does not have
positive HBB staining.
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Figure C.3. Ex vivo Iron Measurements. (A), Colorimetric measurement of total iron
content revealed the same trend as the ICP-OES measurements (myo, n=13, infarct,
n=22), where there was a significant increase in iron content within the infarct region
(P<0.0001). Colorimetric measurement of Fe2+ iron showed the same trend as total iron
(P=0.006) and suggested most of the iron in the tissue is Fe2+ iron. Tissue regions were
compared using a two-tail student’s two-sample t-test for both the total and Fe2+ iron
measurements. Results are reported as mean±SD significance is indicated by *P<0.05
and **P<0.001 by t-test infarct vs. corresponding remote area. (B), Representative
spectra of 180-min group infarct and remote area (myo) tissue specimens by electron
paramagnetic resonance reflecting the tissue content of labile iron in Figure 2 A.
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Figure C.4. Magnetic susceptibility, microvascular obstruction and iron. (A)
microvascular obstruction (MVO), percentage of LGE infarct hypointense region with
respect to LV volume, versus in vivo infarct magnetic susceptibility (slope=24.2% LV
myo increase per 1 ppm increase in tissue magnetic susceptibility, R2=0.31, P=0.048).
(B) Infarct (45-, 90-, 180-min, permanent) and remote myocardium total iron
concentration versus corresponding ex vivo tissue magnetic susceptibility (slope = 1.00
mg/g of total iron per 1 ppm increase in tissue magnetic susceptibility, R2=0.20,
P=0.009). (C) Infarct (90-, 180-min) and remote myocardium total iron concentration
versus corresponding ex vivo tissue magnetic susceptibility (slope = 1.30 mg/g of total
iron per 1 ppm increase in tissue magnetic susceptibility, R2=0.48, P=0.0007). (D) Infarct
(45-, 90-, 180-min, permanent) and remote myocardium total iron concentration versus
corresponding ex vivo transverse relaxation rate (R2*) (slope = 1.67 mg/g of total iron
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per 1 msec-1 increase in R2*, R2=0.19, P=0.011). (E) Infarct (90-, 180-min) and remote
myocardium total iron concentration vs corresponding ex vivo tissue R2* (slope = 2.29
mg/g of total iron per 1 msec-1 increase in R2*, R2=0.58, P<0.0001). Linear regressions
were performed to determine if there was a significant correlation based on the linear
regression coefficient. All post-infarction time points (3-day, 1-week, and 8-week) were
included in the data. Each point in the regressions represent the measurements from a
single animal and total iron concentration was measured by ICP-OES.
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Figure D.1. T2*w, T2* maps, R2* maps, and QSM in reperfused and nonreperfused infarcts at 3 T and 7 T. (a) At 3 T with 0.72 mm3 voxel size, reperfused
infarcts show distinct T2*w and T2* map hypointense regions. At 7 T with 0.03 mm3
voxel size, all infarcts show distinct changes in contrast within T2*w images, T2* maps,
and R2* maps that correspond to a paramagnetic shift in QSM. (b) Non-reperfused
infarct showed less conspicuous infarct regions on R2* maps at 3 T. At 7 T R2* and
magnetic susceptibility was elevated in all infarct groups. T2*w images at 7 T and 3 T
are at echo time (TE) 6.2 and 16.1 ms, respectively. T2*w intensity VOI: isointenseviable myocardium (iso, blue), hypointense-infarct (hypo, red) and hyperintense-infarct
(hyper, yellow). The same cardiac specimen was imaged at 3 T and 7 T.

Figure D.2. T2*w signal versus TE. (a) At 7 T, T2*w signal was measured in
hypointense infarct ROI in a single slice of a representative cardiac specimen at 5 TEs.
The signal approaches zero by the third echo (TE = 0.0096 sec). To mitigate and correct
for Rician noise bias, (b) the exponential regression was truncated to 3 TEs. (c) At 3 T,
T2*w signal was measured in hypointense infarct ROI in a single slice of the same
169

cardiac specimen at 5 TEs, where signal remains high across all TEs. (d) R2* maps from
a single cardiac specimen acquired at 3 T and 7 T at varying amount of echo times and
corresponding chi-square error maps. R2* maps were used for exponential regression
analysis in (a-c). At 7 T, R2* error increases when longer TEs (TE = 0.013, 0.0165 sec)
are included in the linear fit, whereas 3 T R2* map has minimal error when using all 5
TEs. All data was extracted from images acquired at 0.75 mm isotropic resolution.

Figure D.3. Relative enhancement scales with field strength. Correlation of R2* at 7 T
versus 3 T, where R2*0 was measured in remote myocardium and slope is relaxivity
enhancement (RE). T2*w intensity VOI: hypointense-infarct (red), hyperintense-infarct
(yellow). All data was extracted from R2* maps with 0.75 mm isotropic resolution. Each
point on the graph represents a VOI measurement from a 90-min reperfused infarct at 1week post-infarction whole heart specimen. The linear effect (beta) was significant if
P<0.05.
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Figure D.4. Linear regressions of tissue magnetic susceptibility (Δχ), R2* and voxel
size in 90-min reperfused infarcts at 1-week post-infarction. (a) At 7 T, hypo VOI
R2* increased as voxel size increased. (b) Measurements from 7 T (circles) and 3 T
(triangles) show a decline in Δχ as voxel size increased. From 7 T and 3 T VOI
measurements at 0.42 mm3 voxel size, there was a significant difference in R2* at 7 T vs
3 T that was not seen with Δχ (Supplementary Fig. 3b,c). T2*w intensity VOI: isointenseviable myocardium (blue), hypointense-infarct (red), hyperintense-infarct (yellow). All
data was extracted from R2* maps and QSM with 0.75 mm isotropic resolution. Each
point represents a mean±SD of 5 to 9 VOI measurements. The linear effect (beta) was
significant if P<0.05.
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List of abbreviations and acronyms
________________________________________________________________________

MRI

magnetic resonance imaging

LGE

Late Gadolinium Enhancement MRI

T2*w

T2* relaxation time weighted MRI

Iso

Isointense T2*w contrast region of viable myocardium

Hypo

hypointense T2*w contrast region of infarct

Hyper

hyperintense T2*w contrast region of infarct

TE

Echo time

CMR

cardiac magnetic resonance

QSM

Quantitative Susceptibility Mapping

Δχ

magnetic susceptibility difference from water

ppm

Parts-per-million ppm of the main magnetic field, SI units

ICP-OES

Inductively coupled plasma optical emission spectrometry

MI

myocardial infarction

STEMI

ST-elevation myocardial infarction

PCI

Primary percutaneous coronary intervention
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ECG

Electrocardiogram

LV

Left ventricle

EDV

End diastolic volume

ESV

End systolic volume

EDVI

End diastolic volume index

EF

Ejection fraction

CO

Cardiac output

MVO

Microvascular obstruction

TIMI

Thrombolysis in Myocardial Infarction study grading scale

IQR

Interquartile range
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